id	sid	tid	token	lemma	pos
dpc-1867	1	1	dermatology	dermatology	NOUN
dpc-1867	1	2	:	:	PUNCT
dpc-1867	1	3	practical	practical	ADJ
dpc-1867	1	4	and	and	CCONJ
dpc-1867	1	5	conceptual	conceptual	ADJ
dpc-1867	1	6	dermatology	dermatology	NOUN
dpc-1867	1	7	practical	practical	ADJ
dpc-1867	1	8	&	&	CCONJ
dpc-1867	1	9	conceptual	conceptual	ADJ
dpc-1867	1	10	review	review	NOUN
dpc-1867	1	11	|	|	ADV
dpc-1867	1	12	dermatol	dermatol	ADJ
dpc-1867	1	13	pract	pract	NOUN
dpc-1867	1	14	concept	concept	NOUN
dpc-1867	1	15	.	.	PUNCT
dpc-1867	2	1	2022;12(1	2022;12(1	NUM
dpc-1867	2	2	):	):	PUNCT
dpc-1867	2	3	e2022037	e2022037	NOUN
dpc-1867	2	4	1	1	NUM
dpc-1867	2	5	pemphigus	pemphigus	NOUN
dpc-1867	2	6	vulgaris	vulgaris	NOUN
dpc-1867	2	7	:	:	PUNCT
dpc-1867	2	8	present	present	ADJ
dpc-1867	2	9	and	and	CCONJ
dpc-1867	2	10	future	future	ADJ
dpc-1867	2	11	therapeutic	therapeutic	ADJ
dpc-1867	2	12	strategies	strategy	NOUN
dpc-1867	2	13	dario	dario	PROPN
dpc-1867	2	14	didona1	didona1	PROPN
dpc-1867	2	15	,	,	PUNCT
dpc-1867	2	16	giovanni	giovanni	PROPN
dpc-1867	2	17	paolino2	paolino2	PROPN
dpc-1867	2	18	,	,	PUNCT
dpc-1867	2	19	giovanni	giovanni	PROPN
dpc-1867	2	20	di	di	PROPN
dpc-1867	2	21	zenzo3	zenzo3	PROPN
dpc-1867	2	22	,	,	PUNCT
dpc-1867	2	23	biagio	biagio	PROPN
dpc-1867	2	24	didona3	didona3	PROPN
dpc-1867	2	25	,	,	PUNCT
dpc-1867	2	26	riccardo	riccardo	PROPN
dpc-1867	2	27	pampena4	pampena4	PROPN
dpc-1867	2	28	,	,	PUNCT
dpc-1867	2	29	matteo	matteo	PROPN
dpc-1867	2	30	riccardo	riccardo	PROPN
dpc-1867	2	31	di	di	PROPN
dpc-1867	2	32	nicola2	nicola2	PROPN
dpc-1867	2	33	,	,	PUNCT
dpc-1867	2	34	santo	santo	PROPN
dpc-1867	2	35	raffaele	raffaele	PROPN
dpc-1867	2	36	mercuri2	mercuri2	PROPN
dpc-1867	2	37	1	1	NUM
dpc-1867	2	38	department	department	PROPN
dpc-1867	2	39	of	of	ADP
dpc-1867	2	40	dermatology	dermatology	NOUN
dpc-1867	2	41	and	and	CCONJ
dpc-1867	2	42	allergology	allergology	NOUN
dpc-1867	2	43	,	,	PUNCT
dpc-1867	2	44	philipps	philipps	PROPN
dpc-1867	2	45	university	university	PROPN
dpc-1867	2	46	,	,	PUNCT
dpc-1867	2	47	marburg	marburg	PROPN
dpc-1867	2	48	,	,	PUNCT
dpc-1867	2	49	germany	germany	PROPN
dpc-1867	2	50	2	2	NUM
dpc-1867	2	51	unit	unit	NOUN
dpc-1867	2	52	of	of	ADP
dpc-1867	2	53	dermatology	dermatology	NOUN
dpc-1867	2	54	,	,	PUNCT
dpc-1867	2	55	irccs	ircc	VERB
dpc-1867	2	56	san	san	PROPN
dpc-1867	2	57	raffaele	raffaele	PROPN
dpc-1867	2	58	hospital	hospital	PROPN
dpc-1867	2	59	,	,	PUNCT
dpc-1867	2	60	milan	milan	PROPN
dpc-1867	2	61	,	,	PUNCT
dpc-1867	2	62	italy	italy	PROPN
dpc-1867	2	63	3	3	NUM
dpc-1867	2	64	idi	idi	PROPN
dpc-1867	2	65	-	-	PUNCT
dpc-1867	2	66	irccs	irccs	PROPN
dpc-1867	2	67	,	,	PUNCT
dpc-1867	2	68	rome	rome	PROPN
dpc-1867	2	69	,	,	PUNCT
dpc-1867	2	70	italy	italy	PROPN
dpc-1867	2	71	4	4	NUM
dpc-1867	2	72	centro	centro	X
dpc-1867	2	73	oncologico	oncologico	NOUN
dpc-1867	2	74	ad	ad	PROPN
dpc-1867	2	75	alta	alta	PROPN
dpc-1867	2	76	tecnologia	tecnologia	PROPN
dpc-1867	2	77	diagnostica	diagnostica	PROPN
dpc-1867	2	78	-	-	PUNCT
dpc-1867	2	79	dermatologica	dermatologica	PROPN
dpc-1867	2	80	,	,	PUNCT
dpc-1867	2	81	azienda	azienda	PROPN
dpc-1867	2	82	unità	unità	PROPN
dpc-1867	2	83	sanitaria	sanitaria	PROPN
dpc-1867	2	84	locale	locale	PROPN
dpc-1867	2	85	-	-	PUNCT
dpc-1867	2	86	irccs	irccs	NOUN
dpc-1867	2	87	di	di	PROPN
dpc-1867	2	88	reggio	reggio	PROPN
dpc-1867	2	89	emilia	emilia	PROPN
dpc-1867	2	90	,	,	PUNCT
dpc-1867	2	91	italy	italy	PROPN
dpc-1867	2	92	key	key	ADJ
dpc-1867	2	93	words	word	NOUN
dpc-1867	2	94	:	:	PUNCT
dpc-1867	2	95	anti	anti	ADJ
dpc-1867	2	96	-	-	ADJ
dpc-1867	2	97	cd20	cd20	PROPN
dpc-1867	2	98	antibodies	antibodie	VERB
dpc-1867	2	99	,	,	PUNCT
dpc-1867	2	100	neonatal	neonatal	ADJ
dpc-1867	2	101	fc	fc	PROPN
dpc-1867	2	102	receptor	receptor	NOUN
dpc-1867	2	103	(	(	PUNCT
dpc-1867	2	104	fcrn	fcrn	PROPN
dpc-1867	2	105	)	)	PUNCT
dpc-1867	2	106	,	,	PUNCT
dpc-1867	2	107	pemphigus	pemphigus	PROPN
dpc-1867	2	108	,	,	PUNCT
dpc-1867	2	109	rituximab	rituximab	NOUN
dpc-1867	2	110	,	,	PUNCT
dpc-1867	2	111	treatment	treatment	NOUN
dpc-1867	2	112	citation	citation	NOUN
dpc-1867	2	113	:	:	PUNCT
dpc-1867	2	114	didona	didona	PROPN
dpc-1867	2	115	d	d	NOUN
dpc-1867	2	116	,	,	PUNCT
dpc-1867	2	117	paolino	paolino	PROPN
dpc-1867	2	118	g	g	PROPN
dpc-1867	2	119	,	,	PUNCT
dpc-1867	2	120	di	di	NOUN
dpc-1867	2	121	zenzo	zenzo	NOUN
dpc-1867	2	122	g	g	NOUN
dpc-1867	2	123	,	,	PUNCT
dpc-1867	2	124	didona	didona	PROPN
dpc-1867	2	125	b	b	NOUN
dpc-1867	2	126	,	,	PUNCT
dpc-1867	2	127	pampena	pampena	ADJ
dpc-1867	2	128	r	r	NOUN
dpc-1867	2	129	,	,	PUNCT
dpc-1867	2	130	di	di	PROPN
dpc-1867	2	131	nicola	nicola	PROPN
dpc-1867	2	132	mr	mr	PROPN
dpc-1867	2	133	,	,	PUNCT
dpc-1867	2	134	mercuri	mercuri	PROPN
dpc-1867	2	135	sr	sr	PROPN
dpc-1867	2	136	.	.	PUNCT
dpc-1867	3	1	pemphigus	pemphigus	PROPN
dpc-1867	3	2	vulgaris	vulgaris	PROPN
dpc-1867	3	3	:	:	PUNCT
dpc-1867	3	4	present	present	ADJ
dpc-1867	3	5	and	and	CCONJ
dpc-1867	3	6	future	future	ADJ
dpc-1867	3	7	therapeutic	therapeutic	ADJ
dpc-1867	3	8	strategies	strategy	NOUN
dpc-1867	3	9	.	.	PUNCT
dpc-1867	4	1	dermatol	dermatol	NOUN
dpc-1867	4	2	pract	pract	PROPN
dpc-1867	4	3	concept	concept	NOUN
dpc-1867	4	4	.	.	PUNCT
dpc-1867	5	1	2022;12(1	2022;12(1	NUM
dpc-1867	5	2	):	):	PUNCT
dpc-1867	5	3	e2022037	e2022037	NOUN
dpc-1867	5	4	.	.	PUNCT
dpc-1867	5	5	doi	doi	PROPN
dpc-1867	5	6	:	:	PUNCT
dpc-1867	5	7	https://doi.org/10.5826/dpc.1201a37	https://doi.org/10.5826/dpc.1201a37	NOUN
dpc-1867	5	8	accepted	accept	VERB
dpc-1867	5	9	:	:	PUNCT
dpc-1867	5	10	august	august	PROPN
dpc-1867	5	11	18	18	NUM
dpc-1867	5	12	,	,	PUNCT
dpc-1867	5	13	2021	2021	NUM
dpc-1867	5	14	;	;	PUNCT
dpc-1867	5	15	published	publish	VERB
dpc-1867	5	16	:	:	PUNCT
dpc-1867	5	17	january	january	PROPN
dpc-1867	5	18	2022	2022	NUM
dpc-1867	6	1	copyright	copyright	NOUN
dpc-1867	6	2	:	:	PUNCT
dpc-1867	6	3	©	©	PROPN
dpc-1867	6	4	2022	2022	NUM
dpc-1867	6	5	didona	didona	NOUN
dpc-1867	6	6	et	et	PROPN
dpc-1867	6	7	al	al	PROPN
dpc-1867	6	8	.	.	PUNCT
dpc-1867	7	1	this	this	PRON
dpc-1867	7	2	is	be	AUX
dpc-1867	7	3	an	an	DET
dpc-1867	7	4	open	open	ADJ
dpc-1867	7	5	-	-	PUNCT
dpc-1867	7	6	access	access	NOUN
dpc-1867	7	7	article	article	NOUN
dpc-1867	7	8	distributed	distribute	VERB
dpc-1867	7	9	under	under	ADP
dpc-1867	7	10	the	the	DET
dpc-1867	7	11	terms	term	NOUN
dpc-1867	7	12	of	of	ADP
dpc-1867	7	13	the	the	DET
dpc-1867	7	14	creative	creative	ADJ
dpc-1867	7	15	commons	common	NOUN
dpc-1867	7	16	attribution	attribution	NOUN
dpc-1867	7	17	-	-	PUNCT
dpc-1867	7	18	noncommercial	noncommercial	ADJ
dpc-1867	7	19	license	license	NOUN
dpc-1867	7	20	(	(	PUNCT
dpc-1867	7	21	by	by	ADP
dpc-1867	7	22	-	-	PUNCT
dpc-1867	7	23	nc-4.0	nc-4.0	NOUN
dpc-1867	7	24	)	)	PUNCT
dpc-1867	7	25	,	,	PUNCT
dpc-1867	7	26	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-1867	7	27	,	,	PUNCT
dpc-1867	7	28	which	which	PRON
dpc-1867	7	29	permits	permit	VERB
dpc-1867	7	30	unrestricted	unrestricted	ADJ
dpc-1867	7	31	noncommercial	noncommercial	ADJ
dpc-1867	7	32	use	use	NOUN
dpc-1867	7	33	,	,	PUNCT
dpc-1867	7	34	distribution	distribution	NOUN
dpc-1867	7	35	,	,	PUNCT
dpc-1867	7	36	and	and	CCONJ
dpc-1867	7	37	reproduction	reproduction	NOUN
dpc-1867	7	38	in	in	ADP
dpc-1867	7	39	any	any	DET
dpc-1867	7	40	medium	medium	NOUN
dpc-1867	7	41	,	,	PUNCT
dpc-1867	7	42	provided	provide	VERB
dpc-1867	7	43	the	the	DET
dpc-1867	7	44	original	original	ADJ
dpc-1867	7	45	authors	author	NOUN
dpc-1867	7	46	and	and	CCONJ
dpc-1867	7	47	source	source	NOUN
dpc-1867	7	48	are	be	AUX
dpc-1867	7	49	credited	credit	VERB
dpc-1867	7	50	.	.	PUNCT
dpc-1867	8	1	funding	funding	NOUN
dpc-1867	8	2	:	:	PUNCT
dpc-1867	8	3	none	none	NOUN
dpc-1867	8	4	.	.	PUNCT
dpc-1867	9	1	competing	compete	VERB
dpc-1867	9	2	interests	interest	NOUN
dpc-1867	9	3	:	:	PUNCT
dpc-1867	9	4	none	none	NOUN
dpc-1867	9	5	.	.	PUNCT
dpc-1867	10	1	authorship	authorship	NOUN
dpc-1867	10	2	:	:	PUNCT
dpc-1867	10	3	all	all	DET
dpc-1867	10	4	authors	author	NOUN
dpc-1867	10	5	have	have	AUX
dpc-1867	10	6	contributed	contribute	VERB
dpc-1867	10	7	significantly	significantly	ADV
dpc-1867	10	8	to	to	ADP
dpc-1867	10	9	this	this	DET
dpc-1867	10	10	publication	publication	NOUN
dpc-1867	10	11	.	.	PUNCT
dpc-1867	11	1	dd	dd	VERB
dpc-1867	11	2	and	and	CCONJ
dpc-1867	11	3	gp	gp	NOUN
dpc-1867	11	4	have	have	AUX
dpc-1867	11	5	equally	equally	ADV
dpc-1867	11	6	contributed	contribute	VERB
dpc-1867	11	7	to	to	ADP
dpc-1867	11	8	the	the	DET
dpc-1867	11	9	article	article	NOUN
dpc-1867	11	10	and	and	CCONJ
dpc-1867	11	11	share	share	VERB
dpc-1867	11	12	co	co	ADJ
dpc-1867	11	13	-	-	ADJ
dpc-1867	11	14	first	first	ADJ
dpc-1867	11	15	authorship	authorship	NOUN
dpc-1867	11	16	.	.	PUNCT
dpc-1867	12	1	corresponding	correspond	VERB
dpc-1867	12	2	author	author	NOUN
dpc-1867	12	3	:	:	PUNCT
dpc-1867	12	4	matteo	matteo	PROPN
dpc-1867	12	5	riccardo	riccardo	PROPN
dpc-1867	12	6	di	di	PROPN
dpc-1867	12	7	nicola	nicola	PROPN
dpc-1867	12	8	,	,	PUNCT
dpc-1867	12	9	unit	unit	NOUN
dpc-1867	12	10	of	of	ADP
dpc-1867	12	11	dermatology	dermatology	NOUN
dpc-1867	12	12	,	,	PUNCT
dpc-1867	12	13	irccs	ircc	VERB
dpc-1867	12	14	san	san	PROPN
dpc-1867	12	15	raffaele	raffaele	PROPN
dpc-1867	12	16	hospital	hospital	PROPN
dpc-1867	12	17	,	,	PUNCT
dpc-1867	12	18	milan	milan	PROPN
dpc-1867	12	19	,	,	PUNCT
dpc-1867	12	20	italy	italy	PROPN
dpc-1867	12	21	.	.	PUNCT
dpc-1867	13	1	e	e	X
dpc-1867	13	2	-	-	NOUN
dpc-1867	13	3	mail	mail	NOUN
dpc-1867	13	4	:	:	PUNCT
dpc-1867	13	5	dinicola.matteo@hsr.it	dinicola.matteo@hsr.it	DET
dpc-1867	13	6	pemphigus	pemphigus	NOUN
dpc-1867	13	7	vulgaris	vulgaris	NOUN
dpc-1867	13	8	(	(	PUNCT
dpc-1867	13	9	pv	pv	NOUN
dpc-1867	13	10	)	)	PUNCT
dpc-1867	13	11	belongs	belong	VERB
dpc-1867	13	12	to	to	ADP
dpc-1867	13	13	the	the	DET
dpc-1867	13	14	group	group	NOUN
dpc-1867	13	15	of	of	ADP
dpc-1867	13	16	autoimmune	autoimmune	ADJ
dpc-1867	13	17	blistering	blister	VERB
dpc-1867	13	18	diseases	disease	NOUN
dpc-1867	13	19	.	.	PUNCT
dpc-1867	14	1	pv	pv	INTJ
dpc-1867	14	2	can	can	AUX
dpc-1867	14	3	affect	affect	VERB
dpc-1867	14	4	not	not	PART
dpc-1867	14	5	only	only	ADV
dpc-1867	14	6	mucous	mucous	ADJ
dpc-1867	14	7	membranes	membrane	NOUN
dpc-1867	14	8	,	,	PUNCT
dpc-1867	14	9	but	but	CCONJ
dpc-1867	14	10	also	also	ADV
dpc-1867	14	11	the	the	DET
dpc-1867	14	12	skin	skin	NOUN
dpc-1867	14	13	and	and	CCONJ
dpc-1867	14	14	it	it	PRON
dpc-1867	14	15	is	be	AUX
dpc-1867	14	16	characterized	characterize	VERB
dpc-1867	14	17	by	by	ADP
dpc-1867	14	18	serum	serum	NOUN
dpc-1867	14	19	igg	igg	PROPN
dpc-1867	14	20	autoantibodies	autoantibody	NOUN
dpc-1867	14	21	against	against	ADP
dpc-1867	14	22	desmoglein	desmoglein	NOUN
dpc-1867	14	23	1	1	NUM
dpc-1867	14	24	and	and	CCONJ
dpc-1867	14	25	3	3	NUM
dpc-1867	14	26	,	,	PUNCT
dpc-1867	14	27	two	two	NUM
dpc-1867	14	28	major	major	ADJ
dpc-1867	14	29	components	component	NOUN
dpc-1867	14	30	of	of	ADP
dpc-1867	14	31	desmosomes	desmosome	NOUN
dpc-1867	14	32	.	.	PUNCT
dpc-1867	15	1	the	the	DET
dpc-1867	15	2	introduction	introduction	NOUN
dpc-1867	15	3	of	of	ADP
dpc-1867	15	4	glucocorticoids	glucocorticoid	NOUN
dpc-1867	15	5	improved	improve	VERB
dpc-1867	15	6	dramatically	dramatically	ADV
dpc-1867	15	7	the	the	DET
dpc-1867	15	8	prognosis	prognosis	NOUN
dpc-1867	15	9	of	of	ADP
dpc-1867	15	10	patients	patient	NOUN
dpc-1867	15	11	affected	affect	VERB
dpc-1867	15	12	by	by	ADP
dpc-1867	15	13	pv	pv	INTJ
dpc-1867	15	14	.	.	PUNCT
dpc-1867	16	1	however	however	ADV
dpc-1867	16	2	,	,	PUNCT
dpc-1867	16	3	long	long	ADJ
dpc-1867	16	4	-	-	PUNCT
dpc-1867	16	5	term	term	NOUN
dpc-1867	16	6	use	use	NOUN
dpc-1867	16	7	of	of	ADP
dpc-1867	16	8	high	high	ADJ
dpc-1867	16	9	dose	dose	NOUN
dpc-1867	16	10	corticosteroids	corticosteroid	NOUN
dpc-1867	16	11	and	and	CCONJ
dpc-1867	16	12	adjuvant	adjuvant	ADJ
dpc-1867	16	13	steroid	steroid	NOUN
dpc-1867	16	14	-	-	PUNCT
dpc-1867	16	15	sparing	spare	VERB
dpc-1867	16	16	immunosuppressants	immunosuppressant	NOUN
dpc-1867	16	17	can	can	AUX
dpc-1867	16	18	lead	lead	VERB
dpc-1867	16	19	to	to	ADP
dpc-1867	16	20	several	several	ADJ
dpc-1867	16	21	adverse	adverse	ADJ
dpc-1867	16	22	events	event	NOUN
dpc-1867	16	23	.	.	PUNCT
dpc-1867	17	1	rituximab	rituximab	NOUN
dpc-1867	17	2	,	,	PUNCT
dpc-1867	17	3	a	a	DET
dpc-1867	17	4	chimeric	chimeric	ADJ
dpc-1867	17	5	anti	anti	ADJ
dpc-1867	17	6	-	-	ADJ
dpc-1867	17	7	cd20	cd20	ADJ
dpc-1867	17	8	monoclonal	monoclonal	NOUN
dpc-1867	17	9	antibody	antibody	NOUN
dpc-1867	17	10	,	,	PUNCT
dpc-1867	17	11	has	have	AUX
dpc-1867	17	12	been	be	AUX
dpc-1867	17	13	recently	recently	ADV
dpc-1867	17	14	approved	approve	VERB
dpc-1867	17	15	as	as	ADP
dpc-1867	17	16	in	in	ADP
dpc-1867	17	17	-	-	PUNCT
dpc-1867	17	18	label	label	NOUN
dpc-1867	17	19	therapy	therapy	NOUN
dpc-1867	17	20	for	for	ADP
dpc-1867	17	21	pv	pv	NOUN
dpc-1867	17	22	,	,	PUNCT
dpc-1867	17	23	leading	lead	VERB
dpc-1867	17	24	to	to	ADP
dpc-1867	17	25	an	an	DET
dpc-1867	17	26	improvement	improvement	NOUN
dpc-1867	17	27	of	of	ADP
dpc-1867	17	28	the	the	DET
dpc-1867	17	29	prognosis	prognosis	NOUN
dpc-1867	17	30	and	and	CCONJ
dpc-1867	17	31	higher	high	ADJ
dpc-1867	17	32	remission	remission	NOUN
dpc-1867	17	33	rate	rate	NOUN
dpc-1867	17	34	.	.	PUNCT
dpc-1867	18	1	furthermore	furthermore	ADV
dpc-1867	18	2	,	,	PUNCT
dpc-1867	18	3	other	other	ADJ
dpc-1867	18	4	anti	anti	ADJ
dpc-1867	18	5	b	b	NOUN
dpc-1867	18	6	-	-	PUNCT
dpc-1867	18	7	cell	cell	NOUN
dpc-1867	18	8	therapies	therapy	NOUN
dpc-1867	18	9	and	and	CCONJ
dpc-1867	18	10	several	several	ADJ
dpc-1867	18	11	anti	anti	ADJ
dpc-1867	18	12	-	-	ADJ
dpc-1867	18	13	cd20	cd20	ADJ
dpc-1867	18	14	biosimilars	biosimilar	NOUN
dpc-1867	18	15	have	have	AUX
dpc-1867	18	16	been	be	AUX
dpc-1867	18	17	introduced	introduce	VERB
dpc-1867	18	18	in	in	ADP
dpc-1867	18	19	the	the	DET
dpc-1867	18	20	clinical	clinical	ADJ
dpc-1867	18	21	practice	practice	NOUN
dpc-1867	18	22	.	.	PUNCT
dpc-1867	19	1	we	we	PRON
dpc-1867	19	2	focused	focus	VERB
dpc-1867	19	3	on	on	ADP
dpc-1867	19	4	present	present	ADJ
dpc-1867	19	5	and	and	CCONJ
dpc-1867	19	6	future	future	ADJ
dpc-1867	19	7	therapeutic	therapeutic	ADJ
dpc-1867	19	8	approaches	approach	NOUN
dpc-1867	19	9	in	in	ADP
dpc-1867	19	10	pv	pv	NOUN
dpc-1867	19	11	.	.	PUNCT
dpc-1867	20	1	abstract	abstract	ADJ
dpc-1867	20	2	introduction	introduction	NOUN
dpc-1867	20	3	pemphigus	pemphigus	NOUN
dpc-1867	20	4	vulgaris	vulgaris	NOUN
dpc-1867	20	5	(	(	PUNCT
dpc-1867	20	6	pv	pv	NOUN
dpc-1867	20	7	)	)	PUNCT
dpc-1867	20	8	belongs	belong	VERB
dpc-1867	20	9	to	to	ADP
dpc-1867	20	10	autoimmune	autoimmune	ADJ
dpc-1867	20	11	blistering	blister	VERB
dpc-1867	20	12	diseases	disease	NOUN
dpc-1867	20	13	and	and	CCONJ
dpc-1867	20	14	it	it	PRON
dpc-1867	20	15	is	be	AUX
dpc-1867	20	16	characterized	characterize	VERB
dpc-1867	20	17	by	by	ADP
dpc-1867	20	18	flaccid	flaccid	ADJ
dpc-1867	20	19	blisters	blister	NOUN
dpc-1867	20	20	and	and	CCONJ
dpc-1867	20	21	erosions	erosion	NOUN
dpc-1867	20	22	,	,	PUNCT
dpc-1867	20	23	that	that	PRON
dpc-1867	20	24	can	can	AUX
dpc-1867	20	25	involve	involve	VERB
dpc-1867	20	26	not	not	PART
dpc-1867	20	27	only	only	ADV
dpc-1867	20	28	the	the	DET
dpc-1867	20	29	skin	skin	NOUN
dpc-1867	20	30	,	,	PUNCT
dpc-1867	20	31	but	but	CCONJ
dpc-1867	20	32	also	also	ADV
dpc-1867	20	33	mucous	mucous	ADJ
dpc-1867	20	34	membranes	membrane	NOUN
dpc-1867	20	35	[	[	X
dpc-1867	20	36	1	1	NUM
dpc-1867	20	37	]	]	PUNCT
dpc-1867	20	38	.	.	PUNCT
dpc-1867	21	1	three	three	NUM
dpc-1867	21	2	main	main	ADJ
dpc-1867	21	3	forms	form	NOUN
dpc-1867	21	4	of	of	ADP
dpc-1867	21	5	pemphigus	pemphigus	NOUN
dpc-1867	21	6	are	be	AUX
dpc-1867	21	7	described	describe	VERB
dpc-1867	21	8	:	:	PUNCT
dpc-1867	22	1	pv	pv	INTJ
dpc-1867	22	2	,	,	PUNCT
dpc-1867	22	3	pemphigus	pemphigus	PROPN
dpc-1867	22	4	foliaceus	foliaceus	NOUN
dpc-1867	22	5	(	(	PUNCT
dpc-1867	22	6	pf	pf	NOUN
dpc-1867	22	7	)	)	PUNCT
dpc-1867	22	8	,	,	PUNCT
dpc-1867	22	9	and	and	CCONJ
dpc-1867	22	10	paraneoplastic	paraneoplastic	ADJ
dpc-1867	22	11	pemphigus	pemphigus	NOUN
dpc-1867	23	1	[	[	X
dpc-1867	23	2	1–6	1–6	NUM
dpc-1867	23	3	]	]	X
dpc-1867	23	4	.	.	PUNCT
dpc-1867	24	1	2	2	NUM
dpc-1867	24	2	review	review	NOUN
dpc-1867	24	3	|	|	ADV
dpc-1867	24	4	dermatol	dermatol	ADJ
dpc-1867	24	5	pract	pract	NOUN
dpc-1867	24	6	concept	concept	NOUN
dpc-1867	24	7	.	.	PUNCT
dpc-1867	25	1	2022;12(1	2022;12(1	NUM
dpc-1867	25	2	):	):	PUNCT
dpc-1867	25	3	e2022037	e2022037	NOUN
dpc-1867	25	4	methods	method	NOUN
dpc-1867	25	5	we	we	PRON
dpc-1867	25	6	conducted	conduct	VERB
dpc-1867	25	7	a	a	DET
dpc-1867	25	8	review	review	NOUN
dpc-1867	25	9	to	to	PART
dpc-1867	25	10	identify	identify	VERB
dpc-1867	25	11	studies	study	NOUN
dpc-1867	25	12	that	that	PRON
dpc-1867	25	13	documented	document	VERB
dpc-1867	25	14	the	the	DET
dpc-1867	25	15	current	current	ADJ
dpc-1867	25	16	therapeutic	therapeutic	ADJ
dpc-1867	25	17	strategies	strategy	NOUN
dpc-1867	25	18	for	for	ADP
dpc-1867	25	19	pemphigus	pemphigus	NOUN
dpc-1867	25	20	vulgaris	vulgaris	NOUN
dpc-1867	25	21	,	,	PUNCT
dpc-1867	25	22	as	as	ADV
dpc-1867	25	23	well	well	ADV
dpc-1867	25	24	as	as	ADP
dpc-1867	25	25	the	the	DET
dpc-1867	25	26	future	future	ADJ
dpc-1867	25	27	ones	one	NOUN
dpc-1867	25	28	.	.	PUNCT
dpc-1867	26	1	all	all	DET
dpc-1867	26	2	type	type	NOUN
dpc-1867	26	3	of	of	ADP
dpc-1867	26	4	study	study	NOUN
dpc-1867	26	5	,	,	PUNCT
dpc-1867	26	6	in	in	ADP
dpc-1867	26	7	english	english	ADJ
dpc-1867	26	8	language	language	NOUN
dpc-1867	26	9	,	,	PUNCT
dpc-1867	26	10	was	be	AUX
dpc-1867	26	11	considered	consider	VERB
dpc-1867	26	12	eligible	eligible	ADJ
dpc-1867	26	13	for	for	ADP
dpc-1867	26	14	this	this	DET
dpc-1867	26	15	review	review	NOUN
dpc-1867	26	16	,	,	PUNCT
dpc-1867	26	17	including	include	VERB
dpc-1867	26	18	case	case	NOUN
dpc-1867	26	19	reports	report	NOUN
dpc-1867	26	20	and	and	CCONJ
dpc-1867	26	21	case	case	NOUN
dpc-1867	26	22	series	series	NOUN
dpc-1867	26	23	.	.	PUNCT
dpc-1867	27	1	the	the	DET
dpc-1867	27	2	main	main	ADJ
dpc-1867	27	3	search	search	NOUN
dpc-1867	27	4	was	be	AUX
dpc-1867	27	5	conducted	conduct	VERB
dpc-1867	27	6	in	in	ADP
dpc-1867	27	7	the	the	DET
dpc-1867	27	8	electronic	electronic	ADJ
dpc-1867	27	9	databases	database	NOUN
dpc-1867	27	10	of	of	ADP
dpc-1867	27	11	medline	medline	NOUN
dpc-1867	27	12	,	,	PUNCT
dpc-1867	27	13	embase	embase	NOUN
dpc-1867	27	14	and	and	CCONJ
dpc-1867	27	15	cochrane	cochrane	PROPN
dpc-1867	27	16	central	central	ADJ
dpc-1867	27	17	register	register	NOUN
dpc-1867	27	18	of	of	ADP
dpc-1867	27	19	controlled	control	VERB
dpc-1867	27	20	trials	trial	NOUN
dpc-1867	27	21	(	(	PUNCT
dpc-1867	27	22	central	central	ADJ
dpc-1867	27	23	)	)	PUNCT
dpc-1867	27	24	from	from	ADP
dpc-1867	27	25	inception	inception	NOUN
dpc-1867	27	26	to	to	ADP
dpc-1867	27	27	january	january	PROPN
dpc-1867	27	28	2021	2021	NUM
dpc-1867	27	29	using	use	VERB
dpc-1867	27	30	different	different	ADJ
dpc-1867	27	31	combinations	combination	NOUN
dpc-1867	27	32	of	of	ADP
dpc-1867	27	33	the	the	DET
dpc-1867	27	34	following	following	ADJ
dpc-1867	27	35	terms	term	NOUN
dpc-1867	27	36	:	:	PUNCT
dpc-1867	27	37	“	"	PUNCT
dpc-1867	27	38	pemphigus	pemphigus	NOUN
dpc-1867	27	39	”	"	PUNCT
dpc-1867	27	40	,	,	PUNCT
dpc-1867	27	41	“	"	PUNCT
dpc-1867	27	42	pemphigus	pemphigus	NOUN
dpc-1867	27	43	vulgaris	vulgaris	NOUN
dpc-1867	27	44	”	"	PUNCT
dpc-1867	27	45	,	,	PUNCT
dpc-1867	27	46	“	"	PUNCT
dpc-1867	27	47	treatment	treatment	NOUN
dpc-1867	27	48	”	"	PUNCT
dpc-1867	27	49	and	and	CCONJ
dpc-1867	27	50	“	"	PUNCT
dpc-1867	27	51	therapy	therapy	NOUN
dpc-1867	27	52	”	"	PUNCT
dpc-1867	27	53	.	.	PUNCT
dpc-1867	28	1	additionally	additionally	ADV
dpc-1867	28	2	,	,	PUNCT
dpc-1867	28	3	we	we	PRON
dpc-1867	28	4	concluded	conclude	VERB
dpc-1867	28	5	the	the	DET
dpc-1867	28	6	manual	manual	ADJ
dpc-1867	28	7	search	search	NOUN
dpc-1867	28	8	by	by	ADP
dpc-1867	28	9	reviewing	review	VERB
dpc-1867	28	10	all	all	DET
dpc-1867	28	11	relevant	relevant	ADJ
dpc-1867	28	12	citations	citation	NOUN
dpc-1867	28	13	within	within	ADP
dpc-1867	28	14	the	the	DET
dpc-1867	28	15	selected	select	VERB
dpc-1867	28	16	and	and	CCONJ
dpc-1867	28	17	identified	identify	VERB
dpc-1867	28	18	articles	article	NOUN
dpc-1867	28	19	.	.	PUNCT
dpc-1867	29	1	epidemiology	epidemiology	NOUN
dpc-1867	29	2	pv	pv	PROPN
dpc-1867	29	3	is	be	AUX
dpc-1867	29	4	the	the	DET
dpc-1867	29	5	most	most	ADV
dpc-1867	29	6	frequent	frequent	ADJ
dpc-1867	29	7	type	type	NOUN
dpc-1867	29	8	of	of	ADP
dpc-1867	29	9	pemphigus	pemphigus	NOUN
dpc-1867	29	10	[	[	X
dpc-1867	29	11	1	1	NUM
dpc-1867	29	12	]	]	PUNCT
dpc-1867	29	13	.	.	PUNCT
dpc-1867	30	1	it	it	PRON
dpc-1867	30	2	usually	usually	ADV
dpc-1867	30	3	affects	affect	VERB
dpc-1867	30	4	people	people	NOUN
dpc-1867	30	5	between	between	ADP
dpc-1867	30	6	50–60	50–60	NUM
dpc-1867	30	7	years	year	NOUN
dpc-1867	30	8	of	of	ADP
dpc-1867	30	9	age	age	NOUN
dpc-1867	30	10	[	[	X
dpc-1867	30	11	7	7	NUM
dpc-1867	30	12	]	]	PUNCT
dpc-1867	30	13	.	.	PUNCT
dpc-1867	31	1	a	a	DET
dpc-1867	31	2	female	female	NOUN
dpc-1867	31	3	to	to	ADP
dpc-1867	31	4	male	male	ADJ
dpc-1867	31	5	ratio	ratio	NOUN
dpc-1867	31	6	of	of	ADP
dpc-1867	31	7	5.0	5.0	NUM
dpc-1867	31	8	was	be	AUX
dpc-1867	31	9	reported	report	VERB
dpc-1867	31	10	in	in	ADP
dpc-1867	31	11	the	the	DET
dpc-1867	31	12	usa	usa	PROPN
dpc-1867	32	1	[	[	X
dpc-1867	32	2	7	7	NUM
dpc-1867	32	3	]	]	PUNCT
dpc-1867	32	4	.	.	PUNCT
dpc-1867	33	1	in	in	ADP
dpc-1867	33	2	the	the	DET
dpc-1867	33	3	american	american	PROPN
dpc-1867	33	4	general	general	ADJ
dpc-1867	33	5	population	population	NOUN
dpc-1867	33	6	,	,	PUNCT
dpc-1867	33	7	an	an	DET
dpc-1867	33	8	annual	annual	ADJ
dpc-1867	33	9	incidence	incidence	NOUN
dpc-1867	33	10	of	of	ADP
dpc-1867	33	11	4.2/	4.2/	NUM
dpc-1867	33	12	1,000,000	1,000,000	NUM
dpc-1867	33	13	inhabitants	inhabitant	NOUN
dpc-1867	33	14	was	be	AUX
dpc-1867	33	15	reported	report	VERB
dpc-1867	33	16	,	,	PUNCT
dpc-1867	33	17	but	but	CCONJ
dpc-1867	33	18	it	it	PRON
dpc-1867	33	19	was	be	AUX
dpc-1867	33	20	much	much	ADV
dpc-1867	33	21	higher	high	ADJ
dpc-1867	33	22	in	in	ADP
dpc-1867	33	23	the	the	DET
dpc-1867	33	24	jewish	jewish	ADJ
dpc-1867	33	25	-	-	PUNCT
dpc-1867	33	26	american	american	ADJ
dpc-1867	33	27	population	population	NOUN
dpc-1867	34	1	[	[	X
dpc-1867	34	2	7	7	NUM
dpc-1867	34	3	]	]	PUNCT
dpc-1867	34	4	.	.	PUNCT
dpc-1867	35	1	this	this	PRON
dpc-1867	35	2	is	be	AUX
dpc-1867	35	3	due	due	ADJ
dpc-1867	35	4	to	to	ADP
dpc-1867	35	5	the	the	DET
dpc-1867	35	6	most	most	ADV
dpc-1867	35	7	prominent	prominent	ADJ
dpc-1867	35	8	expression	expression	NOUN
dpc-1867	35	9	of	of	ADP
dpc-1867	35	10	specific	specific	ADJ
dpc-1867	35	11	hla	hla	PROPN
dpc-1867	35	12	class	class	NOUN
dpc-1867	35	13	ii	ii	NOUN
dpc-1867	35	14	genes	gene	NOUN
dpc-1867	35	15	in	in	ADP
dpc-1867	35	16	pv	pv	PROPN
dpc-1867	35	17	patients	patient	NOUN
dpc-1867	35	18	with	with	ADP
dpc-1867	35	19	jewish	jewish	ADJ
dpc-1867	35	20	background	background	NOUN
dpc-1867	35	21	,	,	PUNCT
dpc-1867	35	22	such	such	ADJ
dpc-1867	35	23	as	as	ADP
dpc-1867	35	24	hla	hla	PROPN
dpc-1867	35	25	-	-	PUNCT
dpc-1867	35	26	drb1	drb1	PROPN
dpc-1867	35	27	*	*	NOUN
dpc-1867	35	28	0402	0402	NUM
dpc-1867	35	29	and	and	CCONJ
dpc-1867	35	30	hla	hla	PROPN
dpc-1867	35	31	-	-	PUNCT
dpc-1867	35	32	dqb1	dqb1	PROPN
dpc-1867	35	33	*	*	ADJ
dpc-1867	35	34	0503	0503	NUM
dpc-1867	36	1	[	[	X
dpc-1867	36	2	7	7	NUM
dpc-1867	36	3	]	]	PUNCT
dpc-1867	36	4	.	.	PUNCT
dpc-1867	37	1	clinical	clinical	ADJ
dpc-1867	37	2	features	feature	NOUN
dpc-1867	37	3	of	of	ADP
dpc-1867	37	4	pv	pv	INTJ
dpc-1867	37	5	pv	pv	INTJ
dpc-1867	37	6	usually	usually	ADV
dpc-1867	37	7	arises	arise	VERB
dpc-1867	37	8	with	with	ADP
dpc-1867	37	9	painful	painful	ADJ
dpc-1867	37	10	and	and	CCONJ
dpc-1867	37	11	refractory	refractory	NOUN
dpc-1867	37	12	oral	oral	ADJ
dpc-1867	37	13	erosions	erosion	NOUN
dpc-1867	37	14	(	(	PUNCT
dpc-1867	37	15	figure	figure	NOUN
dpc-1867	37	16	1	1	NUM
dpc-1867	37	17	)	)	PUNCT
dpc-1867	38	1	[	[	X
dpc-1867	38	2	1	1	NUM
dpc-1867	38	3	]	]	PUNCT
dpc-1867	38	4	.	.	PUNCT
dpc-1867	39	1	furthermore	furthermore	ADV
dpc-1867	39	2	,	,	PUNCT
dpc-1867	39	3	other	other	ADJ
dpc-1867	39	4	mucous	mucous	ADJ
dpc-1867	39	5	membranes	membrane	NOUN
dpc-1867	39	6	can	can	AUX
dpc-1867	39	7	be	be	AUX
dpc-1867	39	8	affected	affect	VERB
dpc-1867	39	9	[	[	PUNCT
dpc-1867	39	10	1	1	NUM
dpc-1867	39	11	]	]	PUNCT
dpc-1867	39	12	.	.	PUNCT
dpc-1867	40	1	most	most	ADJ
dpc-1867	40	2	of	of	ADP
dpc-1867	40	3	patients	patient	NOUN
dpc-1867	40	4	also	also	ADV
dpc-1867	40	5	develop	develop	VERB
dpc-1867	40	6	flaccid	flaccid	ADJ
dpc-1867	40	7	skin	skin	NOUN
dpc-1867	40	8	blisters	blister	NOUN
dpc-1867	40	9	that	that	PRON
dpc-1867	40	10	rapidly	rapidly	ADV
dpc-1867	40	11	evolve	evolve	VERB
dpc-1867	40	12	into	into	ADP
dpc-1867	40	13	oozing	oozing	ADJ
dpc-1867	40	14	erosions	erosion	NOUN
dpc-1867	40	15	(	(	PUNCT
dpc-1867	40	16	figure	figure	NOUN
dpc-1867	40	17	2	2	NUM
dpc-1867	40	18	)	)	PUNCT
dpc-1867	41	1	[	[	X
dpc-1867	41	2	1	1	NUM
dpc-1867	41	3	]	]	PUNCT
dpc-1867	41	4	.	.	PUNCT
dpc-1867	42	1	rarely	rarely	ADV
dpc-1867	42	2	,	,	PUNCT
dpc-1867	42	3	pemphigus	pemphigus	NOUN
dpc-1867	42	4	patients	patient	NOUN
dpc-1867	42	5	show	show	VERB
dpc-1867	42	6	a	a	DET
dpc-1867	42	7	clinical	clinical	ADJ
dpc-1867	42	8	and	and	CCONJ
dpc-1867	42	9	serological	serological	ADJ
dpc-1867	42	10	transition	transition	NOUN
dpc-1867	42	11	from	from	ADP
dpc-1867	42	12	pv	pv	NOUN
dpc-1867	42	13	to	to	ADP
dpc-1867	42	14	pf	pf	VERB
dpc-1867	42	15	or	or	CCONJ
dpc-1867	42	16	conversely	conversely	ADV
dpc-1867	42	17	.	.	PUNCT
dpc-1867	43	1	this	this	DET
dpc-1867	43	2	phenomenon	phenomenon	NOUN
dpc-1867	43	3	could	could	AUX
dpc-1867	43	4	be	be	AUX
dpc-1867	43	5	due	due	ADJ
dpc-1867	43	6	to	to	ADP
dpc-1867	43	7	the	the	DET
dpc-1867	43	8	epitope	epitope	NOUN
dpc-1867	43	9	spreading	spread	VERB
dpc-1867	43	10	,	,	PUNCT
dpc-1867	43	11	a	a	DET
dpc-1867	43	12	process	process	NOUN
dpc-1867	43	13	of	of	ADP
dpc-1867	43	14	diversification	diversification	NOUN
dpc-1867	43	15	of	of	ADP
dpc-1867	43	16	bor	bor	PROPN
dpc-1867	43	17	t	t	PROPN
dpc-1867	43	18	-	-	PUNCT
dpc-1867	43	19	cell	cell	NOUN
dpc-1867	43	20	responses	response	NOUN
dpc-1867	43	21	from	from	ADP
dpc-1867	43	22	the	the	DET
dpc-1867	43	23	initial	initial	ADJ
dpc-1867	43	24	dominant	dominant	ADJ
dpc-1867	43	25	epitope	epitope	NOUN
dpc-1867	43	26	to	to	ADP
dpc-1867	43	27	a	a	DET
dpc-1867	43	28	second	second	ADJ
dpc-1867	43	29	one	one	NUM
dpc-1867	43	30	[	[	X
dpc-1867	43	31	8	8	NUM
dpc-1867	43	32	]	]	PUNCT
dpc-1867	43	33	.	.	PUNCT
dpc-1867	44	1	pathogenesis	pathogenesis	NOUN
dpc-1867	44	2	cutaneous	cutaneous	ADJ
dpc-1867	44	3	desmoglein-1	desmoglein-1	PROPN
dpc-1867	44	4	(	(	PUNCT
dpc-1867	44	5	dsg1	dsg1	NOUN
dpc-1867	44	6	)	)	PUNCT
dpc-1867	44	7	can	can	AUX
dpc-1867	44	8	be	be	AUX
dpc-1867	44	9	expressed	express	VERB
dpc-1867	44	10	in	in	ADP
dpc-1867	44	11	the	the	DET
dpc-1867	44	12	whole	whole	ADJ
dpc-1867	44	13	epidermis	epidermis	NOUN
dpc-1867	44	14	,	,	PUNCT
dpc-1867	44	15	cutaneous	cutaneous	ADJ
dpc-1867	44	16	dsg3	dsg3	PROPN
dpc-1867	44	17	is	be	AUX
dpc-1867	44	18	typically	typically	ADV
dpc-1867	44	19	found	find	VERB
dpc-1867	44	20	in	in	ADP
dpc-1867	44	21	the	the	DET
dpc-1867	44	22	lower	low	ADJ
dpc-1867	44	23	epidermis	epidermis	NOUN
dpc-1867	44	24	,	,	PUNCT
dpc-1867	44	25	while	while	SCONJ
dpc-1867	44	26	in	in	ADP
dpc-1867	44	27	the	the	DET
dpc-1867	44	28	mucosa	mucosa	NOUN
dpc-1867	44	29	dsg1	dsg1	NOUN
dpc-1867	44	30	and	and	CCONJ
dpc-1867	44	31	dsg3	dsg3	PROPN
dpc-1867	44	32	are	be	AUX
dpc-1867	44	33	located	locate	VERB
dpc-1867	44	34	in	in	ADP
dpc-1867	44	35	the	the	DET
dpc-1867	44	36	whole	whole	ADJ
dpc-1867	44	37	squamous	squamous	ADJ
dpc-1867	44	38	layer	layer	NOUN
dpc-1867	44	39	,	,	PUNCT
dpc-1867	44	40	with	with	ADP
dpc-1867	44	41	a	a	DET
dpc-1867	44	42	higher	high	ADJ
dpc-1867	44	43	expression	expression	NOUN
dpc-1867	44	44	of	of	ADP
dpc-1867	44	45	dsg3	dsg3	PROPN
dpc-1867	45	1	[	[	X
dpc-1867	45	2	9	9	NUM
dpc-1867	45	3	]	]	PUNCT
dpc-1867	45	4	.	.	PUNCT
dpc-1867	46	1	therefore	therefore	ADV
dpc-1867	46	2	,	,	PUNCT
dpc-1867	46	3	pv	pv	NOUN
dpc-1867	46	4	patients	patient	NOUN
dpc-1867	46	5	who	who	PRON
dpc-1867	46	6	show	show	VERB
dpc-1867	46	7	only	only	ADV
dpc-1867	46	8	anti	anti	ADJ
dpc-1867	46	9	-	-	ADJ
dpc-1867	46	10	dsg1	dsg1	ADJ
dpc-1867	46	11	immunoglobulin	immunoglobulin	NOUN
dpc-1867	46	12	g	g	PROPN
dpc-1867	46	13	(	(	PUNCT
dpc-1867	46	14	igg	igg	PROPN
dpc-1867	46	15	)	)	PUNCT
dpc-1867	46	16	serum	serum	PROPN
dpc-1867	46	17	antibodies	antibody	NOUN
dpc-1867	46	18	develop	develop	VERB
dpc-1867	46	19	only	only	ADV
dpc-1867	46	20	skin	skin	NOUN
dpc-1867	46	21	blisters	blister	NOUN
dpc-1867	46	22	,	,	PUNCT
dpc-1867	46	23	and	and	CCONJ
dpc-1867	46	24	,	,	PUNCT
dpc-1867	46	25	in	in	ADP
dpc-1867	46	26	the	the	DET
dpc-1867	46	27	case	case	NOUN
dpc-1867	46	28	of	of	ADP
dpc-1867	46	29	detectable	detectable	ADJ
dpc-1867	46	30	anti	anti	ADJ
dpc-1867	46	31	-	-	ADJ
dpc-1867	46	32	dsg3	dsg3	ADJ
dpc-1867	46	33	igg	igg	PROPN
dpc-1867	46	34	serum	serum	PROPN
dpc-1867	46	35	antibodies	antibodie	VERB
dpc-1867	46	36	,	,	PUNCT
dpc-1867	46	37	the	the	DET
dpc-1867	46	38	clinical	clinical	ADJ
dpc-1867	46	39	phenotype	phenotype	NOUN
dpc-1867	46	40	is	be	AUX
dpc-1867	46	41	characterized	characterize	VERB
dpc-1867	46	42	by	by	ADP
dpc-1867	46	43	erosions	erosion	NOUN
dpc-1867	46	44	or	or	CCONJ
dpc-1867	46	45	ulcerations	ulceration	NOUN
dpc-1867	46	46	of	of	ADP
dpc-1867	46	47	mucosal	mucosal	ADJ
dpc-1867	46	48	membranes	membrane	NOUN
dpc-1867	46	49	[	[	X
dpc-1867	46	50	10	10	NUM
dpc-1867	46	51	]	]	PUNCT
dpc-1867	46	52	.	.	PUNCT
dpc-1867	47	1	furthermore	furthermore	ADV
dpc-1867	47	2	,	,	PUNCT
dpc-1867	47	3	the	the	DET
dpc-1867	47	4	production	production	NOUN
dpc-1867	47	5	of	of	ADP
dpc-1867	47	6	both	both	PRON
dpc-1867	47	7	anti	anti	ADJ
dpc-1867	47	8	-	-	ADJ
dpc-1867	47	9	dsg1	dsg1	NOUN
dpc-1867	47	10	and	and	CCONJ
dpc-1867	47	11	anti	anti	ADJ
dpc-1867	47	12	-	-	ADJ
dpc-1867	47	13	dsg3	dsg3	ADJ
dpc-1867	47	14	igg	igg	NOUN
dpc-1867	47	15	serum	serum	NOUN
dpc-1867	47	16	autoantibodies	autoantibody	NOUN
dpc-1867	47	17	provokes	provoke	VERB
dpc-1867	47	18	skin	skin	NOUN
dpc-1867	47	19	and	and	CCONJ
dpc-1867	47	20	mucosal	mucosal	NOUN
dpc-1867	47	21	lesions	lesion	NOUN
dpc-1867	47	22	[	[	X
dpc-1867	47	23	10	10	NUM
dpc-1867	47	24	]	]	PUNCT
dpc-1867	47	25	.	.	PUNCT
dpc-1867	48	1	evidence	evidence	NOUN
dpc-1867	48	2	suggests	suggest	VERB
dpc-1867	48	3	that	that	SCONJ
dpc-1867	48	4	anti	anti	ADJ
dpc-1867	48	5	-	-	ADJ
dpc-1867	48	6	dsg1	dsg1	NOUN
dpc-1867	48	7	and	and	CCONJ
dpc-1867	48	8	anti	anti	ADJ
dpc-1867	48	9	-	-	ADJ
dpc-1867	48	10	dsg3	dsg3	ADJ
dpc-1867	48	11	autoantibodies	autoantibody	NOUN
dpc-1867	48	12	are	be	AUX
dpc-1867	48	13	responsible	responsible	ADJ
dpc-1867	48	14	for	for	ADP
dpc-1867	48	15	a	a	DET
dpc-1867	48	16	loss	loss	NOUN
dpc-1867	48	17	of	of	ADP
dpc-1867	48	18	cell	cell	NOUN
dpc-1867	48	19	-	-	PUNCT
dpc-1867	48	20	cell	cell	NOUN
dpc-1867	48	21	adhesion	adhesion	NOUN
dpc-1867	48	22	between	between	ADP
dpc-1867	48	23	keratinocytes	keratinocyte	NOUN
dpc-1867	49	1	[	[	X
dpc-1867	49	2	11,12	11,12	NOUN
dpc-1867	49	3	]	]	PUNCT
dpc-1867	49	4	.	.	PUNCT
dpc-1867	50	1	the	the	DET
dpc-1867	50	2	most	most	ADV
dpc-1867	50	3	important	important	ADJ
dpc-1867	50	4	targets	target	NOUN
dpc-1867	50	5	for	for	ADP
dpc-1867	50	6	autoantibodies	autoantibody	NOUN
dpc-1867	50	7	in	in	ADP
dpc-1867	50	8	pv	pv	NOUN
dpc-1867	50	9	are	be	AUX
dpc-1867	50	10	represented	represent	VERB
dpc-1867	50	11	by	by	ADP
dpc-1867	50	12	the	the	DET
dpc-1867	50	13	extracellular	extracellular	ADJ
dpc-1867	50	14	domains	domain	NOUN
dpc-1867	50	15	of	of	ADP
dpc-1867	50	16	dsg	dsg	PROPN
dpc-1867	51	1	[	[	X
dpc-1867	51	2	13,14	13,14	NUM
dpc-1867	51	3	]	]	PUNCT
dpc-1867	51	4	.	.	PUNCT
dpc-1867	52	1	further	further	ADJ
dpc-1867	52	2	mechanisms	mechanism	NOUN
dpc-1867	52	3	can	can	AUX
dpc-1867	52	4	also	also	ADV
dpc-1867	52	5	lead	lead	VERB
dpc-1867	52	6	to	to	ADP
dpc-1867	52	7	acantholysis	acantholysis	NOUN
dpc-1867	52	8	in	in	ADP
dpc-1867	52	9	pv	pv	ADV
dpc-1867	52	10	,	,	PUNCT
dpc-1867	52	11	such	such	ADJ
dpc-1867	52	12	as	as	ADP
dpc-1867	52	13	dsg	dsg	NOUN
dpc-1867	52	14	endocytosis	endocytosis	NOUN
dpc-1867	52	15	and	and	CCONJ
dpc-1867	52	16	desmosome	desmosome	ADJ
dpc-1867	52	17	disassembly	disassembly	NOUN
dpc-1867	53	1	[	[	X
dpc-1867	53	2	15,16	15,16	NUM
dpc-1867	53	3	]	]	PUNCT
dpc-1867	53	4	,	,	PUNCT
dpc-1867	53	5	and	and	CCONJ
dpc-1867	53	6	intercellular	intercellular	ADJ
dpc-1867	53	7	stretch	stretch	NOUN
dpc-1867	53	8	at	at	ADP
dpc-1867	53	9	non	non	ADJ
dpc-1867	53	10	-	-	ADJ
dpc-1867	53	11	acantholytic	acantholytic	ADJ
dpc-1867	53	12	cell	cell	NOUN
dpc-1867	53	13	layers	layer	NOUN
dpc-1867	53	14	caused	cause	VERB
dpc-1867	53	15	by	by	ADP
dpc-1867	53	16	pathogenic	pathogenic	ADJ
dpc-1867	53	17	autoantibodies	autoantibody	NOUN
dpc-1867	53	18	[	[	X
dpc-1867	53	19	17,18	17,18	X
dpc-1867	53	20	]	]	PUNCT
dpc-1867	53	21	.	.	PUNCT
dpc-1867	54	1	in	in	ADP
dpc-1867	54	2	addition	addition	NOUN
dpc-1867	54	3	,	,	PUNCT
dpc-1867	54	4	non	non	ADJ
dpc-1867	54	5	-	-	ADJ
dpc-1867	54	6	dsg	dsg	ADJ
dpc-1867	54	7	igg	igg	PROPN
dpc-1867	54	8	serum	serum	NOUN
dpc-1867	54	9	autoantibodies	autoantibody	NOUN
dpc-1867	54	10	have	have	AUX
dpc-1867	54	11	been	be	AUX
dpc-1867	54	12	reported	report	VERB
dpc-1867	54	13	as	as	ADP
dpc-1867	54	14	important	important	ADJ
dpc-1867	54	15	in	in	ADP
dpc-1867	54	16	pv	pv	NOUN
dpc-1867	54	17	pathogenesis	pathogenesis	NOUN
dpc-1867	54	18	,	,	PUNCT
dpc-1867	54	19	including	include	VERB
dpc-1867	54	20	those	those	PRON
dpc-1867	54	21	directed	direct	VERB
dpc-1867	54	22	against	against	ADP
dpc-1867	54	23	desmocollins	desmocollin	NOUN
dpc-1867	54	24	,	,	PUNCT
dpc-1867	54	25	mitochondria	mitochondria	NOUN
dpc-1867	54	26	,	,	PUNCT
dpc-1867	54	27	pemphaxin	pemphaxin	NOUN
dpc-1867	54	28	,	,	PUNCT
dpc-1867	54	29	and	and	CCONJ
dpc-1867	54	30	alpha-9	alpha-9	NUM
dpc-1867	54	31	acetylcholine	acetylcholine	NOUN
dpc-1867	54	32	receptor	receptor	NOUN
dpc-1867	54	33	[	[	X
dpc-1867	54	34	13,19	13,19	NUM
dpc-1867	54	35	]	]	PUNCT
dpc-1867	54	36	.	.	PUNCT
dpc-1867	55	1	diagnosis	diagnosis	NOUN
dpc-1867	55	2	of	of	ADP
dpc-1867	55	3	pv	pv	INTJ
dpc-1867	55	4	the	the	DET
dpc-1867	55	5	diagnosis	diagnosis	NOUN
dpc-1867	55	6	of	of	ADP
dpc-1867	55	7	pv	pv	NOUN
dpc-1867	55	8	requires	require	VERB
dpc-1867	55	9	not	not	PART
dpc-1867	55	10	only	only	ADV
dpc-1867	55	11	compatible	compatible	ADJ
dpc-1867	55	12	clinical	clinical	ADJ
dpc-1867	55	13	features	feature	NOUN
dpc-1867	55	14	,	,	PUNCT
dpc-1867	55	15	but	but	CCONJ
dpc-1867	55	16	evidence	evidence	NOUN
dpc-1867	55	17	of	of	ADP
dpc-1867	55	18	pathological	pathological	ADJ
dpc-1867	55	19	features	feature	NOUN
dpc-1867	55	20	of	of	ADP
dpc-1867	55	21	involved	involved	ADJ
dpc-1867	55	22	skin	skin	NOUN
dpc-1867	55	23	and	and	CCONJ
dpc-1867	55	24	the	the	DET
dpc-1867	55	25	presence	presence	NOUN
dpc-1867	55	26	of	of	ADP
dpc-1867	55	27	autoantibodies	autoantibody	NOUN
dpc-1867	55	28	by	by	ADP
dpc-1867	55	29	direct	direct	ADJ
dpc-1867	55	30	immunofluorescence	immunofluorescence	NOUN
dpc-1867	55	31	microscopy	microscopy	NOUN
dpc-1867	55	32	of	of	ADP
dpc-1867	55	33	non	non	ADJ
dpc-1867	55	34	-	-	ADJ
dpc-1867	55	35	affected	affected	ADJ
dpc-1867	55	36	skin	skin	NOUN
dpc-1867	55	37	.	.	PUNCT
dpc-1867	56	1	indirect	indirect	ADJ
dpc-1867	56	2	immunofluorescence	immunofluorescence	NOUN
dpc-1867	56	3	microscopy	microscopy	NOUN
dpc-1867	56	4	,	,	PUNCT
dpc-1867	56	5	enzyme	enzyme	NOUN
dpc-1867	56	6	-	-	PUNCT
dpc-1867	56	7	linked	link	VERB
dpc-1867	56	8	immunosorbent	immunosorbent	ADJ
dpc-1867	56	9	assay	assay	NOUN
dpc-1867	56	10	and	and	CCONJ
dpc-1867	56	11	other	other	ADJ
dpc-1867	56	12	techniques	technique	NOUN
dpc-1867	56	13	have	have	VERB
dpc-1867	56	14	a	a	DET
dpc-1867	56	15	confirmatory	confirmatory	ADJ
dpc-1867	56	16	role	role	NOUN
dpc-1867	56	17	[	[	X
dpc-1867	56	18	5	5	NUM
dpc-1867	56	19	]	]	PUNCT
dpc-1867	56	20	.	.	PUNCT
dpc-1867	57	1	the	the	DET
dpc-1867	57	2	most	most	ADV
dpc-1867	57	3	important	important	ADJ
dpc-1867	57	4	pathological	pathological	ADJ
dpc-1867	57	5	feature	feature	NOUN
dpc-1867	57	6	is	be	AUX
dpc-1867	57	7	the	the	DET
dpc-1867	57	8	intraepidermal	intraepidermal	ADJ
dpc-1867	57	9	acantholysis	acantholysis	NOUN
dpc-1867	57	10	[	[	X
dpc-1867	57	11	20	20	NUM
dpc-1867	57	12	]	]	PUNCT
dpc-1867	57	13	.	.	PUNCT
dpc-1867	58	1	direct	direct	ADJ
dpc-1867	58	2	immunofluorescence	immunofluorescence	NOUN
dpc-1867	58	3	of	of	ADP
dpc-1867	58	4	non	non	ADJ
dpc-1867	58	5	-	-	ADJ
dpc-1867	58	6	affected	affected	ADJ
dpc-1867	58	7	skin	skin	NOUN
dpc-1867	58	8	detects	detect	NOUN
dpc-1867	58	9	igg	igg	NOUN
dpc-1867	58	10	and	and	CCONJ
dpc-1867	58	11	proteins	protein	NOUN
dpc-1867	58	12	of	of	ADP
dpc-1867	58	13	complement	complement	NOUN
dpc-1867	58	14	c3	c3	PROPN
dpc-1867	58	15	(	(	PUNCT
dpc-1867	58	16	c3	c3	PROPN
dpc-1867	58	17	)	)	PUNCT
dpc-1867	58	18	on	on	ADP
dpc-1867	58	19	epidermal	epidermal	ADJ
dpc-1867	58	20	keratinocytes	keratinocyte	NOUN
dpc-1867	58	21	(	(	PUNCT
dpc-1867	58	22	figure	figure	NOUN
dpc-1867	58	23	3	3	NUM
dpc-1867	58	24	)	)	PUNCT
dpc-1867	59	1	[	[	X
dpc-1867	59	2	20,21	20,21	NUM
dpc-1867	59	3	]	]	PUNCT
dpc-1867	59	4	.	.	PUNCT
dpc-1867	60	1	indirect	indirect	ADJ
dpc-1867	60	2	figure	figure	NOUN
dpc-1867	60	3	1	1	NUM
dpc-1867	60	4	.	.	PUNCT
dpc-1867	61	1	large	large	ADJ
dpc-1867	61	2	erosions	erosion	NOUN
dpc-1867	61	3	of	of	ADP
dpc-1867	61	4	the	the	DET
dpc-1867	61	5	oral	oral	ADJ
dpc-1867	61	6	mucosa	mucosa	NOUN
dpc-1867	61	7	.	.	PUNCT
dpc-1867	62	1	figure	figure	NOUN
dpc-1867	62	2	2	2	NUM
dpc-1867	62	3	.	.	PUNCT
dpc-1867	62	4	multiple	multiple	ADJ
dpc-1867	62	5	erosions	erosion	NOUN
dpc-1867	62	6	on	on	ADP
dpc-1867	62	7	the	the	DET
dpc-1867	62	8	back	back	NOUN
dpc-1867	62	9	of	of	ADP
dpc-1867	62	10	this	this	DET
dpc-1867	62	11	male	male	ADJ
dpc-1867	62	12	patient	patient	NOUN
dpc-1867	62	13	.	.	PUNCT
dpc-1867	63	1	review	review	VERB
dpc-1867	63	2	|	|	ADV
dpc-1867	63	3	dermatol	dermatol	ADJ
dpc-1867	63	4	pract	pract	NOUN
dpc-1867	63	5	concept	concept	NOUN
dpc-1867	63	6	.	.	PUNCT
dpc-1867	64	1	2022;12(1	2022;12(1	NUM
dpc-1867	64	2	):	):	PUNCT
dpc-1867	64	3	e2022037	e2022037	NOUN
dpc-1867	64	4	3	3	NUM
dpc-1867	64	5	immunofluorescence	immunofluorescence	NOUN
dpc-1867	64	6	on	on	ADP
dpc-1867	64	7	monkey	monkey	NOUN
dpc-1867	64	8	esophagus	esophagus	NOUN
dpc-1867	64	9	detects	detect	VERB
dpc-1867	64	10	a	a	DET
dpc-1867	64	11	fishnet	fishnet	NOUN
dpc-1867	64	12	pattern	pattern	NOUN
dpc-1867	64	13	due	due	ADP
dpc-1867	64	14	to	to	ADP
dpc-1867	64	15	igg	igg	PROPN
dpc-1867	64	16	antibodies	antibodie	VERB
dpc-1867	64	17	reactivity	reactivity	NOUN
dpc-1867	64	18	to	to	PART
dpc-1867	64	19	cell	cell	VERB
dpc-1867	64	20	membrane	membrane	NOUN
dpc-1867	64	21	of	of	ADP
dpc-1867	64	22	epithelial	epithelial	ADJ
dpc-1867	64	23	or	or	CCONJ
dpc-1867	64	24	epidermal	epidermal	ADJ
dpc-1867	64	25	cells	cell	NOUN
dpc-1867	64	26	[	[	X
dpc-1867	64	27	20	20	NUM
dpc-1867	64	28	]	]	PUNCT
dpc-1867	64	29	.	.	PUNCT
dpc-1867	65	1	current	current	ADJ
dpc-1867	65	2	therapies	therapy	NOUN
dpc-1867	65	3	corticosteroids	corticosteroid	NOUN
dpc-1867	65	4	prednisolone	prednisolone	PROPN
dpc-1867	65	5	is	be	AUX
dpc-1867	65	6	usually	usually	ADV
dpc-1867	65	7	administered	administer	VERB
dpc-1867	65	8	as	as	ADP
dpc-1867	65	9	initial	initial	ADJ
dpc-1867	65	10	therapy	therapy	NOUN
dpc-1867	65	11	in	in	ADP
dpc-1867	65	12	pv	pv	ADV
dpc-1867	65	13	in	in	ADP
dpc-1867	65	14	association	association	NOUN
dpc-1867	65	15	with	with	ADP
dpc-1867	65	16	immunosuppressive	immunosuppressive	ADJ
dpc-1867	65	17	agents	agent	NOUN
dpc-1867	65	18	,	,	PUNCT
dpc-1867	65	19	such	such	ADJ
dpc-1867	65	20	as	as	ADP
dpc-1867	65	21	azathioprine	azathioprine	PROPN
dpc-1867	65	22	(	(	PUNCT
dpc-1867	65	23	aza	aza	NOUN
dpc-1867	65	24	)	)	PUNCT
dpc-1867	65	25	and	and	CCONJ
dpc-1867	65	26	mycophenolate	mycophenolate	PROPN
dpc-1867	65	27	mofetil	mofetil	PROPN
dpc-1867	65	28	(	(	PUNCT
dpc-1867	65	29	mmf	mmf	NOUN
dpc-1867	65	30	)	)	PUNCT
dpc-1867	65	31	,	,	PUNCT
dpc-1867	65	32	or	or	CCONJ
dpc-1867	65	33	anti	anti	ADJ
dpc-1867	65	34	-	-	ADJ
dpc-1867	65	35	cd20	cd20	ADJ
dpc-1867	65	36	monoclonal	monoclonal	NOUN
dpc-1867	65	37	antibodies	antibodie	VERB
dpc-1867	66	1	[	[	X
dpc-1867	66	2	1	1	NUM
dpc-1867	66	3	]	]	PUNCT
dpc-1867	66	4	.	.	PUNCT
dpc-1867	67	1	in	in	ADP
dpc-1867	67	2	patients	patient	NOUN
dpc-1867	67	3	with	with	ADP
dpc-1867	67	4	several	several	ADJ
dpc-1867	67	5	comorbidities	comorbiditie	NOUN
dpc-1867	67	6	and	and	CCONJ
dpc-1867	67	7	in	in	ADP
dpc-1867	67	8	those	those	PRON
dpc-1867	67	9	who	who	PRON
dpc-1867	67	10	can	can	AUX
dpc-1867	67	11	not	not	PART
dpc-1867	67	12	undergo	undergo	VERB
dpc-1867	67	13	a	a	DET
dpc-1867	67	14	therapy	therapy	NOUN
dpc-1867	67	15	with	with	ADP
dpc-1867	67	16	anti	anti	ADJ
dpc-1867	67	17	-	-	ADJ
dpc-1867	67	18	cd20	cd20	ADJ
dpc-1867	67	19	monoclonal	monoclonal	NOUN
dpc-1867	67	20	antibodies	antibody	NOUN
dpc-1867	67	21	or	or	CCONJ
dpc-1867	67	22	immunosuppressive	immunosuppressive	ADJ
dpc-1867	67	23	agents	agent	NOUN
dpc-1867	67	24	,	,	PUNCT
dpc-1867	67	25	prednisolone	prednisolone	PROPN
dpc-1867	67	26	as	as	ADP
dpc-1867	67	27	monotherapy	monotherapy	NOUN
dpc-1867	67	28	is	be	AUX
dpc-1867	67	29	still	still	ADV
dpc-1867	67	30	recommended	recommend	VERB
dpc-1867	67	31	as	as	ADP
dpc-1867	67	32	first	first	ADJ
dpc-1867	67	33	-	-	PUNCT
dpc-1867	67	34	line	line	NOUN
dpc-1867	67	35	therapy	therapy	NOUN
dpc-1867	67	36	[	[	X
dpc-1867	67	37	1	1	NUM
dpc-1867	67	38	]	]	PUNCT
dpc-1867	67	39	.	.	PUNCT
dpc-1867	68	1	nevertheless	nevertheless	ADV
dpc-1867	68	2	,	,	PUNCT
dpc-1867	68	3	plenty	plenty	NOUN
dpc-1867	68	4	of	of	ADP
dpc-1867	68	5	side	side	NOUN
dpc-1867	68	6	effects	effect	NOUN
dpc-1867	68	7	have	have	AUX
dpc-1867	68	8	been	be	AUX
dpc-1867	68	9	described	describe	VERB
dpc-1867	68	10	after	after	ADP
dpc-1867	68	11	prolonged	prolong	VERB
dpc-1867	68	12	corticosteroid	corticosteroid	ADJ
dpc-1867	68	13	(	(	PUNCT
dpc-1867	68	14	cs	cs	ADJ
dpc-1867	68	15	)	)	PUNCT
dpc-1867	68	16	therapy	therapy	NOUN
dpc-1867	68	17	,	,	PUNCT
dpc-1867	68	18	including	include	VERB
dpc-1867	68	19	severe	severe	ADJ
dpc-1867	68	20	infections	infection	NOUN
dpc-1867	68	21	,	,	PUNCT
dpc-1867	68	22	secondary	secondary	ADJ
dpc-1867	68	23	impairment	impairment	NOUN
dpc-1867	68	24	of	of	ADP
dpc-1867	68	25	adrenal	adrenal	ADJ
dpc-1867	68	26	glands	gland	NOUN
dpc-1867	68	27	,	,	PUNCT
dpc-1867	68	28	osteoporosis	osteoporosis	NOUN
dpc-1867	68	29	,	,	PUNCT
dpc-1867	68	30	hyperglycemia	hyperglycemia	NOUN
dpc-1867	68	31	,	,	PUNCT
dpc-1867	68	32	and	and	CCONJ
dpc-1867	68	33	hypertension	hypertension	NOUN
dpc-1867	68	34	[	[	X
dpc-1867	68	35	1	1	NUM
dpc-1867	68	36	]	]	PUNCT
dpc-1867	68	37	.	.	PUNCT
dpc-1867	69	1	aza	aza	PROPN
dpc-1867	69	2	aza	aza	NOUN
dpc-1867	69	3	downregulates	downregulate	NOUN
dpc-1867	69	4	purine	purine	NOUN
dpc-1867	69	5	metabolism	metabolism	NOUN
dpc-1867	69	6	,	,	PUNCT
dpc-1867	69	7	and	and	CCONJ
dpc-1867	69	8	blocks	block	VERB
dpc-1867	69	9	the	the	DET
dpc-1867	69	10	synthesis	synthesis	NOUN
dpc-1867	69	11	of	of	ADP
dpc-1867	69	12	dna	dna	PROPN
dpc-1867	69	13	,	,	PUNCT
dpc-1867	69	14	rna	rna	NOUN
dpc-1867	69	15	,	,	PUNCT
dpc-1867	69	16	and	and	CCONJ
dpc-1867	69	17	proteins	protein	NOUN
dpc-1867	69	18	.	.	PUNCT
dpc-1867	70	1	in	in	ADP
dpc-1867	70	2	addition	addition	NOUN
dpc-1867	70	3	,	,	PUNCT
dpc-1867	70	4	aza	aza	NOUN
dpc-1867	70	5	causes	cause	VERB
dpc-1867	70	6	a	a	DET
dpc-1867	70	7	reduction	reduction	NOUN
dpc-1867	70	8	of	of	ADP
dpc-1867	70	9	langerhans	langerhan	NOUN
dpc-1867	70	10	cells	cell	NOUN
dpc-1867	70	11	and	and	CCONJ
dpc-1867	70	12	monocytes	monocyte	NOUN
dpc-1867	70	13	,	,	PUNCT
dpc-1867	70	14	and	and	CCONJ
dpc-1867	70	15	reduces	reduce	VERB
dpc-1867	70	16	the	the	DET
dpc-1867	70	17	activity	activity	NOUN
dpc-1867	70	18	of	of	ADP
dpc-1867	70	19	tand	tand	PROPN
dpc-1867	70	20	b	b	NOUN
dpc-1867	70	21	-	-	PUNCT
dpc-1867	70	22	lymphocytes	lymphocytes	ADJ
dpc-1867	70	23	[	[	X
dpc-1867	70	24	1	1	NUM
dpc-1867	70	25	]	]	PUNCT
dpc-1867	70	26	.	.	PUNCT
dpc-1867	71	1	furthermore	furthermore	ADV
dpc-1867	71	2	,	,	PUNCT
dpc-1867	71	3	aza	aza	NOUN
dpc-1867	71	4	blocks	block	VERB
dpc-1867	71	5	t	t	PROPN
dpc-1867	71	6	-	-	PUNCT
dpc-1867	71	7	helper	helper	NOUN
dpc-1867	71	8	-	-	PUNCT
dpc-1867	71	9	cell	cell	NOUN
dpc-1867	71	10	dependent	dependent	ADJ
dpc-1867	71	11	responses	response	NOUN
dpc-1867	71	12	of	of	ADP
dpc-1867	71	13	b	b	NOUN
dpc-1867	71	14	-	-	PUNCT
dpc-1867	71	15	cells	cell	NOUN
dpc-1867	71	16	[	[	X
dpc-1867	71	17	1	1	NUM
dpc-1867	71	18	]	]	PUNCT
dpc-1867	71	19	.	.	PUNCT
dpc-1867	72	1	aza	aza	NOUN
dpc-1867	72	2	dosage	dosage	NOUN
dpc-1867	72	3	should	should	AUX
dpc-1867	72	4	be	be	AUX
dpc-1867	72	5	adapted	adapt	VERB
dpc-1867	72	6	to	to	ADP
dpc-1867	72	7	thiopurine	thiopurine	NOUN
dpc-1867	72	8	-	-	PUNCT
dpc-1867	72	9	methyltransferase	methyltransferase	NOUN
dpc-1867	72	10	activity	activity	NOUN
dpc-1867	72	11	,	,	PUNCT
dpc-1867	72	12	the	the	DET
dpc-1867	72	13	enzyme	enzyme	NOUN
dpc-1867	72	14	responsible	responsible	ADJ
dpc-1867	72	15	for	for	ADP
dpc-1867	72	16	aza	aza	NOUN
dpc-1867	72	17	metabolism	metabolism	NOUN
dpc-1867	72	18	.	.	PUNCT
dpc-1867	73	1	adverse	adverse	ADJ
dpc-1867	73	2	events	event	NOUN
dpc-1867	73	3	(	(	PUNCT
dpc-1867	73	4	aes	aes	NOUN
dpc-1867	73	5	)	)	PUNCT
dpc-1867	73	6	are	be	AUX
dpc-1867	73	7	reported	report	VERB
dpc-1867	73	8	in	in	ADP
dpc-1867	73	9	up	up	ADP
dpc-1867	73	10	to	to	PART
dpc-1867	73	11	30	30	NUM
dpc-1867	73	12	%	%	NOUN
dpc-1867	73	13	of	of	ADP
dpc-1867	73	14	patients	patient	NOUN
dpc-1867	73	15	,	,	PUNCT
dpc-1867	73	16	including	include	VERB
dpc-1867	73	17	nausea	nausea	NOUN
dpc-1867	73	18	,	,	PUNCT
dpc-1867	73	19	pancreatitis	pancreatitis	PROPN
dpc-1867	73	20	,	,	PUNCT
dpc-1867	73	21	diarrhea	diarrhea	PROPN
dpc-1867	73	22	,	,	PUNCT
dpc-1867	73	23	aphthous	aphthous	ADJ
dpc-1867	73	24	stomatitis	stomatitis	NOUN
dpc-1867	73	25	,	,	PUNCT
dpc-1867	73	26	and	and	CCONJ
dpc-1867	73	27	maculopapular	maculopapular	ADJ
dpc-1867	73	28	rash	rash	NOUN
dpc-1867	73	29	[	[	X
dpc-1867	73	30	1	1	NUM
dpc-1867	73	31	]	]	PUNCT
dpc-1867	73	32	.	.	PUNCT
dpc-1867	74	1	pancytopenia	pancytopenia	NOUN
dpc-1867	74	2	and	and	CCONJ
dpc-1867	74	3	hepatotoxicity	hepatotoxicity	NOUN
dpc-1867	74	4	are	be	AUX
dpc-1867	74	5	reported	report	VERB
dpc-1867	74	6	as	as	ADP
dpc-1867	74	7	severe	severe	ADJ
dpc-1867	74	8	aes	aes	NOUN
dpc-1867	74	9	[	[	X
dpc-1867	74	10	1	1	NUM
dpc-1867	74	11	]	]	PUNCT
dpc-1867	74	12	.	.	PUNCT
dpc-1867	75	1	mmf	mmf	NOUN
dpc-1867	75	2	mmf	mmf	NOUN
dpc-1867	75	3	leads	lead	VERB
dpc-1867	75	4	to	to	ADP
dpc-1867	75	5	a	a	DET
dpc-1867	75	6	suppression	suppression	NOUN
dpc-1867	75	7	of	of	ADP
dpc-1867	75	8	the	the	DET
dpc-1867	75	9	immune	immune	ADJ
dpc-1867	75	10	system	system	NOUN
dpc-1867	75	11	by	by	ADP
dpc-1867	75	12	a	a	DET
dpc-1867	75	13	selective	selective	ADJ
dpc-1867	75	14	blockade	blockade	NOUN
dpc-1867	75	15	of	of	ADP
dpc-1867	75	16	inosine	inosine	NOUN
dpc-1867	75	17	monophosphate	monophosphate	NOUN
dpc-1867	75	18	dehydrogenase	dehydrogenase	NOUN
dpc-1867	75	19	,	,	PUNCT
dpc-1867	75	20	that	that	PRON
dpc-1867	75	21	produces	produce	VERB
dpc-1867	75	22	a	a	DET
dpc-1867	75	23	downregulation	downregulation	NOUN
dpc-1867	75	24	of	of	ADP
dpc-1867	75	25	the	the	DET
dpc-1867	75	26	pathway	pathway	NOUN
dpc-1867	75	27	of	of	ADP
dpc-1867	75	28	purine	purine	NOUN
dpc-1867	75	29	synthesis	synthesis	NOUN
dpc-1867	75	30	in	in	ADP
dpc-1867	75	31	tand	tand	PROPN
dpc-1867	75	32	b	b	NOUN
dpc-1867	75	33	-	-	PUNCT
dpc-1867	75	34	cells	cell	NOUN
dpc-1867	75	35	[	[	X
dpc-1867	75	36	1	1	NUM
dpc-1867	75	37	]	]	PUNCT
dpc-1867	75	38	.	.	PUNCT
dpc-1867	76	1	because	because	SCONJ
dpc-1867	76	2	of	of	ADP
dpc-1867	76	3	its	its	PRON
dpc-1867	76	4	mode	mode	NOUN
dpc-1867	76	5	of	of	ADP
dpc-1867	76	6	action	action	NOUN
dpc-1867	76	7	,	,	PUNCT
dpc-1867	76	8	mmf	mmf	NOUN
dpc-1867	76	9	represents	represent	VERB
dpc-1867	76	10	a	a	DET
dpc-1867	76	11	safer	safe	ADJ
dpc-1867	76	12	cs	cs	ADJ
dpc-1867	76	13	-	-	ADJ
dpc-1867	76	14	sparing	sparing	ADJ
dpc-1867	76	15	drug	drug	NOUN
dpc-1867	76	16	compared	compare	VERB
dpc-1867	76	17	to	to	ADP
dpc-1867	76	18	other	other	ADJ
dpc-1867	76	19	immunosuppressive	immunosuppressive	ADJ
dpc-1867	76	20	drugs	drug	NOUN
dpc-1867	76	21	[	[	X
dpc-1867	76	22	1	1	NUM
dpc-1867	76	23	]	]	PUNCT
dpc-1867	76	24	.	.	PUNCT
dpc-1867	77	1	moderate	moderate	ADJ
dpc-1867	77	2	gastrointestinal	gastrointestinal	ADJ
dpc-1867	77	3	aes	aes	PROPN
dpc-1867	77	4	are	be	AUX
dpc-1867	77	5	frequently	frequently	ADV
dpc-1867	77	6	reported	report	VERB
dpc-1867	77	7	[	[	X
dpc-1867	77	8	1	1	NUM
dpc-1867	77	9	]	]	PUNCT
dpc-1867	77	10	.	.	PUNCT
dpc-1867	78	1	in	in	ADP
dpc-1867	78	2	addition	addition	NOUN
dpc-1867	78	3	,	,	PUNCT
dpc-1867	78	4	mmf	mmf	NOUN
dpc-1867	78	5	can	can	AUX
dpc-1867	78	6	increase	increase	VERB
dpc-1867	78	7	the	the	DET
dpc-1867	78	8	risk	risk	NOUN
dpc-1867	78	9	of	of	ADP
dpc-1867	78	10	hematologic	hematologic	NOUN
dpc-1867	78	11	malignancies	malignancy	NOUN
dpc-1867	78	12	,	,	PUNCT
dpc-1867	78	13	skin	skin	NOUN
dpc-1867	78	14	basal	basal	NOUN
dpc-1867	78	15	cell	cell	NOUN
dpc-1867	78	16	,	,	PUNCT
dpc-1867	78	17	and	and	CCONJ
dpc-1867	78	18	squamous	squamous	ADJ
dpc-1867	78	19	cell	cell	NOUN
dpc-1867	78	20	carcinoma	carcinoma	NOUN
dpc-1867	79	1	[	[	X
dpc-1867	79	2	1	1	NUM
dpc-1867	79	3	]	]	PUNCT
dpc-1867	79	4	.	.	PUNCT
dpc-1867	80	1	cyclophosphamide	cyclophosphamide	PROPN
dpc-1867	80	2	cyclophosphamide	cyclophosphamide	PROPN
dpc-1867	80	3	(	(	PUNCT
dpc-1867	80	4	cyp	cyp	ADJ
dpc-1867	80	5	)	)	PUNCT
dpc-1867	80	6	is	be	AUX
dpc-1867	80	7	an	an	DET
dpc-1867	80	8	alkylating	alkylating	NOUN
dpc-1867	80	9	prodrug	prodrug	NOUN
dpc-1867	80	10	[	[	X
dpc-1867	80	11	1	1	NUM
dpc-1867	80	12	]	]	PUNCT
dpc-1867	80	13	.	.	PUNCT
dpc-1867	81	1	it	it	PRON
dpc-1867	81	2	is	be	AUX
dpc-1867	81	3	converted	convert	VERB
dpc-1867	81	4	in	in	ADP
dpc-1867	81	5	the	the	DET
dpc-1867	81	6	liver	liver	NOUN
dpc-1867	81	7	into	into	ADP
dpc-1867	81	8	2	2	NUM
dpc-1867	81	9	active	active	ADJ
dpc-1867	81	10	metabolites	metabolite	NOUN
dpc-1867	81	11	,	,	PUNCT
dpc-1867	81	12	which	which	PRON
dpc-1867	81	13	cause	cause	VERB
dpc-1867	81	14	cell	cell	NOUN
dpc-1867	81	15	death	death	NOUN
dpc-1867	81	16	through	through	ADP
dpc-1867	81	17	the	the	DET
dpc-1867	81	18	downregulation	downregulation	NOUN
dpc-1867	81	19	of	of	ADP
dpc-1867	81	20	dna	dna	PROPN
dpc-1867	81	21	replication	replication	NOUN
dpc-1867	81	22	.	.	PUNCT
dpc-1867	82	1	cyp	cyp	ADJ
dpc-1867	82	2	blocks	block	VERB
dpc-1867	82	3	the	the	DET
dpc-1867	82	4	release	release	NOUN
dpc-1867	82	5	of	of	ADP
dpc-1867	82	6	cytokines	cytokine	NOUN
dpc-1867	82	7	and	and	CCONJ
dpc-1867	82	8	reduces	reduce	VERB
dpc-1867	82	9	the	the	DET
dpc-1867	82	10	lymphocytic	lymphocytic	ADJ
dpc-1867	82	11	inflammation	inflammation	NOUN
dpc-1867	82	12	[	[	X
dpc-1867	82	13	1	1	NUM
dpc-1867	82	14	]	]	PUNCT
dpc-1867	82	15	.	.	PUNCT
dpc-1867	83	1	it	it	PRON
dpc-1867	83	2	is	be	AUX
dpc-1867	83	3	recommended	recommend	VERB
dpc-1867	83	4	as	as	ADP
dpc-1867	83	5	a	a	DET
dpc-1867	83	6	rescue	rescue	NOUN
dpc-1867	83	7	drug	drug	NOUN
dpc-1867	83	8	,	,	PUNCT
dpc-1867	83	9	since	since	SCONJ
dpc-1867	83	10	its	its	PRON
dpc-1867	83	11	administration	administration	NOUN
dpc-1867	83	12	is	be	AUX
dpc-1867	83	13	characterized	characterize	VERB
dpc-1867	83	14	by	by	ADP
dpc-1867	83	15	several	several	ADJ
dpc-1867	83	16	aes	aes	PROPN
dpc-1867	83	17	,	,	PUNCT
dpc-1867	83	18	such	such	ADJ
dpc-1867	83	19	as	as	ADP
dpc-1867	83	20	nausea	nausea	NOUN
dpc-1867	83	21	,	,	PUNCT
dpc-1867	83	22	fatigue	fatigue	NOUN
dpc-1867	83	23	,	,	PUNCT
dpc-1867	83	24	pancytopenia	pancytopenia	NOUN
dpc-1867	83	25	,	,	PUNCT
dpc-1867	83	26	and	and	CCONJ
dpc-1867	83	27	alopecia	alopecia	NOUN
dpc-1867	84	1	[	[	X
dpc-1867	84	2	1	1	NUM
dpc-1867	84	3	]	]	PUNCT
dpc-1867	84	4	.	.	PUNCT
dpc-1867	85	1	a	a	DET
dpc-1867	85	2	severe	severe	ADJ
dpc-1867	85	3	complication	complication	NOUN
dpc-1867	85	4	of	of	ADP
dpc-1867	85	5	cyp	cyp	ADJ
dpc-1867	85	6	treatment	treatment	NOUN
dpc-1867	85	7	is	be	AUX
dpc-1867	85	8	hemorrhagic	hemorrhagic	ADJ
dpc-1867	85	9	cystitis	cystitis	NOUN
dpc-1867	85	10	,	,	PUNCT
dpc-1867	85	11	which	which	PRON
dpc-1867	85	12	can	can	AUX
dpc-1867	85	13	be	be	AUX
dpc-1867	85	14	avoided	avoid	VERB
dpc-1867	85	15	with	with	ADP
dpc-1867	85	16	the	the	DET
dpc-1867	85	17	administration	administration	NOUN
dpc-1867	85	18	of	of	ADP
dpc-1867	85	19	adequate	adequate	ADJ
dpc-1867	85	20	fluid	fluid	NOUN
dpc-1867	85	21	intake	intake	NOUN
dpc-1867	85	22	and	and	CCONJ
dpc-1867	85	23	sodium	sodium	NOUN
dpc-1867	85	24	2	2	NUM
dpc-1867	85	25	-	-	PUNCT
dpc-1867	85	26	mercaptoethane	mercaptoethane	ADJ
dpc-1867	85	27	sulfonate	sulfonate	NOUN
dpc-1867	86	1	[	[	X
dpc-1867	86	2	1	1	NUM
dpc-1867	86	3	]	]	PUNCT
dpc-1867	86	4	.	.	PUNCT
dpc-1867	87	1	cyp	cyp	ADJ
dpc-1867	87	2	administration	administration	NOUN
dpc-1867	87	3	can	can	AUX
dpc-1867	87	4	cause	cause	VERB
dpc-1867	87	5	transitional	transitional	ADJ
dpc-1867	87	6	cell	cell	NOUN
dpc-1867	87	7	carcinoma	carcinoma	NOUN
dpc-1867	87	8	of	of	ADP
dpc-1867	87	9	the	the	DET
dpc-1867	87	10	bladder	bladder	NOUN
dpc-1867	88	1	[	[	X
dpc-1867	88	2	1	1	NUM
dpc-1867	88	3	]	]	PUNCT
dpc-1867	88	4	.	.	PUNCT
dpc-1867	89	1	in	in	ADP
dpc-1867	89	2	addition	addition	NOUN
dpc-1867	89	3	,	,	PUNCT
dpc-1867	89	4	transient	transient	ADJ
dpc-1867	89	5	or	or	CCONJ
dpc-1867	89	6	lasting	lasting	ADJ
dpc-1867	89	7	impairment	impairment	NOUN
dpc-1867	89	8	of	of	ADP
dpc-1867	89	9	gonadal	gonadal	NOUN
dpc-1867	89	10	function	function	NOUN
dpc-1867	89	11	has	have	AUX
dpc-1867	89	12	been	be	AUX
dpc-1867	89	13	reported	report	VERB
dpc-1867	89	14	[	[	X
dpc-1867	89	15	1	1	NUM
dpc-1867	89	16	]	]	PUNCT
dpc-1867	89	17	.	.	PUNCT
dpc-1867	90	1	rituximab	rituximab	NOUN
dpc-1867	90	2	rituximab	rituximab	NOUN
dpc-1867	90	3	(	(	PUNCT
dpc-1867	90	4	rtx	rtx	PROPN
dpc-1867	90	5	)	)	PUNCT
dpc-1867	90	6	is	be	AUX
dpc-1867	90	7	a	a	DET
dpc-1867	90	8	chimeric	chimeric	ADJ
dpc-1867	90	9	monoclonal	monoclonal	NOUN
dpc-1867	90	10	anti	anti	ADJ
dpc-1867	90	11	-	-	ADJ
dpc-1867	90	12	cd20	cd20	ADJ
dpc-1867	90	13	antibody	antibody	NOUN
dpc-1867	90	14	,	,	PUNCT
dpc-1867	90	15	that	that	PRON
dpc-1867	90	16	targets	target	VERB
dpc-1867	90	17	cd20	cd20	PROPN
dpc-1867	90	18	,	,	PUNCT
dpc-1867	90	19	a	a	DET
dpc-1867	90	20	transmembrane	transmembrane	ADJ
dpc-1867	90	21	receptor	receptor	NOUN
dpc-1867	90	22	,	,	PUNCT
dpc-1867	90	23	expressed	express	VERB
dpc-1867	90	24	at	at	ADP
dpc-1867	90	25	several	several	ADJ
dpc-1867	90	26	stages	stage	NOUN
dpc-1867	90	27	of	of	ADP
dpc-1867	90	28	the	the	DET
dpc-1867	90	29	b	b	NOUN
dpc-1867	90	30	-	-	PUNCT
dpc-1867	90	31	cell	cell	NOUN
dpc-1867	90	32	maturation	maturation	NOUN
dpc-1867	90	33	[	[	X
dpc-1867	90	34	22	22	NUM
dpc-1867	90	35	]	]	PUNCT
dpc-1867	90	36	.	.	PUNCT
dpc-1867	91	1	rtx	rtx	PROPN
dpc-1867	91	2	causes	cause	VERB
dpc-1867	91	3	b	b	NOUN
dpc-1867	91	4	-	-	PUNCT
dpc-1867	91	5	cell	cell	NOUN
dpc-1867	91	6	depletion	depletion	NOUN
dpc-1867	91	7	through	through	ADP
dpc-1867	91	8	different	different	ADJ
dpc-1867	91	9	mechanisms	mechanism	NOUN
dpc-1867	91	10	:	:	PUNCT
dpc-1867	91	11	1	1	X
dpc-1867	91	12	)	)	PUNCT
dpc-1867	91	13	direct	direct	ADJ
dpc-1867	91	14	induction	induction	NOUN
dpc-1867	91	15	of	of	ADP
dpc-1867	91	16	apoptosis	apoptosis	NOUN
dpc-1867	91	17	;	;	PUNCT
dpc-1867	91	18	2	2	X
dpc-1867	91	19	)	)	PUNCT
dpc-1867	91	20	complement	complement	NOUN
dpc-1867	91	21	-	-	PUNCT
dpc-1867	91	22	dependent	dependent	ADJ
dpc-1867	91	23	cytotoxicity	cytotoxicity	NOUN
dpc-1867	91	24	;	;	PUNCT
dpc-1867	91	25	3	3	X
dpc-1867	91	26	)	)	PUNCT
dpc-1867	91	27	antibody	antibody	NOUN
dpc-1867	91	28	-	-	PUNCT
dpc-1867	91	29	dependent	dependent	ADJ
dpc-1867	91	30	cytotoxicity	cytotoxicity	NOUN
dpc-1867	91	31	;	;	PUNCT
dpc-1867	91	32	4	4	X
dpc-1867	91	33	)	)	PUNCT
dpc-1867	91	34	antibody	antibody	NOUN
dpc-1867	91	35	-	-	PUNCT
dpc-1867	91	36	dependent	dependent	ADJ
dpc-1867	91	37	phagocytosis	phagocytosis	NOUN
dpc-1867	91	38	;	;	PUNCT
dpc-1867	91	39	and	and	CCONJ
dpc-1867	91	40	5	5	X
dpc-1867	91	41	)	)	PUNCT
dpc-1867	92	1	trogocytosis	trogocytosis	NOUN
dpc-1867	93	1	[	[	X
dpc-1867	93	2	23,24	23,24	X
dpc-1867	93	3	]	]	PUNCT
dpc-1867	93	4	.	.	PUNCT
dpc-1867	94	1	the	the	DET
dpc-1867	94	2	last	last	ADJ
dpc-1867	94	3	mechanism	mechanism	NOUN
dpc-1867	94	4	is	be	AUX
dpc-1867	94	5	characterized	characterize	VERB
dpc-1867	94	6	by	by	ADP
dpc-1867	94	7	the	the	DET
dpc-1867	94	8	elimination	elimination	NOUN
dpc-1867	94	9	of	of	ADP
dpc-1867	94	10	rtx	rtx	PROPN
dpc-1867	94	11	-	-	PUNCT
dpc-1867	94	12	cd20	cd20	PROPN
dpc-1867	94	13	complexes	complex	NOUN
dpc-1867	94	14	by	by	ADP
dpc-1867	94	15	macrophages	macrophage	NOUN
dpc-1867	94	16	,	,	PUNCT
dpc-1867	94	17	that	that	PRON
dpc-1867	94	18	causes	cause	VERB
dpc-1867	94	19	cell	cell	NOUN
dpc-1867	94	20	death	death	NOUN
dpc-1867	94	21	by	by	ADP
dpc-1867	94	22	a	a	DET
dpc-1867	94	23	still	still	ADV
dpc-1867	94	24	unknown	unknown	ADJ
dpc-1867	94	25	mechanism	mechanism	NOUN
dpc-1867	94	26	[	[	X
dpc-1867	94	27	25	25	NUM
dpc-1867	94	28	]	]	PUNCT
dpc-1867	94	29	.	.	PUNCT
dpc-1867	95	1	pv	pv	NOUN
dpc-1867	95	2	patients	patient	NOUN
dpc-1867	95	3	on	on	ADP
dpc-1867	95	4	rtx	rtx	PROPN
dpc-1867	95	5	can	can	AUX
dpc-1867	95	6	develop	develop	VERB
dpc-1867	95	7	opportunistic	opportunistic	ADJ
dpc-1867	95	8	infections	infection	NOUN
dpc-1867	95	9	,	,	PUNCT
dpc-1867	95	10	such	such	ADJ
dpc-1867	95	11	as	as	ADP
dpc-1867	95	12	pneumocystis	pneumocystis	ADJ
dpc-1867	95	13	jirovecii	jirovecii	ADJ
dpc-1867	95	14	pneumonia	pneumonia	NOUN
dpc-1867	96	1	[	[	X
dpc-1867	96	2	23	23	NUM
dpc-1867	96	3	]	]	PUNCT
dpc-1867	96	4	,	,	PUNCT
dpc-1867	96	5	but	but	CCONJ
dpc-1867	96	6	it	it	PRON
dpc-1867	96	7	is	be	AUX
dpc-1867	96	8	still	still	ADV
dpc-1867	96	9	unclear	unclear	ADJ
dpc-1867	96	10	whether	whether	SCONJ
dpc-1867	96	11	pv	pv	VERB
dpc-1867	96	12	on	on	ADP
dpc-1867	96	13	rtx	rtx	PROPN
dpc-1867	96	14	may	may	AUX
dpc-1867	96	15	receive	receive	VERB
dpc-1867	96	16	a	a	DET
dpc-1867	96	17	pneumocystisjirovecii	pneumocystisjirovecii	NOUN
dpc-1867	96	18	prophylaxis	prophylaxis	NOUN
dpc-1867	97	1	[	[	X
dpc-1867	97	2	26	26	NUM
dpc-1867	97	3	]	]	PUNCT
dpc-1867	97	4	.	.	PUNCT
dpc-1867	98	1	furthermore	furthermore	ADV
dpc-1867	98	2	,	,	PUNCT
dpc-1867	98	3	reactivation	reactivation	NOUN
dpc-1867	98	4	of	of	ADP
dpc-1867	98	5	hepatitis	hepatitis	PROPN
dpc-1867	98	6	b	b	PROPN
dpc-1867	98	7	and	and	CCONJ
dpc-1867	98	8	c	c	PROPN
dpc-1867	98	9	and	and	CCONJ
dpc-1867	98	10	tuberculosis	tuberculosis	NOUN
dpc-1867	98	11	could	could	AUX
dpc-1867	98	12	be	be	AUX
dpc-1867	98	13	possible	possible	ADJ
dpc-1867	98	14	[	[	X
dpc-1867	98	15	23	23	NUM
dpc-1867	98	16	]	]	PUNCT
dpc-1867	98	17	.	.	PUNCT
dpc-1867	99	1	side	side	ADJ
dpc-1867	99	2	effects	effect	NOUN
dpc-1867	99	3	related	relate	VERB
dpc-1867	99	4	to	to	ADP
dpc-1867	99	5	rtx	rtx	PROPN
dpc-1867	99	6	administration	administration	NOUN
dpc-1867	99	7	are	be	AUX
dpc-1867	99	8	represented	represent	VERB
dpc-1867	99	9	mostly	mostly	ADV
dpc-1867	99	10	by	by	ADP
dpc-1867	99	11	type	type	NOUN
dpc-1867	99	12	i	i	PRON
dpc-1867	99	13	allergic	allergic	ADJ
dpc-1867	99	14	reaction	reaction	NOUN
dpc-1867	99	15	and	and	CCONJ
dpc-1867	99	16	cytokine	cytokine	ADJ
dpc-1867	99	17	release	release	NOUN
dpc-1867	99	18	syndrome	syndrome	NOUN
dpc-1867	99	19	[	[	X
dpc-1867	99	20	23	23	NUM
dpc-1867	99	21	]	]	PUNCT
dpc-1867	99	22	.	.	PUNCT
dpc-1867	100	1	furthermore	furthermore	ADV
dpc-1867	100	2	,	,	PUNCT
dpc-1867	100	3	late	late	ADJ
dpc-1867	100	4	aes	aes	PROPN
dpc-1867	100	5	include	include	VERB
dpc-1867	100	6	serum	serum	NOUN
dpc-1867	100	7	sickness	sickness	NOUN
dpc-1867	100	8	and	and	CCONJ
dpc-1867	100	9	toxic	toxic	ADJ
dpc-1867	100	10	epidermal	epidermal	ADJ
dpc-1867	100	11	necrolysis	necrolysis	NOUN
dpc-1867	100	12	[	[	X
dpc-1867	100	13	23,27	23,27	NUM
dpc-1867	100	14	]	]	PUNCT
dpc-1867	100	15	.	.	PUNCT
dpc-1867	101	1	the	the	DET
dpc-1867	101	2	optimal	optimal	ADJ
dpc-1867	101	3	rtx	rtx	PROPN
dpc-1867	101	4	dose	dose	NOUN
dpc-1867	101	5	in	in	ADP
dpc-1867	101	6	pv	pv	PROPN
dpc-1867	101	7	is	be	AUX
dpc-1867	101	8	still	still	ADV
dpc-1867	101	9	under	under	ADP
dpc-1867	101	10	debate	debate	NOUN
dpc-1867	101	11	.	.	PUNCT
dpc-1867	102	1	two	two	NUM
dpc-1867	102	2	main	main	ADJ
dpc-1867	102	3	protocols	protocol	NOUN
dpc-1867	102	4	have	have	AUX
dpc-1867	102	5	been	be	AUX
dpc-1867	102	6	proposed	propose	VERB
dpc-1867	102	7	:	:	PUNCT
dpc-1867	102	8	2	2	NUM
dpc-1867	102	9	intravenous	intravenous	ADJ
dpc-1867	102	10	infusions	infusion	NOUN
dpc-1867	102	11	of	of	ADP
dpc-1867	102	12	1000	1000	NUM
dpc-1867	102	13	mg	mg	NOUN
dpc-1867	102	14	each	each	DET
dpc-1867	102	15	2	2	NUM
dpc-1867	102	16	weeks	week	NOUN
dpc-1867	102	17	apart	apart	ADV
dpc-1867	102	18	(	(	PUNCT
dpc-1867	102	19	rheumatoid	rheumatoid	VERB
dpc-1867	102	20	arthritis	arthritis	NOUN
dpc-1867	102	21	protocol	protocol	NOUN
dpc-1867	102	22	)	)	PUNCT
dpc-1867	102	23	and	and	CCONJ
dpc-1867	102	24	4	4	NUM
dpc-1867	102	25	infusions	infusion	NOUN
dpc-1867	102	26	of	of	ADP
dpc-1867	102	27	500	500	NUM
dpc-1867	102	28	-	-	PUNCT
dpc-1867	102	29	mg	mg	PROPN
dpc-1867	102	30	each	each	DET
dpc-1867	102	31	weekly	weekly	NOUN
dpc-1867	102	32	[	[	X
dpc-1867	102	33	23,28	23,28	NUM
dpc-1867	102	34	]	]	X
dpc-1867	102	35	.	.	PUNCT
dpc-1867	103	1	in	in	ADP
dpc-1867	103	2	2017	2017	NUM
dpc-1867	103	3	,	,	PUNCT
dpc-1867	103	4	a	a	DET
dpc-1867	103	5	prospective	prospective	ADJ
dpc-1867	103	6	randomized	randomized	ADJ
dpc-1867	103	7	controlled	control	VERB
dpc-1867	103	8	trial	trial	NOUN
dpc-1867	103	9	that	that	PRON
dpc-1867	103	10	compared	compare	VERB
dpc-1867	103	11	rtx	rtx	PROPN
dpc-1867	103	12	combined	combine	VERB
dpc-1867	103	13	with	with	ADP
dpc-1867	103	14	cs	cs	PROPN
dpc-1867	103	15	versus	versus	ADP
dpc-1867	103	16	cs	cs	PROPN
dpc-1867	103	17	alone	alone	ADV
dpc-1867	103	18	in	in	ADP
dpc-1867	103	19	patients	patient	NOUN
dpc-1867	103	20	with	with	ADP
dpc-1867	103	21	newly	newly	ADV
dpc-1867	103	22	diagnosed	diagnose	VERB
dpc-1867	103	23	pv	pv	NOUN
dpc-1867	103	24	showed	show	VERB
dpc-1867	103	25	a	a	DET
dpc-1867	103	26	significantly	significantly	ADV
dpc-1867	103	27	higher	high	ADJ
dpc-1867	103	28	remission	remission	NOUN
dpc-1867	103	29	rate	rate	NOUN
dpc-1867	103	30	off	off	ADP
dpc-1867	103	31	-	-	PUNCT
dpc-1867	103	32	therapy	therapy	NOUN
dpc-1867	103	33	in	in	ADP
dpc-1867	103	34	the	the	DET
dpc-1867	103	35	rtx	rtx	PROPN
dpc-1867	103	36	cohort	cohort	NOUN
dpc-1867	103	37	[	[	X
dpc-1867	103	38	29	29	NUM
dpc-1867	103	39	]	]	PUNCT
dpc-1867	103	40	.	.	PUNCT
dpc-1867	104	1	furthermore	furthermore	ADV
dpc-1867	104	2	,	,	PUNCT
dpc-1867	104	3	re	re	NOUN
dpc-1867	104	4	-	-	NOUN
dpc-1867	104	5	treatment	treatment	NOUN
dpc-1867	104	6	with	with	ADP
dpc-1867	104	7	a	a	DET
dpc-1867	104	8	single	single	ADJ
dpc-1867	104	9	rtx	rtx	NOUN
dpc-1867	104	10	dose	dose	NOUN
dpc-1867	104	11	of	of	ADP
dpc-1867	104	12	500	500	NUM
dpc-1867	104	13	mg	mg	NOUN
dpc-1867	104	14	after	after	ADP
dpc-1867	104	15	12	12	NUM
dpc-1867	104	16	and	and	CCONJ
dpc-1867	104	17	figure	figure	VERB
dpc-1867	104	18	3	3	NUM
dpc-1867	104	19	.	.	PUNCT
dpc-1867	105	1	deposition	deposition	NOUN
dpc-1867	105	2	of	of	ADP
dpc-1867	105	3	igg	igg	PROPN
dpc-1867	105	4	and/or	and/or	CCONJ
dpc-1867	105	5	c3	c3	PROPN
dpc-1867	105	6	on	on	ADP
dpc-1867	105	7	the	the	DET
dpc-1867	105	8	surface	surface	NOUN
dpc-1867	105	9	of	of	ADP
dpc-1867	105	10	epidermal	epidermal	ADJ
dpc-1867	105	11	keratinocytes	keratinocyte	NOUN
dpc-1867	105	12	detected	detect	VERB
dpc-1867	105	13	by	by	ADP
dpc-1867	105	14	direct	direct	ADJ
dpc-1867	105	15	immunofluorescence	immunofluorescence	NOUN
dpc-1867	105	16	.	.	PUNCT
dpc-1867	106	1	c3	c3	NOUN
dpc-1867	106	2	=	=	NOUN
dpc-1867	106	3	proteins	protein	NOUN
dpc-1867	106	4	of	of	ADP
dpc-1867	106	5	complement	complement	NOUN
dpc-1867	106	6	c3	c3	NOUN
dpc-1867	106	7	;	;	PUNCT
dpc-1867	107	1	igg	igg	PROPN
dpc-1867	107	2	=	=	PROPN
dpc-1867	107	3	immunoglobulin	immunoglobulin	PROPN
dpc-1867	107	4	g.	g.	PROPN
dpc-1867	107	5	4	4	NUM
dpc-1867	107	6	review	review	NOUN
dpc-1867	107	7	|	|	ADV
dpc-1867	107	8	dermatol	dermatol	ADJ
dpc-1867	107	9	pract	pract	NOUN
dpc-1867	107	10	concept	concept	NOUN
dpc-1867	107	11	.	.	PUNCT
dpc-1867	108	1	2022;12(1	2022;12(1	NUM
dpc-1867	108	2	):	):	PUNCT
dpc-1867	108	3	e2022037	e2022037	NOUN
dpc-1867	108	4	18	18	NUM
dpc-1867	108	5	months	month	NOUN
dpc-1867	108	6	was	be	AUX
dpc-1867	108	7	highly	highly	ADV
dpc-1867	108	8	effective	effective	ADJ
dpc-1867	108	9	in	in	ADP
dpc-1867	108	10	achieving	achieve	VERB
dpc-1867	108	11	a	a	DET
dpc-1867	108	12	long	long	ADJ
dpc-1867	108	13	-	-	PUNCT
dpc-1867	108	14	term	term	NOUN
dpc-1867	108	15	clinical	clinical	ADJ
dpc-1867	108	16	remission	remission	NOUN
dpc-1867	108	17	[	[	X
dpc-1867	108	18	29	29	NUM
dpc-1867	108	19	]	]	PUNCT
dpc-1867	108	20	.	.	PUNCT
dpc-1867	109	1	ofatumumab	ofatumumab	NOUN
dpc-1867	109	2	ofatumumab	ofatumumab	NOUN
dpc-1867	109	3	is	be	AUX
dpc-1867	109	4	a	a	DET
dpc-1867	109	5	fully	fully	ADV
dpc-1867	109	6	human	human	ADJ
dpc-1867	109	7	anti	anti	ADJ
dpc-1867	109	8	-	-	ADJ
dpc-1867	109	9	cd20	cd20	ADJ
dpc-1867	109	10	monoclonal	monoclonal	NOUN
dpc-1867	109	11	antibody	antibody	NOUN
dpc-1867	109	12	used	use	VERB
dpc-1867	109	13	as	as	ADP
dpc-1867	109	14	therapy	therapy	NOUN
dpc-1867	109	15	in	in	ADP
dpc-1867	109	16	chronic	chronic	ADJ
dpc-1867	109	17	lymphocytic	lymphocytic	ADJ
dpc-1867	109	18	leukemia	leukemia	NOUN
dpc-1867	109	19	.	.	PUNCT
dpc-1867	110	1	its	its	PRON
dpc-1867	110	2	target	target	NOUN
dpc-1867	110	3	is	be	AUX
dpc-1867	110	4	represented	represent	VERB
dpc-1867	110	5	by	by	ADP
dpc-1867	110	6	another	another	DET
dpc-1867	110	7	cd20	cd20	PROPN
dpc-1867	110	8	epitope	epitope	PROPN
dpc-1867	110	9	compared	compare	VERB
dpc-1867	110	10	to	to	ADP
dpc-1867	110	11	the	the	DET
dpc-1867	110	12	one	one	NOUN
dpc-1867	110	13	targeted	target	VERB
dpc-1867	110	14	by	by	ADP
dpc-1867	110	15	rtx	rtx	PROPN
dpc-1867	111	1	[	[	X
dpc-1867	111	2	30	30	NUM
dpc-1867	111	3	]	]	PUNCT
dpc-1867	111	4	.	.	PUNCT
dpc-1867	112	1	ofatumumab	ofatumumab	NOUN
dpc-1867	112	2	has	have	AUX
dpc-1867	112	3	been	be	AUX
dpc-1867	112	4	used	use	VERB
dpc-1867	112	5	for	for	ADP
dpc-1867	112	6	pv	pv	NOUN
dpc-1867	112	7	patients	patient	NOUN
dpc-1867	112	8	who	who	PRON
dpc-1867	112	9	developed	develop	VERB
dpc-1867	112	10	side	side	NOUN
dpc-1867	112	11	effects	effect	NOUN
dpc-1867	112	12	or	or	CCONJ
dpc-1867	112	13	loss	loss	NOUN
dpc-1867	112	14	of	of	ADP
dpc-1867	112	15	response	response	NOUN
dpc-1867	112	16	to	to	ADP
dpc-1867	112	17	rtx	rtx	PROPN
dpc-1867	112	18	[	[	X
dpc-1867	112	19	31	31	NUM
dpc-1867	112	20	]	]	PUNCT
dpc-1867	112	21	.	.	PUNCT
dpc-1867	113	1	intravenous	intravenous	ADJ
dpc-1867	113	2	immunoglobulin	immunoglobulin	PROPN
dpc-1867	113	3	intravenous	intravenous	ADJ
dpc-1867	113	4	immunoglobulin	immunoglobulin	NOUN
dpc-1867	113	5	(	(	PUNCT
dpc-1867	113	6	ivig	ivig	NOUN
dpc-1867	113	7	)	)	PUNCT
dpc-1867	113	8	is	be	AUX
dpc-1867	113	9	used	use	VERB
dpc-1867	113	10	for	for	ADP
dpc-1867	113	11	immunomodulatory	immunomodulatory	ADJ
dpc-1867	113	12	therapy	therapy	NOUN
dpc-1867	113	13	of	of	ADP
dpc-1867	113	14	several	several	ADJ
dpc-1867	113	15	inflammatory	inflammatory	ADJ
dpc-1867	113	16	disorders	disorder	NOUN
dpc-1867	113	17	[	[	X
dpc-1867	113	18	32	32	NUM
dpc-1867	113	19	]	]	PUNCT
dpc-1867	113	20	.	.	PUNCT
dpc-1867	114	1	the	the	DET
dpc-1867	114	2	mechanism	mechanism	NOUN
dpc-1867	114	3	of	of	ADP
dpc-1867	114	4	action	action	NOUN
dpc-1867	114	5	of	of	ADP
dpc-1867	114	6	ivig	ivig	NOUN
dpc-1867	114	7	is	be	AUX
dpc-1867	114	8	still	still	ADV
dpc-1867	114	9	not	not	PART
dpc-1867	114	10	completely	completely	ADV
dpc-1867	114	11	known	know	VERB
dpc-1867	114	12	,	,	PUNCT
dpc-1867	114	13	but	but	CCONJ
dpc-1867	114	14	several	several	ADJ
dpc-1867	114	15	modes	mode	NOUN
dpc-1867	114	16	of	of	ADP
dpc-1867	114	17	action	action	NOUN
dpc-1867	114	18	have	have	AUX
dpc-1867	114	19	been	be	AUX
dpc-1867	114	20	proposed	propose	VERB
dpc-1867	114	21	[	[	X
dpc-1867	114	22	33,34	33,34	NOUN
dpc-1867	114	23	]	]	X
dpc-1867	114	24	.	.	PUNCT
dpc-1867	115	1	however	however	ADV
dpc-1867	115	2	,	,	PUNCT
dpc-1867	115	3	the	the	DET
dpc-1867	115	4	main	main	ADJ
dpc-1867	115	5	mechanism	mechanism	NOUN
dpc-1867	115	6	of	of	ADP
dpc-1867	115	7	action	action	NOUN
dpc-1867	115	8	is	be	AUX
dpc-1867	115	9	considered	consider	VERB
dpc-1867	115	10	the	the	DET
dpc-1867	115	11	implementation	implementation	NOUN
dpc-1867	115	12	of	of	ADP
dpc-1867	115	13	degradation	degradation	NOUN
dpc-1867	115	14	of	of	ADP
dpc-1867	115	15	immunoglobulins	immunoglobulin	NOUN
dpc-1867	115	16	by	by	ADP
dpc-1867	115	17	binding	bind	VERB
dpc-1867	115	18	the	the	DET
dpc-1867	115	19	neonatal	neonatal	NOUN
dpc-1867	115	20	of	of	ADP
dpc-1867	115	21	fc	fc	PROPN
dpc-1867	115	22	receptor	receptor	NOUN
dpc-1867	115	23	(	(	PUNCT
dpc-1867	115	24	fcrn	fcrn	PROPN
dpc-1867	115	25	)	)	PUNCT
dpc-1867	116	1	[	[	X
dpc-1867	116	2	33,34	33,34	NOUN
dpc-1867	116	3	]	]	PUNCT
dpc-1867	116	4	.	.	PUNCT
dpc-1867	117	1	the	the	DET
dpc-1867	117	2	standard	standard	ADJ
dpc-1867	117	3	administration	administration	NOUN
dpc-1867	117	4	schedule	schedule	NOUN
dpc-1867	117	5	is	be	AUX
dpc-1867	117	6	2	2	NUM
dpc-1867	117	7	g	g	NOUN
dpc-1867	117	8	/	/	SYM
dpc-1867	117	9	kg	kg	NOUN
dpc-1867	117	10	in	in	ADP
dpc-1867	117	11	5	5	NUM
dpc-1867	117	12	days	day	NOUN
dpc-1867	117	13	(	(	PUNCT
dpc-1867	117	14	400	400	NUM
dpc-1867	117	15	mg	mg	NUM
dpc-1867	117	16	/	/	SYM
dpc-1867	117	17	kg	kg	NOUN
dpc-1867	117	18	per	per	ADP
dpc-1867	117	19	day	day	NOUN
dpc-1867	117	20	in	in	ADP
dpc-1867	117	21	5	5	NUM
dpc-1867	117	22	days	day	NOUN
dpc-1867	117	23	)	)	PUNCT
dpc-1867	117	24	must	must	AUX
dpc-1867	117	25	be	be	AUX
dpc-1867	117	26	kept	keep	VERB
dpc-1867	117	27	in	in	ADP
dpc-1867	117	28	mind	mind	NOUN
dpc-1867	117	29	that	that	SCONJ
dpc-1867	117	30	ivig	ivig	NOUN
dpc-1867	117	31	does	do	AUX
dpc-1867	117	32	not	not	PART
dpc-1867	117	33	show	show	VERB
dpc-1867	117	34	an	an	DET
dpc-1867	117	35	immunosuppressive	immunosuppressive	ADJ
dpc-1867	117	36	activity	activity	NOUN
dpc-1867	117	37	[	[	X
dpc-1867	117	38	32,34	32,34	NUM
dpc-1867	117	39	]	]	X
dpc-1867	117	40	.	.	PUNCT
dpc-1867	118	1	it	it	PRON
dpc-1867	118	2	can	can	AUX
dpc-1867	118	3	be	be	AUX
dpc-1867	118	4	administered	administer	VERB
dpc-1867	118	5	in	in	ADP
dpc-1867	118	6	combination	combination	NOUN
dpc-1867	118	7	with	with	ADP
dpc-1867	118	8	systemic	systemic	ADJ
dpc-1867	118	9	cs	cs	PROPN
dpc-1867	118	10	and	and	CCONJ
dpc-1867	118	11	other	other	ADJ
dpc-1867	118	12	immunosuppressants	immunosuppressant	NOUN
dpc-1867	118	13	in	in	ADP
dpc-1867	118	14	recalcitrant	recalcitrant	ADJ
dpc-1867	118	15	pv	pv	NOUN
dpc-1867	119	1	[	[	X
dpc-1867	119	2	35	35	NUM
dpc-1867	119	3	]	]	SYM
dpc-1867	119	4	.	.	PUNCT
dpc-1867	120	1	side	side	ADJ
dpc-1867	120	2	effects	effect	NOUN
dpc-1867	120	3	were	be	AUX
dpc-1867	120	4	not	not	PART
dpc-1867	120	5	frequently	frequently	ADV
dpc-1867	120	6	described	describe	VERB
dpc-1867	120	7	[	[	X
dpc-1867	120	8	36,37	36,37	NUM
dpc-1867	120	9	]	]	PUNCT
dpc-1867	120	10	.	.	PUNCT
dpc-1867	121	1	early	early	ADJ
dpc-1867	121	2	aes	aes	PROPN
dpc-1867	121	3	include	include	VERB
dpc-1867	121	4	headache	headache	NOUN
dpc-1867	121	5	,	,	PUNCT
dpc-1867	121	6	nausea	nausea	NOUN
dpc-1867	121	7	,	,	PUNCT
dpc-1867	121	8	fever	fever	NOUN
dpc-1867	121	9	,	,	PUNCT
dpc-1867	121	10	tachycardia	tachycardia	NOUN
dpc-1867	121	11	,	,	PUNCT
dpc-1867	121	12	malaise	malaise	NOUN
dpc-1867	121	13	,	,	PUNCT
dpc-1867	121	14	arthralgia	arthralgia	NOUN
dpc-1867	121	15	,	,	PUNCT
dpc-1867	121	16	and	and	CCONJ
dpc-1867	121	17	dyspnea	dyspnea	VERB
dpc-1867	122	1	[	[	X
dpc-1867	122	2	36,37	36,37	X
dpc-1867	122	3	]	]	X
dpc-1867	122	4	.	.	PUNCT
dpc-1867	123	1	late	late	ADJ
dpc-1867	123	2	-	-	PUNCT
dpc-1867	123	3	onset	onset	NOUN
dpc-1867	123	4	aes	aes	NOUN
dpc-1867	123	5	include	include	VERB
dpc-1867	123	6	,	,	PUNCT
dpc-1867	123	7	aseptic	aseptic	ADJ
dpc-1867	123	8	meningitis	meningitis	NOUN
dpc-1867	123	9	,	,	PUNCT
dpc-1867	123	10	acute	acute	ADJ
dpc-1867	123	11	renal	renal	ADJ
dpc-1867	123	12	failure	failure	NOUN
dpc-1867	123	13	,	,	PUNCT
dpc-1867	123	14	thromboembolic	thromboembolic	ADJ
dpc-1867	123	15	events	event	NOUN
dpc-1867	123	16	,	,	PUNCT
dpc-1867	123	17	and	and	CCONJ
dpc-1867	123	18	pseudohyponatremia	pseudohyponatremia	NOUN
dpc-1867	124	1	[	[	X
dpc-1867	124	2	36,37	36,37	X
dpc-1867	124	3	]	]	X
dpc-1867	124	4	.	.	PUNCT
dpc-1867	125	1	immunoadsorption	immunoadsorption	NOUN
dpc-1867	125	2	through	through	ADP
dpc-1867	125	3	immunoadsorption	immunoadsorption	NOUN
dpc-1867	125	4	(	(	PUNCT
dpc-1867	125	5	ia	ia	PROPN
dpc-1867	125	6	)	)	PUNCT
dpc-1867	125	7	igg	igg	PROPN
dpc-1867	125	8	were	be	AUX
dpc-1867	125	9	passively	passively	ADV
dpc-1867	125	10	removed	remove	VERB
dpc-1867	125	11	from	from	ADP
dpc-1867	125	12	systemic	systemic	ADJ
dpc-1867	125	13	circulation	circulation	NOUN
dpc-1867	125	14	[	[	X
dpc-1867	125	15	1	1	NUM
dpc-1867	125	16	]	]	PUNCT
dpc-1867	125	17	.	.	PUNCT
dpc-1867	126	1	the	the	DET
dpc-1867	126	2	combination	combination	NOUN
dpc-1867	126	3	of	of	ADP
dpc-1867	126	4	ia	ia	PROPN
dpc-1867	126	5	with	with	ADP
dpc-1867	126	6	immunosuppressive	immunosuppressive	ADJ
dpc-1867	126	7	therapies	therapy	NOUN
dpc-1867	126	8	is	be	AUX
dpc-1867	126	9	considered	consider	VERB
dpc-1867	126	10	an	an	DET
dpc-1867	126	11	effective	effective	ADJ
dpc-1867	126	12	treatment	treatment	NOUN
dpc-1867	126	13	for	for	ADP
dpc-1867	126	14	pemphigus	pemphigus	NOUN
dpc-1867	126	15	patients	patient	NOUN
dpc-1867	126	16	with	with	ADP
dpc-1867	126	17	severe	severe	ADJ
dpc-1867	126	18	activity	activity	NOUN
dpc-1867	126	19	,	,	PUNCT
dpc-1867	126	20	because	because	SCONJ
dpc-1867	126	21	ia	ia	PROPN
dpc-1867	126	22	allows	allow	VERB
dpc-1867	126	23	an	an	DET
dpc-1867	126	24	immediate	immediate	ADJ
dpc-1867	126	25	removal	removal	NOUN
dpc-1867	126	26	of	of	ADP
dpc-1867	126	27	pathogenic	pathogenic	ADJ
dpc-1867	126	28	autoantibodies	autoantibody	NOUN
dpc-1867	126	29	.	.	PUNCT
dpc-1867	127	1	infections	infection	NOUN
dpc-1867	127	2	are	be	AUX
dpc-1867	127	3	still	still	ADV
dpc-1867	127	4	the	the	DET
dpc-1867	127	5	most	most	ADV
dpc-1867	127	6	frequently	frequently	ADV
dpc-1867	127	7	complications	complication	NOUN
dpc-1867	127	8	[	[	X
dpc-1867	127	9	1	1	NUM
dpc-1867	127	10	]	]	PUNCT
dpc-1867	127	11	.	.	PUNCT
dpc-1867	128	1	ia	ia	PROPN
dpc-1867	128	2	is	be	AUX
dpc-1867	128	3	considered	consider	VERB
dpc-1867	128	4	an	an	DET
dpc-1867	128	5	effective	effective	ADJ
dpc-1867	128	6	treatment	treatment	NOUN
dpc-1867	128	7	in	in	ADP
dpc-1867	128	8	patients	patient	NOUN
dpc-1867	128	9	with	with	ADP
dpc-1867	128	10	severe	severe	ADJ
dpc-1867	128	11	disease	disease	NOUN
dpc-1867	128	12	(	(	PUNCT
dpc-1867	128	13	>	>	X
dpc-1867	128	14	30	30	NUM
dpc-1867	128	15	%	%	NOUN
dpc-1867	128	16	of	of	ADP
dpc-1867	128	17	the	the	DET
dpc-1867	128	18	body	body	NOUN
dpc-1867	128	19	surface	surface	NOUN
dpc-1867	128	20	or	or	CCONJ
dpc-1867	128	21	>	>	SYM
dpc-1867	128	22	25	25	NUM
dpc-1867	128	23	%	%	NOUN
dpc-1867	128	24	of	of	ADP
dpc-1867	128	25	genital	genital	ADJ
dpc-1867	128	26	or	or	CCONJ
dpc-1867	128	27	oral	oral	ADJ
dpc-1867	128	28	mucosa	mucosa	NOUN
dpc-1867	128	29	)	)	PUNCT
dpc-1867	128	30	or	or	CCONJ
dpc-1867	128	31	with	with	ADP
dpc-1867	128	32	involvement	involvement	NOUN
dpc-1867	128	33	of	of	ADP
dpc-1867	128	34	the	the	DET
dpc-1867	128	35	conjunctiva	conjunctiva	NOUN
dpc-1867	128	36	or	or	CCONJ
dpc-1867	128	37	esophagus	esophagus	NOUN
dpc-1867	129	1	[	[	X
dpc-1867	129	2	1	1	NUM
dpc-1867	129	3	]	]	PUNCT
dpc-1867	129	4	.	.	PUNCT
dpc-1867	130	1	future	future	ADJ
dpc-1867	130	2	therapeutic	therapeutic	ADJ
dpc-1867	130	3	approaches	approach	NOUN
dpc-1867	130	4	car	car	NOUN
dpc-1867	130	5	-	-	PUNCT
dpc-1867	130	6	t	t	NOUN
dpc-1867	130	7	cell	cell	NOUN
dpc-1867	130	8	therapies	therapy	NOUN
dpc-1867	130	9	chimeric	chimeric	ADJ
dpc-1867	130	10	antigen	antigen	ADJ
dpc-1867	130	11	receptor	receptor	NOUN
dpc-1867	130	12	(	(	PUNCT
dpc-1867	130	13	car)-t	car)-t	NOUN
dpc-1867	130	14	-	-	PUNCT
dpc-1867	130	15	cell	cell	NOUN
dpc-1867	130	16	therapy	therapy	NOUN
dpc-1867	130	17	has	have	AUX
dpc-1867	130	18	been	be	AUX
dpc-1867	130	19	described	describe	VERB
dpc-1867	130	20	as	as	ADP
dpc-1867	130	21	promising	promise	VERB
dpc-1867	130	22	therapy	therapy	NOUN
dpc-1867	130	23	in	in	ADP
dpc-1867	130	24	hematology	hematology	NOUN
dpc-1867	130	25	[	[	X
dpc-1867	130	26	1	1	NUM
dpc-1867	130	27	]	]	PUNCT
dpc-1867	130	28	.	.	PUNCT
dpc-1867	131	1	car	car	NOUN
dpc-1867	131	2	-	-	PUNCT
dpc-1867	131	3	t	t	NOUN
dpc-1867	131	4	cell	cell	NOUN
dpc-1867	131	5	therapy	therapy	NOUN
dpc-1867	131	6	is	be	AUX
dpc-1867	131	7	a	a	DET
dpc-1867	131	8	paradigmatic	paradigmatic	ADJ
dpc-1867	131	9	example	example	NOUN
dpc-1867	131	10	of	of	ADP
dpc-1867	131	11	adoptive	adoptive	ADJ
dpc-1867	131	12	cell	cell	NOUN
dpc-1867	131	13	transfer	transfer	NOUN
dpc-1867	131	14	therapy	therapy	NOUN
dpc-1867	131	15	.	.	PUNCT
dpc-1867	132	1	indeed	indeed	ADV
dpc-1867	132	2	,	,	PUNCT
dpc-1867	132	3	autologous	autologous	ADJ
dpc-1867	132	4	t	t	NOUN
dpc-1867	132	5	-	-	PUNCT
dpc-1867	132	6	cells	cell	NOUN
dpc-1867	132	7	are	be	AUX
dpc-1867	132	8	modified	modify	VERB
dpc-1867	132	9	ex	ex	NOUN
dpc-1867	132	10	-	-	NOUN
dpc-1867	132	11	vivo	vivo	ADJ
dpc-1867	132	12	to	to	PART
dpc-1867	132	13	express	express	VERB
dpc-1867	132	14	a	a	DET
dpc-1867	132	15	car	car	NOUN
dpc-1867	132	16	,	,	PUNCT
dpc-1867	132	17	which	which	PRON
dpc-1867	132	18	leads	lead	VERB
dpc-1867	132	19	to	to	ADP
dpc-1867	132	20	a	a	DET
dpc-1867	132	21	specific	specific	ADJ
dpc-1867	132	22	targeting	targeting	NOUN
dpc-1867	132	23	of	of	ADP
dpc-1867	132	24	a	a	DET
dpc-1867	132	25	particular	particular	ADJ
dpc-1867	132	26	antigen	antigen	NOUN
dpc-1867	132	27	and	and	CCONJ
dpc-1867	132	28	elimination	elimination	NOUN
dpc-1867	132	29	of	of	ADP
dpc-1867	132	30	the	the	DET
dpc-1867	132	31	antigen	antigen	NOUN
dpc-1867	132	32	-	-	PUNCT
dpc-1867	132	33	expressing	express	VERB
dpc-1867	132	34	cells	cell	NOUN
dpc-1867	132	35	[	[	X
dpc-1867	132	36	38,39	38,39	NOUN
dpc-1867	132	37	]	]	X
dpc-1867	132	38	.	.	PUNCT
dpc-1867	133	1	the	the	DET
dpc-1867	133	2	cars	car	NOUN
dpc-1867	133	3	are	be	AUX
dpc-1867	133	4	composed	compose	VERB
dpc-1867	133	5	of	of	ADP
dpc-1867	133	6	3	3	NUM
dpc-1867	133	7	domains	domain	NOUN
dpc-1867	133	8	:	:	PUNCT
dpc-1867	133	9	1	1	NUM
dpc-1867	133	10	)	)	PUNCT
dpc-1867	133	11	the	the	DET
dpc-1867	133	12	extracellular	extracellular	ADJ
dpc-1867	133	13	domain	domain	NOUN
dpc-1867	133	14	,	,	PUNCT
dpc-1867	133	15	which	which	PRON
dpc-1867	133	16	represents	represent	VERB
dpc-1867	133	17	the	the	DET
dpc-1867	133	18	antigen	antigen	ADJ
dpc-1867	133	19	recognition	recognition	NOUN
dpc-1867	133	20	domain	domain	NOUN
dpc-1867	133	21	;	;	PUNCT
dpc-1867	133	22	2	2	X
dpc-1867	133	23	)	)	PUNCT
dpc-1867	133	24	the	the	DET
dpc-1867	133	25	transmembrane	transmembrane	NOUN
dpc-1867	133	26	and	and	CCONJ
dpc-1867	133	27	hinge	hinge	NOUN
dpc-1867	133	28	domain	domain	NOUN
dpc-1867	133	29	;	;	PUNCT
dpc-1867	133	30	3	3	X
dpc-1867	133	31	)	)	PUNCT
dpc-1867	133	32	the	the	DET
dpc-1867	133	33	one	one	NUM
dpc-1867	133	34	or	or	CCONJ
dpc-1867	133	35	more	more	ADV
dpc-1867	133	36	intracellular	intracellular	ADJ
dpc-1867	133	37	t	t	NOUN
dpc-1867	133	38	-	-	PUNCT
dpc-1867	133	39	cell	cell	NOUN
dpc-1867	133	40	signaling	signal	VERB
dpc-1867	133	41	domains	domain	NOUN
dpc-1867	133	42	[	[	X
dpc-1867	133	43	39	39	NUM
dpc-1867	133	44	]	]	PUNCT
dpc-1867	133	45	.	.	PUNCT
dpc-1867	134	1	in	in	ADP
dpc-1867	134	2	2016	2016	NUM
dpc-1867	134	3	,	,	PUNCT
dpc-1867	134	4	t	t	PROPN
dpc-1867	134	5	-	-	PUNCT
dpc-1867	134	6	cells	cell	NOUN
dpc-1867	134	7	were	be	AUX
dpc-1867	134	8	modified	modify	VERB
dpc-1867	134	9	to	to	PART
dpc-1867	134	10	express	express	VERB
dpc-1867	134	11	a	a	DET
dpc-1867	134	12	chimeric	chimeric	ADJ
dpc-1867	134	13	autoantibody	autoantibody	ADJ
dpc-1867	134	14	receptor	receptor	NOUN
dpc-1867	134	15	(	(	PUNCT
dpc-1867	134	16	caar	caar	NOUN
dpc-1867	134	17	)	)	PUNCT
dpc-1867	134	18	,	,	PUNCT
dpc-1867	134	19	which	which	PRON
dpc-1867	134	20	was	be	AUX
dpc-1867	134	21	composed	compose	VERB
dpc-1867	134	22	by	by	ADP
dpc-1867	134	23	dsg	dsg	PROPN
dpc-1867	134	24	3	3	NUM
dpc-1867	134	25	fused	fuse	VERB
dpc-1867	134	26	to	to	ADP
dpc-1867	134	27	a	a	DET
dpc-1867	134	28	cd137cd3	cd137cd3	NOUN
dpc-1867	134	29	-	-	PUNCT
dpc-1867	134	30	zeta	zeta	NOUN
dpc-1867	134	31	signaling	signal	VERB
dpc-1867	134	32	domains	domain	NOUN
dpc-1867	134	33	[	[	X
dpc-1867	134	34	39	39	NUM
dpc-1867	134	35	]	]	PUNCT
dpc-1867	134	36	.	.	PUNCT
dpc-1867	135	1	desmoglein-3	desmoglein-3	PROPN
dpc-1867	135	2	caar	caar	PROPN
dpc-1867	135	3	-	-	PUNCT
dpc-1867	135	4	t	t	NOUN
dpc-1867	135	5	-	-	PUNCT
dpc-1867	135	6	cells	cell	NOUN
dpc-1867	135	7	show	show	VERB
dpc-1867	135	8	a	a	DET
dpc-1867	135	9	selective	selective	ADJ
dpc-1867	135	10	cytotoxicity	cytotoxicity	NOUN
dpc-1867	135	11	directed	direct	VERB
dpc-1867	135	12	to	to	ADP
dpc-1867	135	13	cells	cell	NOUN
dpc-1867	135	14	with	with	ADP
dpc-1867	135	15	anti	anti	ADJ
dpc-1867	135	16	-	-	ADJ
dpc-1867	135	17	dsg3	dsg3	ADJ
dpc-1867	135	18	b	b	NOUN
dpc-1867	135	19	cell	cell	NOUN
dpc-1867	135	20	receptors	receptor	NOUN
dpc-1867	135	21	in	in	ADP
dpc-1867	135	22	vitro	vitro	X
dpc-1867	135	23	and	and	CCONJ
dpc-1867	135	24	destroy	destroy	VERB
dpc-1867	135	25	dsg3	dsg3	NOUN
dpc-1867	135	26	-	-	PUNCT
dpc-1867	135	27	specific	specific	ADJ
dpc-1867	135	28	b	b	NOUN
dpc-1867	135	29	-	-	PUNCT
dpc-1867	135	30	cells	cell	NOUN
dpc-1867	135	31	in	in	ADP
dpc-1867	135	32	vivo	vivo	NOUN
dpc-1867	135	33	.	.	PUNCT
dpc-1867	136	1	in	in	ADP
dpc-1867	136	2	a	a	DET
dpc-1867	136	3	pv	pv	NOUN
dpc-1867	136	4	mouse	mouse	NOUN
dpc-1867	136	5	model	model	NOUN
dpc-1867	136	6	,	,	PUNCT
dpc-1867	136	7	caar	caar	NOUN
dpc-1867	136	8	-	-	PUNCT
dpc-1867	136	9	t	t	NOUN
dpc-1867	136	10	cells	cell	NOUN
dpc-1867	136	11	reduced	reduce	VERB
dpc-1867	136	12	pathogenic	pathogenic	ADJ
dpc-1867	136	13	igg	igg	PROPN
dpc-1867	136	14	antibodies	antibody	NOUN
dpc-1867	136	15	and	and	CCONJ
dpc-1867	136	16	improved	improve	VERB
dpc-1867	136	17	the	the	DET
dpc-1867	136	18	clinical	clinical	ADJ
dpc-1867	136	19	picture	picture	NOUN
dpc-1867	137	1	[	[	X
dpc-1867	137	2	40	40	NUM
dpc-1867	137	3	]	]	PUNCT
dpc-1867	137	4	.	.	PUNCT
dpc-1867	138	1	anti	anti	ADJ
dpc-1867	138	2	-	-	ADJ
dpc-1867	138	3	neonatal	neonatal	ADJ
dpc-1867	138	4	fc	fc	NOUN
dpc-1867	138	5	receptor	receptor	NOUN
dpc-1867	138	6	(	(	PUNCT
dpc-1867	138	7	fcrn	fcrn	PROPN
dpc-1867	138	8	)	)	PUNCT
dpc-1867	138	9	the	the	DET
dpc-1867	138	10	fcrn	fcrn	NOUN
dpc-1867	138	11	is	be	AUX
dpc-1867	138	12	formed	form	VERB
dpc-1867	138	13	by	by	ADP
dpc-1867	138	14	the	the	DET
dpc-1867	138	15	mhc	mhc	PROPN
dpc-1867	138	16	class	class	NOUN
dpc-1867	138	17	i	i	NOUN
dpc-1867	138	18	-	-	PUNCT
dpc-1867	138	19	like	like	VERB
dpc-1867	138	20	heavy	heavy	ADJ
dpc-1867	138	21	chain	chain	NOUN
dpc-1867	138	22	and	and	CCONJ
dpc-1867	138	23	the	the	DET
dpc-1867	138	24	β2	β2	PROPN
dpc-1867	138	25	-	-	PUNCT
dpc-1867	138	26	microglobulin	microglobulin	PROPN
dpc-1867	138	27	light	light	PROPN
dpc-1867	138	28	chain	chain	NOUN
dpc-1867	138	29	[	[	X
dpc-1867	138	30	41	41	NUM
dpc-1867	138	31	]	]	PUNCT
dpc-1867	138	32	.	.	PUNCT
dpc-1867	139	1	it	it	PRON
dpc-1867	139	2	has	have	AUX
dpc-1867	139	3	played	play	VERB
dpc-1867	139	4	a	a	DET
dpc-1867	139	5	central	central	ADJ
dpc-1867	139	6	role	role	NOUN
dpc-1867	139	7	in	in	ADP
dpc-1867	139	8	the	the	DET
dpc-1867	139	9	homeostasis	homeostasis	NOUN
dpc-1867	139	10	of	of	ADP
dpc-1867	139	11	igg	igg	PROPN
dpc-1867	139	12	.	.	PUNCT
dpc-1867	140	1	indeed	indeed	ADV
dpc-1867	140	2	,	,	PUNCT
dpc-1867	140	3	the	the	DET
dpc-1867	140	4	igg	igg	NOUN
dpc-1867	140	5	-	-	PUNCT
dpc-1867	140	6	fcrn	fcrn	NOUN
dpc-1867	140	7	complex	complex	NOUN
dpc-1867	140	8	avoids	avoid	VERB
dpc-1867	140	9	the	the	DET
dpc-1867	140	10	degradation	degradation	NOUN
dpc-1867	140	11	of	of	ADP
dpc-1867	140	12	igg	igg	PROPN
dpc-1867	140	13	,	,	PUNCT
dpc-1867	140	14	leading	lead	VERB
dpc-1867	140	15	to	to	ADP
dpc-1867	140	16	a	a	DET
dpc-1867	140	17	recycle	recycle	NOUN
dpc-1867	140	18	and	and	CCONJ
dpc-1867	140	19	release	release	NOUN
dpc-1867	140	20	of	of	ADP
dpc-1867	140	21	igg	igg	PROPN
dpc-1867	140	22	[	[	X
dpc-1867	140	23	42,43	42,43	PROPN
dpc-1867	140	24	]	]	PUNCT
dpc-1867	140	25	.	.	PUNCT
dpc-1867	141	1	in	in	ADP
dpc-1867	141	2	a	a	DET
dpc-1867	141	3	knockout	knockout	NOUN
dpc-1867	141	4	mouse	mouse	NOUN
dpc-1867	141	5	for	for	ADP
dpc-1867	141	6	fcrn	fcrn	NOUN
dpc-1867	141	7	,	,	PUNCT
dpc-1867	141	8	loss	loss	NOUN
dpc-1867	141	9	of	of	ADP
dpc-1867	141	10	cell	cell	NOUN
dpc-1867	141	11	-	-	PUNCT
dpc-1867	141	12	cell	cell	NOUN
dpc-1867	141	13	adhesion	adhesion	NOUN
dpc-1867	141	14	by	by	ADP
dpc-1867	141	15	passive	passive	ADJ
dpc-1867	141	16	transfer	transfer	NOUN
dpc-1867	141	17	of	of	ADP
dpc-1867	141	18	antibodies	antibody	NOUN
dpc-1867	141	19	against	against	ADP
dpc-1867	141	20	dsg	dsg	PROPN
dpc-1867	141	21	was	be	AUX
dpc-1867	141	22	not	not	PART
dpc-1867	141	23	evident	evident	ADJ
dpc-1867	141	24	[	[	X
dpc-1867	141	25	44	44	NUM
dpc-1867	141	26	]	]	PUNCT
dpc-1867	141	27	.	.	PUNCT
dpc-1867	142	1	furthermore	furthermore	ADV
dpc-1867	142	2	,	,	PUNCT
dpc-1867	142	3	it	it	PRON
dpc-1867	142	4	was	be	AUX
dpc-1867	142	5	reported	report	VERB
dpc-1867	142	6	that	that	SCONJ
dpc-1867	142	7	blocking	block	VERB
dpc-1867	142	8	fcrn	fcrn	NOUN
dpc-1867	142	9	impaired	impair	VERB
dpc-1867	142	10	the	the	DET
dpc-1867	142	11	capability	capability	NOUN
dpc-1867	142	12	of	of	ADP
dpc-1867	142	13	pv	pv	NOUN
dpc-1867	142	14	to	to	PART
dpc-1867	142	15	determine	determine	VERB
dpc-1867	142	16	acantholysis	acantholysis	NOUN
dpc-1867	142	17	[	[	X
dpc-1867	142	18	45	45	NUM
dpc-1867	142	19	]	]	PUNCT
dpc-1867	142	20	.	.	PUNCT
dpc-1867	143	1	a	a	DET
dpc-1867	143	2	randomized	randomized	ADJ
dpc-1867	143	3	,	,	PUNCT
dpc-1867	143	4	double	double	ADJ
dpc-1867	143	5	-	-	PUNCT
dpc-1867	143	6	blind	blind	ADJ
dpc-1867	143	7	,	,	PUNCT
dpc-1867	143	8	placebo	placebo	NOUN
dpc-1867	143	9	-	-	PUNCT
dpc-1867	143	10	controlled	control	VERB
dpc-1867	143	11	study	study	NOUN
dpc-1867	143	12	with	with	ADP
dpc-1867	143	13	efgartigimod	efgartigimod	PROPN
dpc-1867	143	14	,	,	PUNCT
dpc-1867	143	15	a	a	DET
dpc-1867	143	16	human	human	ADJ
dpc-1867	143	17	igg1	igg1	NOUN
dpc-1867	143	18	-	-	PUNCT
dpc-1867	143	19	derived	derive	VERB
dpc-1867	143	20	fc	fc	NOUN
dpc-1867	143	21	fragments	fragment	NOUN
dpc-1867	143	22	bound	bind	VERB
dpc-1867	143	23	to	to	PART
dpc-1867	143	24	fcrn	fcrn	NOUN
dpc-1867	143	25	,	,	PUNCT
dpc-1867	143	26	reported	report	VERB
dpc-1867	143	27	the	the	DET
dpc-1867	143	28	efficacy	efficacy	NOUN
dpc-1867	143	29	of	of	ADP
dpc-1867	143	30	the	the	DET
dpc-1867	143	31	drug	drug	NOUN
dpc-1867	143	32	in	in	ADP
dpc-1867	143	33	reducing	reduce	VERB
dpc-1867	143	34	the	the	DET
dpc-1867	143	35	igg	igg	NOUN
dpc-1867	143	36	titer	titer	NOUN
dpc-1867	143	37	in	in	ADP
dpc-1867	143	38	up	up	ADP
dpc-1867	143	39	to	to	PART
dpc-1867	143	40	75	75	NUM
dpc-1867	143	41	%	%	NOUN
dpc-1867	143	42	of	of	ADP
dpc-1867	143	43	patients	patient	NOUN
dpc-1867	143	44	[	[	X
dpc-1867	143	45	46	46	NUM
dpc-1867	143	46	]	]	PUNCT
dpc-1867	143	47	.	.	PUNCT
dpc-1867	144	1	conclusions	conclusion	NOUN
dpc-1867	144	2	pv	pv	PROPN
dpc-1867	144	3	remains	remain	VERB
dpc-1867	144	4	a	a	DET
dpc-1867	144	5	therapeutic	therapeutic	ADJ
dpc-1867	144	6	challenge	challenge	NOUN
dpc-1867	144	7	for	for	ADP
dpc-1867	144	8	clinicians	clinician	NOUN
dpc-1867	144	9	.	.	PUNCT
dpc-1867	145	1	several	several	ADJ
dpc-1867	145	2	therapeutic	therapeutic	ADJ
dpc-1867	145	3	options	option	NOUN
dpc-1867	145	4	are	be	AUX
dpc-1867	145	5	currently	currently	ADV
dpc-1867	145	6	available	available	ADJ
dpc-1867	145	7	.	.	PUNCT
dpc-1867	146	1	however	however	ADV
dpc-1867	146	2	,	,	PUNCT
dpc-1867	146	3	finding	find	VERB
dpc-1867	146	4	a	a	DET
dpc-1867	146	5	specific	specific	ADJ
dpc-1867	146	6	treatment	treatment	NOUN
dpc-1867	146	7	for	for	ADP
dpc-1867	146	8	a	a	DET
dpc-1867	146	9	particular	particular	ADJ
dpc-1867	146	10	patient	patient	NOUN
dpc-1867	146	11	is	be	AUX
dpc-1867	146	12	not	not	PART
dpc-1867	146	13	easy	easy	ADJ
dpc-1867	146	14	.	.	PUNCT
dpc-1867	147	1	therefore	therefore	ADV
dpc-1867	147	2	,	,	PUNCT
dpc-1867	147	3	knowledge	knowledge	NOUN
dpc-1867	147	4	and	and	CCONJ
dpc-1867	147	5	management	management	NOUN
dpc-1867	147	6	of	of	ADP
dpc-1867	147	7	multiple	multiple	ADJ
dpc-1867	147	8	therapeutic	therapeutic	ADJ
dpc-1867	147	9	choices	choice	NOUN
dpc-1867	147	10	for	for	ADP
dpc-1867	147	11	patients	patient	NOUN
dpc-1867	147	12	with	with	ADP
dpc-1867	147	13	pv	pv	NOUN
dpc-1867	147	14	play	play	VERB
dpc-1867	147	15	a	a	DET
dpc-1867	147	16	pivotal	pivotal	ADJ
dpc-1867	147	17	role	role	NOUN
dpc-1867	147	18	in	in	ADP
dpc-1867	147	19	better	well	ADJ
dpc-1867	147	20	patient	patient	ADJ
dpc-1867	147	21	management	management	NOUN
dpc-1867	147	22	.	.	PUNCT
dpc-1867	148	1	references	reference	NOUN
dpc-1867	148	2	1	1	NUM
dpc-1867	148	3	.	.	PUNCT
dpc-1867	149	1	didona	didona	PROPN
dpc-1867	149	2	d	d	PROPN
dpc-1867	149	3	,	,	PUNCT
dpc-1867	149	4	maglie	maglie	PROPN
dpc-1867	149	5	r	r	NOUN
dpc-1867	149	6	,	,	PUNCT
dpc-1867	149	7	eming	eme	VERB
dpc-1867	149	8	r	r	NOUN
dpc-1867	149	9	,	,	PUNCT
dpc-1867	149	10	hertl	hertl	NOUN
dpc-1867	149	11	m.	m.	NOUN
dpc-1867	149	12	pemphigus	pemphigus	PROPN
dpc-1867	149	13	:	:	PUNCT
dpc-1867	149	14	current	current	ADJ
dpc-1867	149	15	and	and	CCONJ
dpc-1867	149	16	future	future	ADJ
dpc-1867	149	17	therapeutic	therapeutic	ADJ
dpc-1867	149	18	strategies	strategy	NOUN
dpc-1867	149	19	.	.	PUNCT
dpc-1867	150	1	front	front	ADJ
dpc-1867	150	2	immunol	immunol	NOUN
dpc-1867	150	3	.	.	PUNCT
dpc-1867	151	1	2019;10:1418	2019;10:1418	NUM
dpc-1867	151	2	.	.	PUNCT
dpc-1867	152	1	doi	doi	NOUN
dpc-1867	152	2	:	:	PUNCT
dpc-1867	152	3	10.3389	10.3389	NUM
dpc-1867	152	4	/	/	SYM
dpc-1867	152	5	fimmu.2019.01418	fimmu.2019.01418	NOUN
dpc-1867	152	6	.	.	PUNCT
dpc-1867	153	1	pmid	pmid	NOUN
dpc-1867	153	2	:	:	PUNCT
dpc-1867	153	3	31293582	31293582	NUM
dpc-1867	153	4	;	;	PUNCT
dpc-1867	153	5	pmcid	pmcid	NOUN
dpc-1867	153	6	:	:	PUNCT
dpc-1867	153	7	pmc6603181	pmc6603181	ADJ
dpc-1867	153	8	.	.	PUNCT
dpc-1867	154	1	2	2	X
dpc-1867	154	2	.	.	X
dpc-1867	154	3	solimani	solimani	PROPN
dpc-1867	154	4	f	f	PROPN
dpc-1867	154	5	,	,	PUNCT
dpc-1867	154	6	maglie	maglie	PROPN
dpc-1867	154	7	r	r	PROPN
dpc-1867	154	8	,	,	PUNCT
dpc-1867	154	9	pollmann	pollmann	ADJ
dpc-1867	154	10	r	r	NOUN
dpc-1867	154	11	,	,	PUNCT
dpc-1867	154	12	et	et	PROPN
dpc-1867	154	13	al	al	PROPN
dpc-1867	154	14	.	.	PROPN
dpc-1867	154	15	thymoma	thymoma	PROPN
dpc-1867	154	16	-	-	PUNCT
dpc-1867	154	17	associated	associate	VERB
dpc-1867	154	18	paraneoplastic	paraneoplastic	ADJ
dpc-1867	154	19	autoimmune	autoimmune	ADJ
dpc-1867	154	20	multiorgan	multiorgan	NOUN
dpc-1867	154	21	syndrome	syndrome	NOUN
dpc-1867	154	22	-	-	PUNCT
dpc-1867	154	23	from	from	ADP
dpc-1867	154	24	pemphigus	pemphigus	NOUN
dpc-1867	154	25	to	to	ADP
dpc-1867	154	26	lichenoid	lichenoid	PROPN
dpc-1867	154	27	dermatitis	dermatitis	PROPN
dpc-1867	154	28	.	.	PUNCT
dpc-1867	155	1	front	front	ADJ
dpc-1867	155	2	immunol	immunol	NOUN
dpc-1867	155	3	.	.	PUNCT
dpc-1867	156	1	2019;10:1413	2019;10:1413	NUM
dpc-1867	156	2	.	.	PUNCT
dpc-1867	156	3	doi	doi	NOUN
dpc-1867	156	4	:	:	PUNCT
dpc-1867	156	5	10.3389	10.3389	NUM
dpc-1867	156	6	/	/	SYM
dpc-1867	156	7	fimmu.2019.01413	fimmu.2019.01413	NOUN
dpc-1867	156	8	.	.	PUNCT
dpc-1867	157	1	pmid	pmid	NOUN
dpc-1867	157	2	:	:	PUNCT
dpc-1867	157	3	31293579	31293579	NUM
dpc-1867	157	4	;	;	PUNCT
dpc-1867	157	5	pmcid	pmcid	NOUN
dpc-1867	157	6	:	:	PUNCT
dpc-1867	157	7	pmc6598597	pmc6598597	NOUN
dpc-1867	157	8	.	.	PUNCT
dpc-1867	158	1	3	3	X
dpc-1867	158	2	.	.	X
dpc-1867	158	3	didona	didona	PROPN
dpc-1867	158	4	d	d	PROPN
dpc-1867	158	5	,	,	PUNCT
dpc-1867	158	6	di	di	NOUN
dpc-1867	158	7	zenzo	zenzo	NOUN
dpc-1867	158	8	g	g	NOUN
dpc-1867	158	9	,	,	PUNCT
dpc-1867	158	10	joly	joly	PROPN
dpc-1867	158	11	p.	p.	PROPN
dpc-1867	158	12	paraneoplastic	paraneoplastic	ADJ
dpc-1867	158	13	autoimmune	autoimmune	ADJ
dpc-1867	158	14	multiorgan	multiorgan	NOUN
dpc-1867	158	15	syndrome	syndrome	PROPN
dpc-1867	158	16	.	.	PUNCT
dpc-1867	159	1	ital	ital	PROPN
dpc-1867	159	2	j	j	PROPN
dpc-1867	159	3	dermatol	dermatol	PROPN
dpc-1867	159	4	venerol	venerol	PROPN
dpc-1867	159	5	.	.	PUNCT
dpc-1867	160	1	2021;156(2):174	2021;156(2):174	NUM
dpc-1867	160	2	-	-	SYM
dpc-1867	160	3	183	183	NUM
dpc-1867	160	4	.	.	PUNCT
dpc-1867	161	1	doi	doi	NOUN
dpc-1867	161	2	:	:	PUNCT
dpc-1867	161	3	10.23736	10.23736	NUM
dpc-1867	161	4	/	/	SYM
dpc-1867	161	5	s0392	s0392	NOUN
dpc-1867	161	6	-	-	PUNCT
dpc-1867	161	7	0488.20.06675	0488.20.06675	NOUN
dpc-1867	161	8	-	-	PUNCT
dpc-1867	161	9	4	4	NUM
dpc-1867	161	10	.	.	PUNCT
dpc-1867	162	1	pmid	pmid	NOUN
dpc-1867	162	2	:	:	PUNCT
dpc-1867	162	3	33070576	33070576	NUM
dpc-1867	162	4	.	.	PUNCT
dpc-1867	163	1	4	4	X
dpc-1867	163	2	.	.	X
dpc-1867	163	3	didona	didona	PROPN
dpc-1867	163	4	d	d	PROPN
dpc-1867	163	5	,	,	PUNCT
dpc-1867	163	6	fania	fania	PROPN
dpc-1867	163	7	l	l	PROPN
dpc-1867	163	8	,	,	PUNCT
dpc-1867	163	9	didona	didona	PROPN
dpc-1867	163	10	b	b	NOUN
dpc-1867	163	11	,	,	PUNCT
dpc-1867	163	12	eming	eme	VERB
dpc-1867	163	13	r	r	NOUN
dpc-1867	163	14	,	,	PUNCT
dpc-1867	163	15	hertl	hertl	NOUN
dpc-1867	163	16	m	m	PROPN
dpc-1867	163	17	,	,	PUNCT
dpc-1867	163	18	di	di	NOUN
dpc-1867	163	19	zenzo	zenzo	NOUN
dpc-1867	163	20	g.	g.	PROPN
dpc-1867	163	21	paraneoplastic	paraneoplastic	PROPN
dpc-1867	163	22	dermatoses	dermatosis	NOUN
dpc-1867	163	23	:	:	PUNCT
dpc-1867	163	24	a	a	DET
dpc-1867	163	25	brief	brief	ADJ
dpc-1867	163	26	general	general	ADJ
dpc-1867	163	27	review	review	NOUN
dpc-1867	163	28	and	and	CCONJ
dpc-1867	163	29	an	an	DET
dpc-1867	163	30	extensive	extensive	ADJ
dpc-1867	163	31	analysis	analysis	NOUN
dpc-1867	163	32	of	of	ADP
dpc-1867	163	33	paraneoplastic	paraneoplastic	ADJ
dpc-1867	163	34	pemphigus	pemphigus	NOUN
dpc-1867	163	35	and	and	CCONJ
dpc-1867	163	36	paraneoplastic	paraneoplastic	ADJ
dpc-1867	163	37	dermatomyositis	dermatomyositis	PROPN
dpc-1867	163	38	.	.	PUNCT
dpc-1867	164	1	int	int	PROPN
dpc-1867	164	2	j	j	PROPN
dpc-1867	164	3	mol	mol	ADP
dpc-1867	164	4	sci	sci	PROPN
dpc-1867	164	5	.	.	PUNCT
dpc-1867	165	1	2020;21(6):2178	2020;21(6):2178	NUM
dpc-1867	165	2	.	.	PUNCT
dpc-1867	166	1	doi	doi	NOUN
dpc-1867	166	2	:	:	PUNCT
dpc-1867	166	3	10.3390/	10.3390/	NUM
dpc-1867	166	4	ijms21062178	ijms21062178	PROPN
dpc-1867	166	5	.	.	PUNCT
dpc-1867	167	1	pmid	pmid	NOUN
dpc-1867	167	2	:	:	PUNCT
dpc-1867	167	3	32245283	32245283	NUM
dpc-1867	167	4	;	;	PUNCT
dpc-1867	167	5	pmcid	pmcid	ADJ
dpc-1867	167	6	:	:	PUNCT
dpc-1867	167	7	pmc7139382	pmc7139382	ADJ
dpc-1867	167	8	.	.	PUNCT
dpc-1867	168	1	5	5	X
dpc-1867	168	2	.	.	X
dpc-1867	168	3	solimani	solimani	PROPN
dpc-1867	168	4	f	f	PROPN
dpc-1867	168	5	,	,	PUNCT
dpc-1867	168	6	meier	meier	PROPN
dpc-1867	168	7	k	k	PROPN
dpc-1867	168	8	,	,	PUNCT
dpc-1867	168	9	zimmer	zimmer	PROPN
dpc-1867	168	10	cl	cl	PROPN
dpc-1867	168	11	,	,	PUNCT
dpc-1867	168	12	hashimoto	hashimoto	NOUN
dpc-1867	168	13	t.	t.	NOUN
dpc-1867	168	14	immune	immune	ADJ
dpc-1867	168	15	serological	serological	ADJ
dpc-1867	168	16	diagnosis	diagnosis	NOUN
dpc-1867	168	17	of	of	ADP
dpc-1867	168	18	pemphigus	pemphigus	NOUN
dpc-1867	168	19	.	.	PUNCT
dpc-1867	169	1	g	g	PROPN
dpc-1867	169	2	ital	ital	ADJ
dpc-1867	169	3	dermatol	dermatol	NOUN
dpc-1867	169	4	venereol	venereol	NOUN
dpc-1867	169	5	.	.	PUNCT
dpc-1867	170	1	2021;156(2):151	2021;156(2):151	NUM
dpc-1867	170	2	-	-	SYM
dpc-1867	170	3	160	160	NUM
dpc-1867	170	4	.	.	PUNCT
dpc-1867	171	1	doi	doi	NOUN
dpc-1867	171	2	:	:	PUNCT
dpc-1867	171	3	10.23736	10.23736	NUM
dpc-1867	171	4	/	/	SYM
dpc-1867	171	5	s2784	s2784	PROPN
dpc-1867	171	6	-	-	PUNCT
dpc-1867	171	7	8671.20.06788	8671.20.06788	NUM
dpc-1867	171	8	-	-	SYM
dpc-1867	171	9	7	7	NUM
dpc-1867	171	10	.	.	PUNCT
dpc-1867	172	1	review	review	NOUN
dpc-1867	172	2	|	|	ADV
dpc-1867	172	3	dermatol	dermatol	ADJ
dpc-1867	172	4	pract	pract	NOUN
dpc-1867	172	5	concept	concept	NOUN
dpc-1867	172	6	.	.	PUNCT
dpc-1867	173	1	2022;12(1	2022;12(1	NUM
dpc-1867	173	2	):	):	PUNCT
dpc-1867	173	3	e2022037	e2022037	NOUN
dpc-1867	173	4	5	5	NUM
dpc-1867	173	5	6	6	NUM
dpc-1867	173	6	.	.	PUNCT
dpc-1867	174	1	paolino	paolino	NOUN
dpc-1867	174	2	g	g	PROPN
dpc-1867	174	3	,	,	PUNCT
dpc-1867	174	4	didona	didona	PROPN
dpc-1867	174	5	d	d	NOUN
dpc-1867	174	6	,	,	PUNCT
dpc-1867	174	7	magliulo	magliulo	NOUN
dpc-1867	174	8	g	g	NOUN
dpc-1867	174	9	,	,	PUNCT
dpc-1867	174	10	et	et	PROPN
dpc-1867	174	11	al	al	PROPN
dpc-1867	174	12	.	.	PUNCT
dpc-1867	175	1	paraneoplastic	paraneoplastic	ADJ
dpc-1867	175	2	pemphigus	pemphigus	NOUN
dpc-1867	175	3	:	:	PUNCT
dpc-1867	175	4	insight	insight	NOUN
dpc-1867	175	5	into	into	ADP
dpc-1867	175	6	the	the	DET
dpc-1867	175	7	autoimmune	autoimmune	ADJ
dpc-1867	175	8	pathogenesis	pathogenesis	NOUN
dpc-1867	175	9	,	,	PUNCT
dpc-1867	175	10	clinical	clinical	ADJ
dpc-1867	175	11	features	feature	NOUN
dpc-1867	175	12	and	and	CCONJ
dpc-1867	175	13	therapy	therapy	NOUN
dpc-1867	175	14	.	.	PUNCT
dpc-1867	176	1	int	int	PROPN
dpc-1867	176	2	j	j	PROPN
dpc-1867	176	3	mol	mol	ADP
dpc-1867	176	4	sci	sci	PROPN
dpc-1867	176	5	.	.	PUNCT
dpc-1867	177	1	2017;18(12):2532	2017;18(12):2532	X
dpc-1867	177	2	.	.	X
dpc-1867	177	3	doi	doi	NOUN
dpc-1867	177	4	:	:	PUNCT
dpc-1867	177	5	10.3390/	10.3390/	NUM
dpc-1867	177	6	ijms18122532	ijms18122532	NOUN
dpc-1867	177	7	.	.	PUNCT
dpc-1867	178	1	pmid	pmid	NOUN
dpc-1867	178	2	:	:	PUNCT
dpc-1867	178	3	29186863	29186863	NUM
dpc-1867	178	4	;	;	PUNCT
dpc-1867	178	5	pmcid	pmcid	ADJ
dpc-1867	178	6	:	:	PUNCT
dpc-1867	178	7	pmc5751135	pmc5751135	NOUN
dpc-1867	178	8	.	.	PUNCT
dpc-1867	179	1	7	7	X
dpc-1867	179	2	.	.	X
dpc-1867	179	3	kridin	kridin	VERB
dpc-1867	179	4	k	k	PROPN
dpc-1867	179	5	,	,	PUNCT
dpc-1867	179	6	zelber	zelber	PROPN
dpc-1867	179	7	-	-	PUNCT
dpc-1867	179	8	sagi	sagi	PROPN
dpc-1867	179	9	s	s	PROPN
dpc-1867	179	10	,	,	PUNCT
dpc-1867	179	11	bergman	bergman	PROPN
dpc-1867	179	12	r.	r.	PROPN
dpc-1867	179	13	pemphigus	pemphigus	PROPN
dpc-1867	179	14	vulgaris	vulgaris	PROPN
dpc-1867	179	15	and	and	CCONJ
dpc-1867	179	16	pemphigus	pemphigus	PROPN
dpc-1867	179	17	foliaceus	foliaceus	NOUN
dpc-1867	179	18	:	:	PUNCT
dpc-1867	179	19	differences	difference	NOUN
dpc-1867	179	20	in	in	ADP
dpc-1867	179	21	epidemiology	epidemiology	NOUN
dpc-1867	179	22	and	and	CCONJ
dpc-1867	179	23	mortality	mortality	NOUN
dpc-1867	179	24	.	.	PUNCT
dpc-1867	180	1	acta	acta	PROPN
dpc-1867	180	2	derm	derm	PROPN
dpc-1867	180	3	venereol	venereol	NOUN
dpc-1867	180	4	.	.	PUNCT
dpc-1867	181	1	2017;97(9):1095	2017;97(9):1095	NUM
dpc-1867	181	2	-	-	SYM
dpc-1867	181	3	1099	1099	NUM
dpc-1867	181	4	.	.	PUNCT
dpc-1867	182	1	doi	doi	NOUN
dpc-1867	182	2	:	:	PUNCT
dpc-1867	182	3	10.2340/00015555	10.2340/00015555	NUM
dpc-1867	182	4	-	-	SYM
dpc-1867	182	5	2706	2706	NUM
dpc-1867	182	6	.	.	PUNCT
dpc-1867	183	1	pmid	pmid	NOUN
dpc-1867	183	2	:	:	PUNCT
dpc-1867	183	3	28536732	28536732	NUM
dpc-1867	183	4	.	.	PUNCT
dpc-1867	184	1	8	8	X
dpc-1867	184	2	.	.	PUNCT
dpc-1867	185	1	didona	didona	PROPN
dpc-1867	185	2	d	d	PROPN
dpc-1867	185	3	,	,	PUNCT
dpc-1867	185	4	di	di	NOUN
dpc-1867	185	5	zenzo	zenzo	NOUN
dpc-1867	185	6	g.	g.	VERB
dpc-1867	185	7	humoral	humoral	ADJ
dpc-1867	185	8	epitope	epitope	NOUN
dpc-1867	185	9	spreading	spread	VERB
dpc-1867	185	10	in	in	ADP
dpc-1867	185	11	autoimmune	autoimmune	ADJ
dpc-1867	185	12	bullous	bullous	ADJ
dpc-1867	185	13	diseases	disease	NOUN
dpc-1867	185	14	.	.	PUNCT
dpc-1867	186	1	front	front	ADJ
dpc-1867	186	2	immunol	immunol	NOUN
dpc-1867	186	3	.	.	PUNCT
dpc-1867	187	1	2018;9:779	2018;9:779	X
dpc-1867	187	2	.	.	PUNCT
dpc-1867	188	1	doi	doi	NOUN
dpc-1867	188	2	:	:	PUNCT
dpc-1867	188	3	10.3389	10.3389	NUM
dpc-1867	188	4	/	/	SYM
dpc-1867	188	5	fimmu.2018.00779	fimmu.2018.00779	PROPN
dpc-1867	188	6	.	.	PUNCT
dpc-1867	189	1	pmid	pmid	NOUN
dpc-1867	189	2	:	:	PUNCT
dpc-1867	189	3	29719538	29719538	NUM
dpc-1867	189	4	;	;	PUNCT
dpc-1867	189	5	pmcid	pmcid	NOUN
dpc-1867	189	6	:	:	PUNCT
dpc-1867	189	7	pmc5913575	pmc5913575	NOUN
dpc-1867	189	8	.	.	PUNCT
dpc-1867	190	1	9	9	X
dpc-1867	190	2	.	.	X
dpc-1867	190	3	hanakawa	hanakawa	PROPN
dpc-1867	190	4	y	y	PROPN
dpc-1867	190	5	,	,	PUNCT
dpc-1867	190	6	amagai	amagai	PROPN
dpc-1867	190	7	m	m	PROPN
dpc-1867	190	8	,	,	PUNCT
dpc-1867	190	9	shirakata	shirakata	PROPN
dpc-1867	190	10	y	y	PROPN
dpc-1867	190	11	,	,	PUNCT
dpc-1867	190	12	et	et	PROPN
dpc-1867	190	13	al	al	PROPN
dpc-1867	190	14	.	.	PROPN
dpc-1867	190	15	differential	differential	ADJ
dpc-1867	190	16	effects	effect	NOUN
dpc-1867	190	17	of	of	ADP
dpc-1867	190	18	desmoglein	desmoglein	NOUN
dpc-1867	190	19	1	1	NUM
dpc-1867	190	20	and	and	CCONJ
dpc-1867	190	21	desmoglein	desmoglein	NOUN
dpc-1867	190	22	3	3	NUM
dpc-1867	190	23	on	on	ADP
dpc-1867	190	24	desmosome	desmosome	ADJ
dpc-1867	190	25	formation	formation	NOUN
dpc-1867	190	26	.	.	PUNCT
dpc-1867	191	1	j	j	PROPN
dpc-1867	191	2	invest	invest	VERB
dpc-1867	191	3	dermatol	dermatol	NOUN
dpc-1867	191	4	.	.	PUNCT
dpc-1867	192	1	2002;119(6):1231	2002;119(6):1231	NUM
dpc-1867	192	2	-	-	SYM
dpc-1867	192	3	1236	1236	NUM
dpc-1867	192	4	.	.	PUNCT
dpc-1867	193	1	doi	doi	NOUN
dpc-1867	193	2	:	:	PUNCT
dpc-1867	193	3	10.1046	10.1046	NUM
dpc-1867	193	4	/	/	SYM
dpc-1867	193	5	j.15231747.2002.19648.x	j.15231747.2002.19648.x	NOUN
dpc-1867	193	6	.	.	PUNCT
dpc-1867	194	1	pmid	pmid	NOUN
dpc-1867	194	2	:	:	PUNCT
dpc-1867	194	3	12485422	12485422	NUM
dpc-1867	194	4	.	.	PUNCT
dpc-1867	195	1	10	10	NUM
dpc-1867	195	2	.	.	PUNCT
dpc-1867	196	1	kitajima	kitajima	PROPN
dpc-1867	196	2	y.	y.	PROPN
dpc-1867	196	3	150(th	150(th	NUM
dpc-1867	196	4	)	)	PUNCT
dpc-1867	196	5	anniversary	anniversary	NOUN
dpc-1867	196	6	series	series	NOUN
dpc-1867	196	7	:	:	PUNCT
dpc-1867	196	8	desmosomes	desmosomes	PROPN
dpc-1867	196	9	and	and	CCONJ
dpc-1867	196	10	autoimmune	autoimmune	ADJ
dpc-1867	196	11	disease	disease	NOUN
dpc-1867	196	12	,	,	PUNCT
dpc-1867	196	13	perspective	perspective	NOUN
dpc-1867	196	14	of	of	ADP
dpc-1867	196	15	dynamic	dynamic	ADJ
dpc-1867	196	16	desmosome	desmosome	ADJ
dpc-1867	196	17	remodeling	remodeling	NOUN
dpc-1867	196	18	and	and	CCONJ
dpc-1867	196	19	its	its	PRON
dpc-1867	196	20	impairments	impairment	NOUN
dpc-1867	196	21	in	in	ADP
dpc-1867	196	22	pemphigus	pemphigus	PROPN
dpc-1867	196	23	.	.	PUNCT
dpc-1867	197	1	cell	cell	PROPN
dpc-1867	197	2	commun	commun	PROPN
dpc-1867	197	3	adhes	adhe	NOUN
dpc-1867	197	4	.	.	PUNCT
dpc-1867	198	1	2014;21(6):269	2014;21(6):269	NUM
dpc-1867	198	2	-	-	SYM
dpc-1867	198	3	280	280	NUM
dpc-1867	198	4	.	.	PUNCT
dpc-1867	199	1	doi	doi	NOUN
dpc-1867	199	2	:	:	PUNCT
dpc-1867	199	3	10.3109/15419061.2014.943397	10.3109/15419061.2014.943397	NUM
dpc-1867	199	4	.	.	PUNCT
dpc-1867	200	1	pmid	pmid	NOUN
dpc-1867	200	2	:	:	PUNCT
dpc-1867	200	3	25078507	25078507	NUM
dpc-1867	200	4	.	.	PUNCT
dpc-1867	201	1	11	11	NUM
dpc-1867	201	2	.	.	X
dpc-1867	202	1	kasperkiewicz	kasperkiewicz	PROPN
dpc-1867	202	2	m	m	PROPN
dpc-1867	202	3	,	,	PUNCT
dpc-1867	202	4	ellebrecht	ellebrecht	PROPN
dpc-1867	202	5	ct	ct	PROPN
dpc-1867	202	6	,	,	PUNCT
dpc-1867	202	7	takahashi	takahashi	PROPN
dpc-1867	202	8	h	h	PROPN
dpc-1867	202	9	,	,	PUNCT
dpc-1867	202	10	et	et	PROPN
dpc-1867	202	11	al	al	PROPN
dpc-1867	202	12	.	.	PUNCT
dpc-1867	203	1	nat	nat	PROPN
dpc-1867	203	2	rev	rev	VERB
dpc-1867	203	3	dis	dis	PROPN
dpc-1867	203	4	primers	primer	NOUN
dpc-1867	203	5	.	.	PUNCT
dpc-1867	204	1	2017;3:17026	2017;3:17026	NOUN
dpc-1867	204	2	.	.	PUNCT
dpc-1867	205	1	doi	doi	NOUN
dpc-1867	205	2	:	:	PUNCT
dpc-1867	205	3	10.1038	10.1038	NUM
dpc-1867	205	4	/	/	SYM
dpc-1867	205	5	nrdp.2017.26	nrdp.2017.26	ADJ
dpc-1867	205	6	.	.	PUNCT
dpc-1867	206	1	pmid	pmid	NOUN
dpc-1867	206	2	:	:	PUNCT
dpc-1867	206	3	28492232	28492232	NUM
dpc-1867	206	4	;	;	PUNCT
dpc-1867	206	5	pmcid	pmcid	NOUN
dpc-1867	206	6	:	:	PUNCT
dpc-1867	206	7	pmc5901732	pmc5901732	NOUN
dpc-1867	206	8	.	.	PUNCT
dpc-1867	207	1	12	12	NUM
dpc-1867	207	2	.	.	PUNCT
dpc-1867	208	1	schmidt	schmidt	PROPN
dpc-1867	208	2	e	e	PROPN
dpc-1867	208	3	,	,	PUNCT
dpc-1867	208	4	kasperkiewicz	kasperkiewicz	PROPN
dpc-1867	208	5	m	m	PROPN
dpc-1867	208	6	,	,	PUNCT
dpc-1867	208	7	joly	joly	PROPN
dpc-1867	208	8	p.	p.	PROPN
dpc-1867	208	9	pemphigus	pemphigus	PROPN
dpc-1867	208	10	.	.	PUNCT
dpc-1867	209	1	lancet	lancet	PROPN
dpc-1867	209	2	.	.	PUNCT
dpc-1867	210	1	2019;394(10201):882	2019;394(10201):882	NUM
dpc-1867	210	2	-	-	SYM
dpc-1867	210	3	894	894	NUM
dpc-1867	210	4	.	.	PUNCT
dpc-1867	210	5	doi	doi	NOUN
dpc-1867	210	6	:	:	PUNCT
dpc-1867	210	7	10.1016	10.1016	NUM
dpc-1867	210	8	/	/	SYM
dpc-1867	210	9	s01406736(19)31778	s01406736(19)31778	NOUN
dpc-1867	210	10	-	-	PUNCT
dpc-1867	210	11	7	7	NUM
dpc-1867	210	12	.	.	PUNCT
dpc-1867	211	1	pmid	pmid	NOUN
dpc-1867	211	2	:	:	PUNCT
dpc-1867	211	3	31498102	31498102	NUM
dpc-1867	211	4	.	.	PUNCT
dpc-1867	212	1	13	13	NUM
dpc-1867	212	2	.	.	X
dpc-1867	212	3	di	di	NOUN
dpc-1867	212	4	zenzo	zenzo	NOUN
dpc-1867	212	5	g	g	NOUN
dpc-1867	212	6	,	,	PUNCT
dpc-1867	212	7	di	di	X
dpc-1867	212	8	lullo	lullo	NOUN
dpc-1867	212	9	g	g	PROPN
dpc-1867	212	10	,	,	PUNCT
dpc-1867	212	11	corti	corti	PROPN
dpc-1867	212	12	d	d	PROPN
dpc-1867	212	13	,	,	PUNCT
dpc-1867	212	14	et	et	PROPN
dpc-1867	212	15	al	al	PROPN
dpc-1867	212	16	.	.	PUNCT
dpc-1867	213	1	pemphigus	pemphigus	PROPN
dpc-1867	213	2	autoantibodies	autoantibody	NOUN
dpc-1867	213	3	generated	generate	VERB
dpc-1867	213	4	through	through	ADP
dpc-1867	213	5	somatic	somatic	ADJ
dpc-1867	213	6	mutations	mutation	NOUN
dpc-1867	213	7	target	target	VERB
dpc-1867	213	8	the	the	DET
dpc-1867	213	9	desmoglein-3	desmoglein-3	NUM
dpc-1867	213	10	cis	cis	NOUN
dpc-1867	213	11	-	-	PUNCT
dpc-1867	213	12	interface	interface	NOUN
dpc-1867	213	13	.	.	PUNCT
dpc-1867	214	1	j	j	PROPN
dpc-1867	214	2	clin	clin	PROPN
dpc-1867	214	3	invest	invest	PROPN
dpc-1867	214	4	.	.	PUNCT
dpc-1867	215	1	2012;122(10):3781	2012;122(10):3781	X
dpc-1867	215	2	-	-	SYM
dpc-1867	215	3	3790	3790	NUM
dpc-1867	215	4	.	.	PUNCT
dpc-1867	216	1	doi	doi	NOUN
dpc-1867	216	2	:	:	PUNCT
dpc-1867	216	3	10.1172	10.1172	NUM
dpc-1867	216	4	/	/	SYM
dpc-1867	216	5	jci64413	jci64413	ADJ
dpc-1867	216	6	.	.	PUNCT
dpc-1867	217	1	pmid	pmid	NOUN
dpc-1867	217	2	:	:	PUNCT
dpc-1867	217	3	22996451	22996451	NUM
dpc-1867	217	4	;	;	PUNCT
dpc-1867	217	5	pmcid	pmcid	ADJ
dpc-1867	217	6	:	:	PUNCT
dpc-1867	217	7	pmc3461925	pmc3461925	NOUN
dpc-1867	217	8	.	.	PUNCT
dpc-1867	218	1	14	14	NUM
dpc-1867	218	2	.	.	PUNCT
dpc-1867	219	1	tsunoda	tsunoda	PROPN
dpc-1867	219	2	k	k	PROPN
dpc-1867	219	3	,	,	PUNCT
dpc-1867	219	4	ota	ota	PROPN
dpc-1867	219	5	t	t	PROPN
dpc-1867	219	6	,	,	PUNCT
dpc-1867	219	7	aoki	aoki	PROPN
dpc-1867	219	8	m	m	PROPN
dpc-1867	219	9	,	,	PUNCT
dpc-1867	219	10	et	et	PROPN
dpc-1867	219	11	al	al	PROPN
dpc-1867	219	12	.	.	PROPN
dpc-1867	219	13	induction	induction	NOUN
dpc-1867	219	14	of	of	ADP
dpc-1867	219	15	pemphigus	pemphigus	ADJ
dpc-1867	219	16	phenotype	phenotype	NOUN
dpc-1867	219	17	by	by	ADP
dpc-1867	219	18	a	a	DET
dpc-1867	219	19	mouse	mouse	NOUN
dpc-1867	219	20	monoclonal	monoclonal	NOUN
dpc-1867	219	21	antibody	antibody	NOUN
dpc-1867	219	22	against	against	ADP
dpc-1867	219	23	the	the	DET
dpc-1867	219	24	amino	amino	NOUN
dpc-1867	219	25	-	-	PUNCT
dpc-1867	219	26	terminal	terminal	ADJ
dpc-1867	219	27	adhesive	adhesive	ADJ
dpc-1867	219	28	interface	interface	NOUN
dpc-1867	219	29	of	of	ADP
dpc-1867	219	30	desmoglein	desmoglein	NOUN
dpc-1867	219	31	3	3	NUM
dpc-1867	219	32	.	.	PUNCT
dpc-1867	220	1	j	j	PROPN
dpc-1867	220	2	immunol	immunol	NOUN
dpc-1867	220	3	.	.	PUNCT
dpc-1867	221	1	2003;170(4):21702178	2003;170(4):21702178	NUM
dpc-1867	221	2	.	.	PUNCT
dpc-1867	222	1	doi	doi	NOUN
dpc-1867	222	2	:	:	PUNCT
dpc-1867	222	3	10.4049	10.4049	NUM
dpc-1867	222	4	/	/	SYM
dpc-1867	222	5	jimmunol.170.4.2170	jimmunol.170.4.2170	SYM
dpc-1867	222	6	.	.	PUNCT
dpc-1867	223	1	pmid	pmid	NOUN
dpc-1867	223	2	:	:	PUNCT
dpc-1867	223	3	12574390	12574390	NUM
dpc-1867	223	4	.	.	PUNCT
dpc-1867	224	1	15	15	NUM
dpc-1867	224	2	.	.	PUNCT
dpc-1867	225	1	calkins	calkins	PROPN
dpc-1867	225	2	cc	cc	PROPN
dpc-1867	225	3	,	,	PUNCT
dpc-1867	225	4	setzer	setzer	PROPN
dpc-1867	225	5	sv	sv	PROPN
dpc-1867	225	6	,	,	PUNCT
dpc-1867	225	7	jennings	jennings	PROPN
dpc-1867	225	8	jm	jm	PROPN
dpc-1867	225	9	,	,	PUNCT
dpc-1867	225	10	et	et	PROPN
dpc-1867	225	11	al	al	PROPN
dpc-1867	225	12	.	.	PROPN
dpc-1867	225	13	desmoglein	desmoglein	PROPN
dpc-1867	225	14	endocytosis	endocytosis	NOUN
dpc-1867	225	15	and	and	CCONJ
dpc-1867	225	16	desmosome	desmosome	ADJ
dpc-1867	225	17	disassembly	disassembly	NOUN
dpc-1867	225	18	are	be	AUX
dpc-1867	225	19	coordinated	coordinate	VERB
dpc-1867	225	20	responses	response	NOUN
dpc-1867	225	21	to	to	ADP
dpc-1867	225	22	pemphigus	pemphigus	NOUN
dpc-1867	225	23	autoantibodies	autoantibody	NOUN
dpc-1867	225	24	.	.	PUNCT
dpc-1867	226	1	j	j	PROPN
dpc-1867	226	2	biol	biol	PROPN
dpc-1867	226	3	chem	chem	NOUN
dpc-1867	226	4	.	.	PUNCT
dpc-1867	227	1	2006;281(11):7623	2006;281(11):7623	NUM
dpc-1867	227	2	-	-	SYM
dpc-1867	227	3	7634	7634	NUM
dpc-1867	227	4	.	.	PUNCT
dpc-1867	228	1	doi	doi	NOUN
dpc-1867	228	2	:	:	PUNCT
dpc-1867	228	3	10.1074	10.1074	NUM
dpc-1867	228	4	/	/	SYM
dpc-1867	228	5	jbc.m512447200	jbc.m512447200	PROPN
dpc-1867	228	6	.	.	PUNCT
dpc-1867	229	1	pmid	pmid	PROPN
dpc-1867	229	2	:	:	PUNCT
dpc-1867	229	3	16377623	16377623	NUM
dpc-1867	229	4	.	.	PUNCT
dpc-1867	230	1	16	16	NUM
dpc-1867	230	2	.	.	PUNCT
dpc-1867	230	3	mao	mao	PROPN
dpc-1867	231	1	x	x	X
dpc-1867	231	2	,	,	PUNCT
dpc-1867	231	3	choi	choi	PROPN
dpc-1867	231	4	ej	ej	PROPN
dpc-1867	231	5	,	,	PUNCT
dpc-1867	231	6	payne	payne	PROPN
dpc-1867	231	7	as	as	ADP
dpc-1867	231	8	.	.	PUNCT
dpc-1867	232	1	disruption	disruption	NOUN
dpc-1867	232	2	of	of	ADP
dpc-1867	232	3	desmosome	desmosome	ADJ
dpc-1867	232	4	assembly	assembly	NOUN
dpc-1867	232	5	by	by	ADP
dpc-1867	232	6	monovalent	monovalent	NOUN
dpc-1867	232	7	human	human	ADJ
dpc-1867	232	8	pemphigus	pemphigus	PROPN
dpc-1867	232	9	vulgaris	vulgaris	NOUN
dpc-1867	232	10	monoclonal	monoclonal	NOUN
dpc-1867	232	11	antibodies	antibodie	VERB
dpc-1867	232	12	.	.	PUNCT
dpc-1867	233	1	j	j	PROPN
dpc-1867	233	2	invest	invest	VERB
dpc-1867	233	3	dermatol	dermatol	NOUN
dpc-1867	233	4	.	.	PUNCT
dpc-1867	234	1	2009;129(4):908	2009;129(4):908	NUM
dpc-1867	234	2	-	-	SYM
dpc-1867	234	3	918	918	NUM
dpc-1867	234	4	.	.	PUNCT
dpc-1867	235	1	doi	doi	NOUN
dpc-1867	235	2	:	:	PUNCT
dpc-1867	235	3	10.1038/	10.1038/	NUM
dpc-1867	235	4	jid.2008.339	jid.2008.339	PROPN
dpc-1867	235	5	.	.	PUNCT
dpc-1867	236	1	pmid	pmid	NOUN
dpc-1867	236	2	:	:	PUNCT
dpc-1867	236	3	19037235	19037235	NUM
dpc-1867	236	4	;	;	PUNCT
dpc-1867	236	5	pmcid	pmcid	NOUN
dpc-1867	236	6	:	:	PUNCT
dpc-1867	236	7	pmc2743719	pmc2743719	NOUN
dpc-1867	236	8	.	.	PUNCT
dpc-1867	237	1	17	17	NUM
dpc-1867	237	2	.	.	PUNCT
dpc-1867	238	1	sokol	sokol	PROPN
dpc-1867	238	2	e	e	PROPN
dpc-1867	238	3	,	,	PUNCT
dpc-1867	238	4	kramer	kramer	PROPN
dpc-1867	238	5	d	d	PROPN
dpc-1867	238	6	,	,	PUNCT
dpc-1867	238	7	diercks	diercks	PROPN
dpc-1867	238	8	gfh	gfh	PROPN
dpc-1867	238	9	,	,	PUNCT
dpc-1867	238	10	et	et	PROPN
dpc-1867	238	11	al	al	PROPN
dpc-1867	238	12	.	.	PUNCT
dpc-1867	239	1	large	large	ADJ
dpc-1867	239	2	-	-	PUNCT
dpc-1867	239	3	scale	scale	NOUN
dpc-1867	239	4	electron	electron	NOUN
dpc-1867	239	5	microscopy	microscopy	NOUN
dpc-1867	239	6	maps	map	NOUN
dpc-1867	239	7	of	of	ADP
dpc-1867	239	8	patient	patient	ADJ
dpc-1867	239	9	skin	skin	NOUN
dpc-1867	239	10	and	and	CCONJ
dpc-1867	239	11	mucosa	mucosa	NOUN
dpc-1867	239	12	provide	provide	VERB
dpc-1867	239	13	insight	insight	NOUN
dpc-1867	239	14	into	into	ADP
dpc-1867	239	15	pathogenesis	pathogenesis	NOUN
dpc-1867	239	16	of	of	ADP
dpc-1867	239	17	blistering	blister	VERB
dpc-1867	239	18	diseases	disease	NOUN
dpc-1867	239	19	.	.	PUNCT
dpc-1867	240	1	j	j	PROPN
dpc-1867	240	2	invest	invest	VERB
dpc-1867	240	3	dermatol	dermatol	NOUN
dpc-1867	240	4	.	.	PUNCT
dpc-1867	241	1	2015;135(7):1763	2015;135(7):1763	NUM
dpc-1867	241	2	-	-	SYM
dpc-1867	241	3	1770	1770	NUM
dpc-1867	241	4	.	.	PUNCT
dpc-1867	242	1	doi	doi	NOUN
dpc-1867	242	2	:	:	PUNCT
dpc-1867	242	3	10.1038	10.1038	NUM
dpc-1867	242	4	/	/	SYM
dpc-1867	242	5	jid.2015.109	jid.2015.109	PROPN
dpc-1867	242	6	.	.	PUNCT
dpc-1867	243	1	pmid	pmid	NOUN
dpc-1867	243	2	:	:	PUNCT
dpc-1867	243	3	25789704	25789704	NUM
dpc-1867	243	4	.	.	PUNCT
dpc-1867	244	1	18	18	NUM
dpc-1867	244	2	.	.	X
dpc-1867	244	3	oktarina	oktarina	PROPN
dpc-1867	244	4	da	da	PROPN
dpc-1867	244	5	,	,	PUNCT
dpc-1867	244	6	van	van	PROPN
dpc-1867	244	7	der	der	PROPN
dpc-1867	244	8	wier	wier	PROPN
dpc-1867	244	9	g	g	PROPN
dpc-1867	244	10	,	,	PUNCT
dpc-1867	244	11	diercks	diercks	PROPN
dpc-1867	244	12	gf	gf	PROPN
dpc-1867	244	13	,	,	PUNCT
dpc-1867	244	14	jonkman	jonkman	NOUN
dpc-1867	244	15	mf	mf	NOUN
dpc-1867	244	16	,	,	PUNCT
dpc-1867	244	17	pas	pas	PROPN
dpc-1867	244	18	hh	hh	PROPN
dpc-1867	244	19	.	.	PUNCT
dpc-1867	245	1	igg	igg	PROPN
dpc-1867	245	2	-	-	PUNCT
dpc-1867	245	3	induced	induce	VERB
dpc-1867	245	4	clustering	clustering	NOUN
dpc-1867	245	5	of	of	ADP
dpc-1867	245	6	desmogleins	desmoglein	NOUN
dpc-1867	245	7	1	1	NUM
dpc-1867	245	8	and	and	CCONJ
dpc-1867	245	9	3	3	NUM
dpc-1867	245	10	in	in	ADP
dpc-1867	245	11	skin	skin	NOUN
dpc-1867	245	12	of	of	ADP
dpc-1867	245	13	patients	patient	NOUN
dpc-1867	245	14	with	with	ADP
dpc-1867	245	15	pemphigus	pemphigus	PROPN
dpc-1867	245	16	fits	fit	VERB
dpc-1867	245	17	with	with	ADP
dpc-1867	245	18	the	the	DET
dpc-1867	245	19	desmoglein	desmoglein	ADJ
dpc-1867	245	20	nonassembly	nonassembly	ADV
dpc-1867	245	21	depletion	depletion	NOUN
dpc-1867	245	22	hypothesis	hypothesis	NOUN
dpc-1867	245	23	.	.	PUNCT
dpc-1867	246	1	br	br	PROPN
dpc-1867	246	2	j	j	PROPN
dpc-1867	246	3	dermatol	dermatol	NOUN
dpc-1867	246	4	.	.	PUNCT
dpc-1867	247	1	2011;165(3):552	2011;165(3):552	NUM
dpc-1867	247	2	-	-	SYM
dpc-1867	247	3	562	562	NUM
dpc-1867	247	4	.	.	PUNCT
dpc-1867	248	1	doi	doi	NOUN
dpc-1867	248	2	:	:	PUNCT
dpc-1867	248	3	10.1111	10.1111	NUM
dpc-1867	248	4	/	/	SYM
dpc-1867	248	5	j.1365	j.1365	NOUN
dpc-1867	248	6	-	-	PUNCT
dpc-1867	248	7	2133.2011.10463.x	2133.2011.10463.x	NUM
dpc-1867	248	8	.	.	PUNCT
dpc-1867	249	1	pmid	pmid	NOUN
dpc-1867	249	2	:	:	PUNCT
dpc-1867	249	3	21692763	21692763	NUM
dpc-1867	249	4	.	.	PUNCT
dpc-1867	250	1	19	19	NUM
dpc-1867	250	2	.	.	X
dpc-1867	250	3	di	di	NOUN
dpc-1867	250	4	lullo	lullo	PROPN
dpc-1867	250	5	g	g	PROPN
dpc-1867	250	6	,	,	PUNCT
dpc-1867	250	7	calabresi	calabresi	PROPN
dpc-1867	250	8	v	v	PROPN
dpc-1867	250	9	,	,	PUNCT
dpc-1867	250	10	mariotti	mariotti	PROPN
dpc-1867	250	11	f	f	PROPN
dpc-1867	250	12	,	,	PUNCT
dpc-1867	250	13	zambruno	zambruno	PROPN
dpc-1867	250	14	g	g	NOUN
dpc-1867	250	15	,	,	PUNCT
dpc-1867	250	16	lanzavecchia	lanzavecchia	VERB
dpc-1867	250	17	a	a	PRON
dpc-1867	250	18	,	,	PUNCT
dpc-1867	250	19	di	di	NOUN
dpc-1867	250	20	zenzo	zenzo	NOUN
dpc-1867	250	21	g.	g.	NOUN
dpc-1867	250	22	identification	identification	NOUN
dpc-1867	250	23	of	of	ADP
dpc-1867	250	24	a	a	DET
dpc-1867	250	25	novel	novel	ADJ
dpc-1867	250	26	non	non	ADJ
dpc-1867	250	27	-	-	ADJ
dpc-1867	250	28	desmoglein	desmoglein	ADJ
dpc-1867	250	29	autoantigen	autoantigen	NOUN
dpc-1867	250	30	in	in	ADP
dpc-1867	250	31	pemphigus	pemphigus	PROPN
dpc-1867	250	32	vulgaris	vulgaris	NOUN
dpc-1867	250	33	.	.	PUNCT
dpc-1867	251	1	front	front	ADJ
dpc-1867	251	2	immunol	immunol	NOUN
dpc-1867	251	3	.	.	PUNCT
dpc-1867	252	1	2019;10:1391	2019;10:1391	NUM
dpc-1867	252	2	.	.	PUNCT
dpc-1867	252	3	doi	doi	NOUN
dpc-1867	252	4	:	:	PUNCT
dpc-1867	252	5	10.3389	10.3389	NUM
dpc-1867	252	6	/	/	SYM
dpc-1867	252	7	fimmu.2019.01391	fimmu.2019.01391	PROPN
dpc-1867	252	8	.	.	PUNCT
dpc-1867	253	1	pmid	pmid	NOUN
dpc-1867	253	2	:	:	PUNCT
dpc-1867	253	3	31275324	31275324	NUM
dpc-1867	253	4	;	;	PUNCT
dpc-1867	253	5	pmcid	pmcid	ADJ
dpc-1867	253	6	:	:	PUNCT
dpc-1867	253	7	pmc6593111	pmc6593111	NOUN
dpc-1867	253	8	.	.	PUNCT
dpc-1867	254	1	20	20	NUM
dpc-1867	254	2	.	.	PUNCT
dpc-1867	255	1	hoffmann	hoffmann	PROPN
dpc-1867	255	2	k	k	PROPN
dpc-1867	255	3	,	,	PUNCT
dpc-1867	255	4	hertl	hertl	NOUN
dpc-1867	255	5	m	m	PROPN
dpc-1867	255	6	,	,	PUNCT
dpc-1867	255	7	sitaru	sitaru	PROPN
dpc-1867	255	8	c.	c.	PROPN
dpc-1867	255	9	molekulare	molekulare	PROPN
dpc-1867	255	10	diagnostik	diagnostik	PROPN
dpc-1867	255	11	der	der	PROPN
dpc-1867	255	12	blasenbildenden	blasenbildenden	VERB
dpc-1867	255	13	autoimmundermatosen	autoimmundermatosen	PROPN
dpc-1867	256	1	[	[	X
dpc-1867	257	1	molecular	molecular	ADJ
dpc-1867	257	2	diagnosis	diagnosis	NOUN
dpc-1867	257	3	of	of	ADP
dpc-1867	257	4	autoimmune	autoimmune	ADJ
dpc-1867	257	5	dermatoses	dermatosis	NOUN
dpc-1867	257	6	]	]	PUNCT
dpc-1867	257	7	.	.	PUNCT
dpc-1867	258	1	hautarzt	hautarzt	PROPN
dpc-1867	258	2	.	.	PUNCT
dpc-1867	259	1	2016;67(1):33	2016;67(1):33	NUM
dpc-1867	259	2	-	-	SYM
dpc-1867	259	3	39	39	NUM
dpc-1867	259	4	.	.	PUNCT
dpc-1867	260	1	doi	doi	NOUN
dpc-1867	260	2	:	:	PUNCT
dpc-1867	260	3	10.1007	10.1007	NUM
dpc-1867	260	4	/	/	SYM
dpc-1867	260	5	s00105	s00105	PROPN
dpc-1867	260	6	-	-	PUNCT
dpc-1867	260	7	015	015	NUM
dpc-1867	260	8	-	-	PUNCT
dpc-1867	260	9	3723	3723	NUM
dpc-1867	260	10	-	-	SYM
dpc-1867	260	11	9	9	NUM
dpc-1867	260	12	.	.	PUNCT
dpc-1867	261	1	pmid	pmid	NOUN
dpc-1867	261	2	:	:	PUNCT
dpc-1867	261	3	26612472	26612472	NUM
dpc-1867	261	4	.	.	PUNCT
dpc-1867	262	1	21	21	NUM
dpc-1867	262	2	.	.	PUNCT
dpc-1867	263	1	witte	witte	PROPN
dpc-1867	263	2	m	m	PROPN
dpc-1867	263	3	,	,	PUNCT
dpc-1867	263	4	zillikens	zillikens	PROPN
dpc-1867	263	5	d	d	PROPN
dpc-1867	263	6	,	,	PUNCT
dpc-1867	263	7	schmidt	schmidt	PROPN
dpc-1867	263	8	e.	e.	PROPN
dpc-1867	263	9	diagnosis	diagnosis	PROPN
dpc-1867	263	10	of	of	ADP
dpc-1867	263	11	autoimmune	autoimmune	ADJ
dpc-1867	263	12	blistering	blister	VERB
dpc-1867	263	13	diseases	disease	NOUN
dpc-1867	263	14	.	.	PUNCT
dpc-1867	264	1	front	front	ADJ
dpc-1867	264	2	med	med	PROPN
dpc-1867	264	3	(	(	PUNCT
dpc-1867	264	4	lausanne	lausanne	PROPN
dpc-1867	264	5	)	)	PUNCT
dpc-1867	264	6	.	.	PUNCT
dpc-1867	265	1	2018;5:296	2018;5:296	X
dpc-1867	265	2	.	.	PUNCT
dpc-1867	266	1	doi	doi	NOUN
dpc-1867	266	2	:	:	PUNCT
dpc-1867	266	3	10.3389/	10.3389/	NUM
dpc-1867	266	4	fmed.2018.00296	fmed.2018.00296	NOUN
dpc-1867	266	5	.	.	PUNCT
dpc-1867	267	1	pmid	pmid	NOUN
dpc-1867	267	2	:	:	PUNCT
dpc-1867	267	3	30450358	30450358	NUM
dpc-1867	267	4	;	;	PUNCT
dpc-1867	267	5	pmcid	pmcid	ADJ
dpc-1867	267	6	:	:	PUNCT
dpc-1867	267	7	pmc6224342	pmc6224342	NOUN
dpc-1867	267	8	.	.	PUNCT
dpc-1867	268	1	22	22	NUM
dpc-1867	268	2	.	.	PUNCT
dpc-1867	269	1	musette	musette	PROPN
dpc-1867	269	2	p	p	PROPN
dpc-1867	269	3	,	,	PUNCT
dpc-1867	269	4	bouaziz	bouaziz	PROPN
dpc-1867	269	5	jd	jd	PROPN
dpc-1867	269	6	.	.	PROPN
dpc-1867	270	1	b	b	X
dpc-1867	270	2	cell	cell	NOUN
dpc-1867	270	3	modulation	modulation	NOUN
dpc-1867	270	4	strategies	strategy	NOUN
dpc-1867	270	5	in	in	ADP
dpc-1867	270	6	autoimmune	autoimmune	ADJ
dpc-1867	270	7	diseases	disease	NOUN
dpc-1867	270	8	:	:	PUNCT
dpc-1867	270	9	new	new	ADJ
dpc-1867	270	10	concepts	concept	NOUN
dpc-1867	270	11	.	.	PUNCT
dpc-1867	271	1	front	front	ADJ
dpc-1867	271	2	immunol	immunol	NOUN
dpc-1867	271	3	.	.	PUNCT
dpc-1867	272	1	2018;9:622	2018;9:622	X
dpc-1867	272	2	.	.	PUNCT
dpc-1867	272	3	doi	doi	NOUN
dpc-1867	272	4	:	:	PUNCT
dpc-1867	272	5	10.3389	10.3389	NUM
dpc-1867	272	6	/	/	SYM
dpc-1867	272	7	fimmu.2018.00622	fimmu.2018.00622	NOUN
dpc-1867	272	8	.	.	PUNCT
dpc-1867	273	1	pmid	pmid	NOUN
dpc-1867	273	2	:	:	PUNCT
dpc-1867	273	3	29706952	29706952	NUM
dpc-1867	273	4	;	;	PUNCT
dpc-1867	273	5	pmcid	pmcid	PROPN
dpc-1867	273	6	:	:	PUNCT
dpc-1867	273	7	pmc5908887	pmc5908887	VERB
dpc-1867	273	8	.	.	PUNCT
dpc-1867	274	1	23	23	NUM
dpc-1867	274	2	.	.	PUNCT
dpc-1867	275	1	hebert	hebert	PROPN
dpc-1867	275	2	v	v	PROPN
dpc-1867	275	3	,	,	PUNCT
dpc-1867	275	4	joly	joly	PROPN
dpc-1867	275	5	p.	p.	PROPN
dpc-1867	275	6	rituximab	rituximab	NOUN
dpc-1867	275	7	in	in	ADP
dpc-1867	275	8	pemphigus	pemphigus	PROPN
dpc-1867	275	9	.	.	PUNCT
dpc-1867	276	1	immunotherapy	immunotherapy	NOUN
dpc-1867	276	2	.	.	PUNCT
dpc-1867	277	1	2018;10(1):27	2018;10(1):27	NUM
dpc-1867	277	2	-	-	SYM
dpc-1867	277	3	37	37	NUM
dpc-1867	277	4	.	.	PUNCT
dpc-1867	278	1	doi	doi	NOUN
dpc-1867	278	2	:	:	PUNCT
dpc-1867	278	3	10.2217	10.2217	NUM
dpc-1867	278	4	/	/	SYM
dpc-1867	278	5	imt-2017	imt-2017	NOUN
dpc-1867	278	6	-	-	PUNCT
dpc-1867	278	7	0104	0104	NUM
dpc-1867	278	8	.	.	PUNCT
dpc-1867	279	1	pmid	pmid	NOUN
dpc-1867	279	2	:	:	PUNCT
dpc-1867	279	3	29064314	29064314	NUM
dpc-1867	279	4	.	.	PUNCT
dpc-1867	280	1	24	24	NUM
dpc-1867	280	2	.	.	PUNCT
dpc-1867	280	3	hennerici	hennerici	PROPN
dpc-1867	280	4	t	t	PROPN
dpc-1867	280	5	,	,	PUNCT
dpc-1867	280	6	pollmann	pollmann	ADJ
dpc-1867	280	7	r	r	NOUN
dpc-1867	280	8	,	,	PUNCT
dpc-1867	280	9	schmidt	schmidt	PROPN
dpc-1867	280	10	t	t	PROPN
dpc-1867	280	11	,	,	PUNCT
dpc-1867	280	12	et	et	PROPN
dpc-1867	280	13	al	al	PROPN
dpc-1867	280	14	.	.	PROPN
dpc-1867	280	15	increased	increase	VERB
dpc-1867	280	16	frequency	frequency	NOUN
dpc-1867	280	17	of	of	ADP
dpc-1867	280	18	t	t	PROPN
dpc-1867	280	19	follicular	follicular	ADJ
dpc-1867	280	20	helper	helper	NOUN
dpc-1867	280	21	cells	cell	NOUN
dpc-1867	280	22	and	and	CCONJ
dpc-1867	280	23	elevated	elevate	VERB
dpc-1867	280	24	interleukin-27	interleukin-27	PROPN
dpc-1867	280	25	plasma	plasma	NOUN
dpc-1867	280	26	levels	level	NOUN
dpc-1867	280	27	in	in	ADP
dpc-1867	280	28	patients	patient	NOUN
dpc-1867	280	29	with	with	ADP
dpc-1867	280	30	pemphigus	pemphigus	PROPN
dpc-1867	280	31	.	.	PUNCT
dpc-1867	281	1	plos	plos	PROPN
dpc-1867	281	2	one	one	NUM
dpc-1867	281	3	.	.	PUNCT
dpc-1867	282	1	2016;11(2):e0148919	2016;11(2):e0148919	X
dpc-1867	282	2	.	.	PUNCT
dpc-1867	282	3	doi	doi	NOUN
dpc-1867	282	4	:	:	PUNCT
dpc-1867	282	5	10.1371	10.1371	NUM
dpc-1867	282	6	/	/	SYM
dpc-1867	282	7	journal.pone.0148919	journal.pone.0148919	PROPN
dpc-1867	282	8	.	.	PUNCT
dpc-1867	283	1	pmid	pmid	NOUN
dpc-1867	283	2	:	:	PUNCT
dpc-1867	283	3	26872212	26872212	NUM
dpc-1867	283	4	;	;	PUNCT
dpc-1867	283	5	pmcid	pmcid	PROPN
dpc-1867	283	6	:	:	PUNCT
dpc-1867	283	7	pmc4752242	pmc4752242	NOUN
dpc-1867	283	8	.	.	PUNCT
dpc-1867	284	1	25	25	NUM
dpc-1867	284	2	.	.	PUNCT
dpc-1867	285	1	boross	boross	PROPN
dpc-1867	285	2	p	p	NOUN
dpc-1867	285	3	,	,	PUNCT
dpc-1867	285	4	jansen	jansen	PROPN
dpc-1867	285	5	jh	jh	PROPN
dpc-1867	285	6	,	,	PUNCT
dpc-1867	285	7	pastula	pastula	ADP
dpc-1867	285	8	a	a	PRON
dpc-1867	285	9	,	,	PUNCT
dpc-1867	285	10	van	van	PROPN
dpc-1867	285	11	der	der	PROPN
dpc-1867	285	12	poel	poel	PROPN
dpc-1867	285	13	ce	ce	PROPN
dpc-1867	285	14	,	,	PUNCT
dpc-1867	285	15	leusen	leusen	PROPN
dpc-1867	285	16	jh	jh	PROPN
dpc-1867	285	17	.	.	PUNCT
dpc-1867	286	1	both	both	PRON
dpc-1867	286	2	activating	activate	VERB
dpc-1867	286	3	and	and	CCONJ
dpc-1867	286	4	inhibitory	inhibitory	ADJ
dpc-1867	286	5	fc	fc	PROPN
dpc-1867	286	6	gamma	gamma	PROPN
dpc-1867	286	7	receptors	receptor	NOUN
dpc-1867	286	8	mediate	mediate	VERB
dpc-1867	286	9	rituximab	rituximab	NOUN
dpc-1867	286	10	-	-	PUNCT
dpc-1867	286	11	induced	induce	VERB
dpc-1867	286	12	trogocytosis	trogocytosis	NOUN
dpc-1867	286	13	of	of	ADP
dpc-1867	286	14	cd20	cd20	PROPN
dpc-1867	286	15	in	in	ADP
dpc-1867	286	16	mice	mouse	NOUN
dpc-1867	286	17	.	.	PUNCT
dpc-1867	287	1	immunol	immunol	PROPN
dpc-1867	287	2	lett	lett	PROPN
dpc-1867	287	3	.	.	PUNCT
dpc-1867	288	1	2012;143(1):44	2012;143(1):44	NUM
dpc-1867	288	2	-	-	SYM
dpc-1867	288	3	52	52	NUM
dpc-1867	288	4	.	.	PUNCT
dpc-1867	289	1	doi	doi	NOUN
dpc-1867	289	2	:	:	PUNCT
dpc-1867	289	3	10.1016	10.1016	NUM
dpc-1867	289	4	/	/	SYM
dpc-1867	289	5	j.imlet.2012.01.004	j.imlet.2012.01.004	PROPN
dpc-1867	289	6	.	.	PUNCT
dpc-1867	290	1	pmid	pmid	NOUN
dpc-1867	290	2	:	:	PUNCT
dpc-1867	290	3	22285696	22285696	NUM
dpc-1867	290	4	.	.	PUNCT
dpc-1867	291	1	26	26	NUM
dpc-1867	291	2	.	.	PUNCT
dpc-1867	291	3	amber	amber	PROPN
dpc-1867	291	4	kt	kt	PROPN
dpc-1867	291	5	,	,	PUNCT
dpc-1867	291	6	lamberts	lamberts	PROPN
dpc-1867	291	7	a	a	X
dpc-1867	291	8	,	,	PUNCT
dpc-1867	291	9	solimani	solimani	PROPN
dpc-1867	291	10	f	f	PROPN
dpc-1867	291	11	,	,	PUNCT
dpc-1867	291	12	et	et	PROPN
dpc-1867	291	13	al	al	PROPN
dpc-1867	291	14	.	.	PUNCT
dpc-1867	292	1	determining	determine	VERB
dpc-1867	292	2	the	the	DET
dpc-1867	292	3	incidence	incidence	NOUN
dpc-1867	292	4	of	of	ADP
dpc-1867	292	5	pneumocystis	pneumocystis	ADJ
dpc-1867	292	6	pneumonia	pneumonia	NOUN
dpc-1867	292	7	in	in	ADP
dpc-1867	292	8	patients	patient	NOUN
dpc-1867	292	9	with	with	ADP
dpc-1867	292	10	autoimmune	autoimmune	ADJ
dpc-1867	292	11	blistering	blister	VERB
dpc-1867	292	12	diseases	disease	NOUN
dpc-1867	292	13	not	not	PART
dpc-1867	292	14	receiving	receive	VERB
dpc-1867	292	15	routine	routine	ADJ
dpc-1867	292	16	prophylaxis	prophylaxis	NOUN
dpc-1867	292	17	.	.	PUNCT
dpc-1867	293	1	jama	jama	PROPN
dpc-1867	293	2	dermatol	dermatol	NOUN
dpc-1867	293	3	.	.	PUNCT
dpc-1867	294	1	2017;153(11):1137	2017;153(11):1137	NUM
dpc-1867	294	2	-	-	SYM
dpc-1867	294	3	1141	1141	NUM
dpc-1867	294	4	.	.	PUNCT
dpc-1867	295	1	doi	doi	NOUN
dpc-1867	295	2	:	:	PUNCT
dpc-1867	295	3	10.1001	10.1001	NUM
dpc-1867	295	4	/	/	SYM
dpc-1867	295	5	jamadermatol.2017.2808	jamadermatol.2017.2808	NOUN
dpc-1867	295	6	.	.	PUNCT
dpc-1867	296	1	pmid	pmid	NOUN
dpc-1867	296	2	:	:	PUNCT
dpc-1867	296	3	28854309	28854309	NUM
dpc-1867	296	4	;	;	PUNCT
dpc-1867	296	5	pmcid	pmcid	ADJ
dpc-1867	296	6	:	:	PUNCT
dpc-1867	296	7	pmc5710438	pmc5710438	NOUN
dpc-1867	296	8	.	.	PUNCT
dpc-1867	297	1	27	27	NUM
dpc-1867	297	2	.	.	PUNCT
dpc-1867	298	1	didona	didona	PROPN
dpc-1867	298	2	d	d	PROPN
dpc-1867	298	3	,	,	PUNCT
dpc-1867	298	4	paolino	paolino	PROPN
dpc-1867	298	5	g	g	NOUN
dpc-1867	298	6	,	,	PUNCT
dpc-1867	298	7	garcovich	garcovich	PROPN
dpc-1867	298	8	s	s	PART
dpc-1867	298	9	,	,	PUNCT
dpc-1867	298	10	caposiena	caposiena	PROPN
dpc-1867	298	11	caro	caro	PROPN
dpc-1867	298	12	rd	rd	PROPN
dpc-1867	298	13	,	,	PUNCT
dpc-1867	298	14	didona	didona	PROPN
dpc-1867	298	15	b.	b.	PROPN
dpc-1867	298	16	successful	successful	ADJ
dpc-1867	298	17	use	use	NOUN
dpc-1867	298	18	of	of	ADP
dpc-1867	298	19	etanercept	etanercept	NOUN
dpc-1867	298	20	in	in	ADP
dpc-1867	298	21	a	a	DET
dpc-1867	298	22	case	case	NOUN
dpc-1867	298	23	of	of	ADP
dpc-1867	298	24	toxic	toxic	ADJ
dpc-1867	298	25	epidermal	epidermal	ADJ
dpc-1867	298	26	necrolysis	necrolysis	NOUN
dpc-1867	298	27	induced	induce	VERB
dpc-1867	298	28	by	by	ADP
dpc-1867	298	29	rituximab	rituximab	NOUN
dpc-1867	298	30	.	.	PUNCT
dpc-1867	299	1	j	j	PROPN
dpc-1867	299	2	eur	eur	PROPN
dpc-1867	299	3	acad	acad	PROPN
dpc-1867	299	4	dermatol	dermatol	NOUN
dpc-1867	299	5	venereol	venereol	NOUN
dpc-1867	299	6	.	.	PUNCT
dpc-1867	300	1	2016;30(10):e83	2016;30(10):e83	NUM
dpc-1867	300	2	-	-	PUNCT
dpc-1867	300	3	e84	e84	PROPN
dpc-1867	300	4	.	.	PUNCT
dpc-1867	301	1	doi	doi	NOUN
dpc-1867	301	2	:	:	PUNCT
dpc-1867	301	3	10.1111	10.1111	NUM
dpc-1867	301	4	/	/	SYM
dpc-1867	301	5	jdv.13330	jdv.13330	PROPN
dpc-1867	301	6	.	.	PUNCT
dpc-1867	302	1	pmid	pmid	NOUN
dpc-1867	302	2	:	:	PUNCT
dpc-1867	302	3	26428058	26428058	NUM
dpc-1867	302	4	.	.	PUNCT
dpc-1867	303	1	form	form	NOUN
dpc-1867	303	2	28	28	NUM
dpc-1867	303	3	.	.	PUNCT
dpc-1867	304	1	murrell	murrell	PROPN
dpc-1867	304	2	df	df	PROPN
dpc-1867	304	3	,	,	PUNCT
dpc-1867	304	4	peña	peña	PROPN
dpc-1867	304	5	s	s	PROPN
dpc-1867	304	6	,	,	PUNCT
dpc-1867	304	7	joly	joly	PROPN
dpc-1867	304	8	p	p	PROPN
dpc-1867	304	9	,	,	PUNCT
dpc-1867	304	10	et	et	PROPN
dpc-1867	304	11	al	al	PROPN
dpc-1867	304	12	.	.	PUNCT
dpc-1867	304	13	diagnosis	diagnosis	NOUN
dpc-1867	304	14	and	and	CCONJ
dpc-1867	304	15	management	management	NOUN
dpc-1867	304	16	of	of	ADP
dpc-1867	304	17	pemphigus	pemphigus	NOUN
dpc-1867	304	18	:	:	PUNCT
dpc-1867	304	19	recommendations	recommendation	NOUN
dpc-1867	304	20	of	of	ADP
dpc-1867	304	21	an	an	DET
dpc-1867	304	22	international	international	ADJ
dpc-1867	304	23	panel	panel	NOUN
dpc-1867	304	24	of	of	ADP
dpc-1867	304	25	experts	expert	NOUN
dpc-1867	304	26	.	.	PUNCT
dpc-1867	305	1	j	j	PROPN
dpc-1867	305	2	am	be	AUX
dpc-1867	305	3	acad	acad	ADJ
dpc-1867	305	4	dermatol	dermatol	NOUN
dpc-1867	305	5	.	.	PUNCT
dpc-1867	306	1	2020;82(3):575	2020;82(3):575	NUM
dpc-1867	306	2	-	-	PUNCT
dpc-1867	306	3	585.e1	585.e1	PROPN
dpc-1867	306	4	.	.	PUNCT
dpc-1867	307	1	doi	doi	NOUN
dpc-1867	307	2	:	:	PUNCT
dpc-1867	307	3	10.1016	10.1016	NUM
dpc-1867	307	4	/	/	SYM
dpc-1867	307	5	j.jaad.2018.02.021	j.jaad.2018.02.021	PROPN
dpc-1867	307	6	.	.	PUNCT
dpc-1867	308	1	pmid	pmid	NOUN
dpc-1867	308	2	:	:	PUNCT
dpc-1867	308	3	29438767	29438767	NUM
dpc-1867	308	4	;	;	PUNCT
dpc-1867	308	5	pmcid	pmcid	ADJ
dpc-1867	308	6	:	:	PUNCT
dpc-1867	308	7	pmc7313440	pmc7313440	ADJ
dpc-1867	308	8	.	.	PUNCT
dpc-1867	309	1	29	29	NUM
dpc-1867	309	2	.	.	X
dpc-1867	309	3	joly	joly	PROPN
dpc-1867	309	4	p	p	PROPN
dpc-1867	309	5	,	,	PUNCT
dpc-1867	309	6	maho	maho	PROPN
dpc-1867	309	7	-	-	PUNCT
dpc-1867	309	8	vaillant	vaillant	PROPN
dpc-1867	309	9	m	m	PROPN
dpc-1867	309	10	,	,	PUNCT
dpc-1867	309	11	prost	prost	PROPN
dpc-1867	309	12	-	-	NOUN
dpc-1867	309	13	squarcioni	squarcioni	PROPN
dpc-1867	309	14	c	c	PROPN
dpc-1867	309	15	,	,	PUNCT
dpc-1867	309	16	et	et	PROPN
dpc-1867	309	17	al	al	PROPN
dpc-1867	309	18	.	.	PUNCT
dpc-1867	310	1	first	first	ADJ
dpc-1867	310	2	-	-	PUNCT
dpc-1867	310	3	line	line	NOUN
dpc-1867	310	4	rituximab	rituximab	NOUN
dpc-1867	310	5	combined	combine	VERB
dpc-1867	310	6	with	with	ADP
dpc-1867	310	7	short	short	ADJ
dpc-1867	310	8	-	-	PUNCT
dpc-1867	310	9	term	term	NOUN
dpc-1867	310	10	prednisone	prednisone	NOUN
dpc-1867	310	11	versus	versus	ADP
dpc-1867	310	12	prednisone	prednisone	NOUN
dpc-1867	310	13	alone	alone	ADV
dpc-1867	310	14	for	for	ADP
dpc-1867	310	15	the	the	DET
dpc-1867	310	16	treatment	treatment	NOUN
dpc-1867	310	17	of	of	ADP
dpc-1867	310	18	pemphigus	pemphigus	NOUN
dpc-1867	310	19	(	(	PUNCT
dpc-1867	310	20	ritux	ritux	NOUN
dpc-1867	310	21	3	3	NUM
dpc-1867	310	22	):	):	PUNCT
dpc-1867	310	23	a	a	DET
dpc-1867	310	24	prospective	prospective	ADJ
dpc-1867	310	25	,	,	PUNCT
dpc-1867	310	26	multicentre	multicentre	NOUN
dpc-1867	310	27	,	,	PUNCT
dpc-1867	310	28	parallel	parallel	NOUN
dpc-1867	310	29	-	-	PUNCT
dpc-1867	310	30	group	group	NOUN
dpc-1867	310	31	,	,	PUNCT
dpc-1867	310	32	open	open	ADJ
dpc-1867	310	33	-	-	PUNCT
dpc-1867	310	34	label	label	NOUN
dpc-1867	310	35	randomised	randomised	ADJ
dpc-1867	310	36	trial	trial	NOUN
dpc-1867	310	37	.	.	PUNCT
dpc-1867	311	1	lancet	lancet	PROPN
dpc-1867	311	2	.	.	PUNCT
dpc-1867	312	1	2017;389(10083):2031	2017;389(10083):2031	NUM
dpc-1867	312	2	-	-	SYM
dpc-1867	312	3	2040	2040	NUM
dpc-1867	312	4	.	.	PUNCT
dpc-1867	313	1	doi	doi	NOUN
dpc-1867	313	2	:	:	PUNCT
dpc-1867	313	3	10.1016	10.1016	NUM
dpc-1867	313	4	/	/	SYM
dpc-1867	313	5	s01406736(17)30070	s01406736(17)30070	PROPN
dpc-1867	313	6	-	-	PUNCT
dpc-1867	313	7	3	3	NUM
dpc-1867	313	8	.	.	PUNCT
dpc-1867	314	1	pmid	pmid	NOUN
dpc-1867	314	2	:	:	PUNCT
dpc-1867	314	3	28342637	28342637	NUM
dpc-1867	314	4	.	.	PUNCT
dpc-1867	315	1	30	30	NUM
dpc-1867	315	2	.	.	PUNCT
dpc-1867	316	1	cang	cang	PROPN
dpc-1867	316	2	s	s	PROPN
dpc-1867	316	3	,	,	PUNCT
dpc-1867	316	4	mukhi	mukhi	PROPN
dpc-1867	316	5	n	n	PART
dpc-1867	316	6	,	,	PUNCT
dpc-1867	316	7	wang	wang	PROPN
dpc-1867	316	8	k	k	PROPN
dpc-1867	316	9	,	,	PUNCT
dpc-1867	316	10	liu	liu	PROPN
dpc-1867	316	11	d.	d.	PROPN
dpc-1867	316	12	novel	novel	PROPN
dpc-1867	316	13	cd20	cd20	PROPN
dpc-1867	316	14	monoclonal	monoclonal	NOUN
dpc-1867	316	15	antibodies	antibodie	VERB
dpc-1867	316	16	for	for	ADP
dpc-1867	316	17	lymphoma	lymphoma	NOUN
dpc-1867	316	18	therapy	therapy	NOUN
dpc-1867	316	19	.	.	PUNCT
dpc-1867	317	1	j	j	PROPN
dpc-1867	317	2	hematol	hematol	PROPN
dpc-1867	317	3	oncol	oncol	PROPN
dpc-1867	317	4	.	.	PUNCT
dpc-1867	318	1	2012;5:64	2012;5:64	PROPN
dpc-1867	318	2	.	.	PUNCT
dpc-1867	319	1	doi	doi	NOUN
dpc-1867	319	2	:	:	PUNCT
dpc-1867	319	3	10.1186/1756	10.1186/1756	NUM
dpc-1867	319	4	-	-	SYM
dpc-1867	319	5	8722	8722	NUM
dpc-1867	319	6	-	-	SYM
dpc-1867	319	7	5	5	NUM
dpc-1867	319	8	-	-	SYM
dpc-1867	319	9	64	64	NUM
dpc-1867	319	10	.	.	PUNCT
dpc-1867	320	1	pmid	pmid	NOUN
dpc-1867	320	2	:	:	PUNCT
dpc-1867	320	3	23057966	23057966	NUM
dpc-1867	320	4	;	;	PUNCT
dpc-1867	320	5	pmcid	pmcid	ADJ
dpc-1867	320	6	:	:	PUNCT
dpc-1867	320	7	pmc3479003	pmc3479003	NOUN
dpc-1867	320	8	.	.	PUNCT
dpc-1867	321	1	31	31	NUM
dpc-1867	321	2	.	.	PUNCT
dpc-1867	321	3	rapp	rapp	PROPN
dpc-1867	321	4	m	m	PROPN
dpc-1867	321	5	,	,	PUNCT
dpc-1867	321	6	pentland	pentland	PROPN
dpc-1867	321	7	a	a	PROPN
dpc-1867	321	8	,	,	PUNCT
dpc-1867	321	9	richardson	richardson	PROPN
dpc-1867	321	10	c.	c.	PROPN
dpc-1867	321	11	successful	successful	ADJ
dpc-1867	321	12	treatment	treatment	NOUN
dpc-1867	321	13	of	of	ADP
dpc-1867	321	14	pemphigus	pemphigus	ADJ
dpc-1867	321	15	vulgaris	vulgaris	NOUN
dpc-1867	321	16	with	with	ADP
dpc-1867	321	17	ofatumumab	ofatumumab	NOUN
dpc-1867	321	18	.	.	PUNCT
dpc-1867	322	1	j	j	PROPN
dpc-1867	322	2	drugs	drug	NOUN
dpc-1867	322	3	dermatol	dermatol	NOUN
dpc-1867	322	4	.	.	PUNCT
dpc-1867	323	1	2018;17(12):1338	2018;17(12):1338	NUM
dpc-1867	323	2	-	-	SYM
dpc-1867	323	3	1339	1339	NUM
dpc-1867	323	4	.	.	PUNCT
dpc-1867	324	1	pmid	pmid	NOUN
dpc-1867	324	2	:	:	PUNCT
dpc-1867	324	3	30586270	30586270	NUM
dpc-1867	324	4	.	.	PUNCT
dpc-1867	325	1	32	32	NUM
dpc-1867	325	2	.	.	PUNCT
dpc-1867	326	1	forbat	forbat	PROPN
dpc-1867	326	2	e	e	PROPN
dpc-1867	326	3	,	,	PUNCT
dpc-1867	326	4	ali	ali	PROPN
dpc-1867	326	5	fr	fr	PROPN
dpc-1867	326	6	,	,	PUNCT
dpc-1867	326	7	al	al	PROPN
dpc-1867	326	8	-	-	PUNCT
dpc-1867	326	9	niaimi	niaimi	PROPN
dpc-1867	326	10	f.	f.	PROPN
dpc-1867	326	11	intravenous	intravenous	PROPN
dpc-1867	326	12	immunoglobulins	immunoglobulin	NOUN
dpc-1867	326	13	in	in	ADP
dpc-1867	326	14	dermatology	dermatology	NOUN
dpc-1867	326	15	.	.	PUNCT
dpc-1867	327	1	part	part	NOUN
dpc-1867	327	2	2	2	NUM
dpc-1867	327	3	:	:	PUNCT
dpc-1867	327	4	clinical	clinical	ADJ
dpc-1867	327	5	indications	indication	NOUN
dpc-1867	327	6	and	and	CCONJ
dpc-1867	327	7	outcomes	outcome	NOUN
dpc-1867	327	8	.	.	PUNCT
dpc-1867	328	1	clin	clin	PROPN
dpc-1867	328	2	exp	exp	NOUN
dpc-1867	328	3	dermatol	dermatol	NOUN
dpc-1867	328	4	.	.	PUNCT
dpc-1867	329	1	2018;43(6):659	2018;43(6):659	PROPN
dpc-1867	329	2	-	-	SYM
dpc-1867	329	3	666	666	NUM
dpc-1867	329	4	.	.	PUNCT
dpc-1867	329	5	doi	doi	NOUN
dpc-1867	329	6	:	:	PUNCT
dpc-1867	329	7	10.1111	10.1111	NUM
dpc-1867	329	8	/	/	SYM
dpc-1867	329	9	ced.13552	ced.13552	NOUN
dpc-1867	329	10	.	.	PUNCT
dpc-1867	330	1	pmid	pmid	NOUN
dpc-1867	330	2	:	:	PUNCT
dpc-1867	330	3	29774587	29774587	NUM
dpc-1867	330	4	.	.	PUNCT
dpc-1867	331	1	33	33	NUM
dpc-1867	331	2	.	.	PUNCT
dpc-1867	331	3	dourmishev	dourmishev	PROPN
dpc-1867	331	4	la	la	PROPN
dpc-1867	331	5	,	,	PUNCT
dpc-1867	331	6	guleva	guleva	PROPN
dpc-1867	331	7	dv	dv	PROPN
dpc-1867	331	8	,	,	PUNCT
dpc-1867	331	9	miteva	miteva	PROPN
dpc-1867	331	10	lg	lg	PROPN
dpc-1867	331	11	.	.	PROPN
dpc-1867	331	12	intravenous	intravenous	ADJ
dpc-1867	331	13	immunoglobulins	immunoglobulin	NOUN
dpc-1867	331	14	:	:	PUNCT
dpc-1867	331	15	mode	mode	NOUN
dpc-1867	331	16	of	of	ADP
dpc-1867	331	17	action	action	NOUN
dpc-1867	331	18	and	and	CCONJ
dpc-1867	331	19	indications	indication	NOUN
dpc-1867	331	20	in	in	ADP
dpc-1867	331	21	autoimmune	autoimmune	ADJ
dpc-1867	331	22	and	and	CCONJ
dpc-1867	331	23	inflammatory	inflammatory	ADJ
dpc-1867	331	24	dermatoses	dermatosis	NOUN
dpc-1867	331	25	.	.	PUNCT
dpc-1867	332	1	int	int	PROPN
dpc-1867	332	2	j	j	PROPN
dpc-1867	332	3	inflam	inflam	PROPN
dpc-1867	332	4	.	.	PUNCT
dpc-1867	333	1	2016;2016:3523057	2016;2016:3523057	NUM
dpc-1867	333	2	.	.	PUNCT
dpc-1867	334	1	doi	doi	NOUN
dpc-1867	334	2	:	:	PUNCT
dpc-1867	334	3	10.1155/2016/3523057	10.1155/2016/3523057	NUM
dpc-1867	334	4	.	.	PUNCT
dpc-1867	335	1	pmid	pmid	NOUN
dpc-1867	335	2	:	:	PUNCT
dpc-1867	335	3	26885437	26885437	NUM
dpc-1867	335	4	;	;	PUNCT
dpc-1867	335	5	pmcid	pmcid	ADJ
dpc-1867	335	6	:	:	PUNCT
dpc-1867	335	7	pmc4739470	pmc4739470	ADJ
dpc-1867	335	8	.	.	PUNCT
dpc-1867	336	1	6	6	NUM
dpc-1867	336	2	review	review	NOUN
dpc-1867	336	3	|	|	ADV
dpc-1867	336	4	dermatol	dermatol	ADJ
dpc-1867	336	5	pract	pract	NOUN
dpc-1867	336	6	concept	concept	NOUN
dpc-1867	336	7	.	.	PUNCT
dpc-1867	337	1	2022;12(1	2022;12(1	NUM
dpc-1867	337	2	):	):	PUNCT
dpc-1867	337	3	e2022037	e2022037	NOUN
dpc-1867	337	4	34	34	NUM
dpc-1867	337	5	.	.	PUNCT
dpc-1867	338	1	forbat	forbat	PROPN
dpc-1867	338	2	e	e	PROPN
dpc-1867	338	3	,	,	PUNCT
dpc-1867	338	4	ali	ali	PROPN
dpc-1867	338	5	fr	fr	PROPN
dpc-1867	338	6	,	,	PUNCT
dpc-1867	338	7	al	al	PROPN
dpc-1867	338	8	-	-	PUNCT
dpc-1867	338	9	niaimi	niaimi	PROPN
dpc-1867	338	10	f.	f.	PROPN
dpc-1867	338	11	intravenous	intravenous	PROPN
dpc-1867	338	12	immunoglobulins	immunoglobulin	NOUN
dpc-1867	338	13	in	in	ADP
dpc-1867	338	14	dermatology	dermatology	NOUN
dpc-1867	338	15	.	.	PUNCT
dpc-1867	339	1	part	part	NOUN
dpc-1867	339	2	1	1	NUM
dpc-1867	339	3	:	:	PUNCT
dpc-1867	339	4	biological	biological	ADJ
dpc-1867	339	5	mechanisms	mechanism	NOUN
dpc-1867	339	6	and	and	CCONJ
dpc-1867	339	7	methods	method	NOUN
dpc-1867	339	8	of	of	ADP
dpc-1867	339	9	administration	administration	NOUN
dpc-1867	339	10	.	.	PUNCT
dpc-1867	340	1	clin	clin	PROPN
dpc-1867	340	2	exp	exp	NOUN
dpc-1867	340	3	dermatol	dermatol	NOUN
dpc-1867	340	4	.	.	PUNCT
dpc-1867	341	1	2018;43(5):513	2018;43(5):513	NUM
dpc-1867	341	2	-	-	PUNCT
dpc-1867	341	3	517	517	NUM
dpc-1867	341	4	.	.	PUNCT
dpc-1867	342	1	doi	doi	NOUN
dpc-1867	342	2	:	:	PUNCT
dpc-1867	342	3	10.1111	10.1111	NUM
dpc-1867	342	4	/	/	SYM
dpc-1867	342	5	ced.13553	ced.13553	PROPN
dpc-1867	342	6	.	.	PUNCT
dpc-1867	343	1	pmid	pmid	NOUN
dpc-1867	343	2	:	:	PUNCT
dpc-1867	343	3	29774583	29774583	NUM
dpc-1867	343	4	.	.	PUNCT
dpc-1867	344	1	35	35	NUM
dpc-1867	344	2	.	.	PUNCT
dpc-1867	345	1	amagai	amagai	PROPN
dpc-1867	345	2	m	m	PROPN
dpc-1867	345	3	,	,	PUNCT
dpc-1867	345	4	ikeda	ikeda	PROPN
dpc-1867	345	5	s	s	PROPN
dpc-1867	345	6	,	,	PUNCT
dpc-1867	345	7	shimizu	shimizu	PROPN
dpc-1867	345	8	h	h	PROPN
dpc-1867	345	9	,	,	PUNCT
dpc-1867	345	10	et	et	PROPN
dpc-1867	345	11	al	al	PROPN
dpc-1867	345	12	.	.	PUNCT
dpc-1867	346	1	a	a	DET
dpc-1867	346	2	randomized	randomized	ADJ
dpc-1867	346	3	double	double	ADJ
dpc-1867	346	4	-	-	PUNCT
dpc-1867	346	5	blind	blind	ADJ
dpc-1867	346	6	trial	trial	NOUN
dpc-1867	346	7	of	of	ADP
dpc-1867	346	8	intravenous	intravenous	ADJ
dpc-1867	346	9	immunoglobulin	immunoglobulin	NOUN
dpc-1867	346	10	for	for	ADP
dpc-1867	346	11	pemphigus	pemphigus	PROPN
dpc-1867	346	12	.	.	PUNCT
dpc-1867	347	1	j	j	PROPN
dpc-1867	347	2	am	be	AUX
dpc-1867	347	3	acad	acad	ADJ
dpc-1867	347	4	dermatol	dermatol	NOUN
dpc-1867	347	5	.	.	PUNCT
dpc-1867	348	1	2009;60(4):595	2009;60(4):595	NOUN
dpc-1867	348	2	-	-	SYM
dpc-1867	348	3	603	603	NUM
dpc-1867	348	4	.	.	PUNCT
dpc-1867	349	1	doi	doi	NOUN
dpc-1867	349	2	:	:	PUNCT
dpc-1867	349	3	10.1016	10.1016	NUM
dpc-1867	349	4	/	/	SYM
dpc-1867	349	5	j.	j.	PROPN
dpc-1867	349	6	jaad.2008.09.052	jaad.2008.09.052	PROPN
dpc-1867	349	7	.	.	PUNCT
dpc-1867	350	1	pmid	pmid	NOUN
dpc-1867	350	2	:	:	PUNCT
dpc-1867	350	3	19293008	19293008	NUM
dpc-1867	350	4	.	.	PUNCT
dpc-1867	351	1	36	36	NUM
dpc-1867	351	2	.	.	PUNCT
dpc-1867	351	3	tufan	tufan	PROPN
dpc-1867	351	4	f	f	PROPN
dpc-1867	351	5	,	,	PUNCT
dpc-1867	351	6	kamali	kamali	PROPN
dpc-1867	351	7	s	s	PART
dpc-1867	351	8	,	,	PUNCT
dpc-1867	351	9	erer	erer	PROPN
dpc-1867	351	10	b	b	PROPN
dpc-1867	351	11	,	,	PUNCT
dpc-1867	351	12	et	et	PROPN
dpc-1867	351	13	al	al	PROPN
dpc-1867	351	14	.	.	PROPN
dpc-1867	351	15	safety	safety	NOUN
dpc-1867	351	16	of	of	ADP
dpc-1867	351	17	high	high	ADJ
dpc-1867	351	18	-	-	PUNCT
dpc-1867	351	19	dose	dose	NOUN
dpc-1867	351	20	intravenous	intravenous	ADJ
dpc-1867	351	21	immunoglobulin	immunoglobulin	NOUN
dpc-1867	351	22	in	in	ADP
dpc-1867	351	23	systemic	systemic	ADJ
dpc-1867	351	24	autoimmune	autoimmune	ADJ
dpc-1867	351	25	diseases	disease	NOUN
dpc-1867	351	26	.	.	PUNCT
dpc-1867	352	1	clin	clin	PROPN
dpc-1867	352	2	rheumatol	rheumatol	NOUN
dpc-1867	352	3	.	.	PUNCT
dpc-1867	353	1	2007;26(11):1913	2007;26(11):1913	NUM
dpc-1867	353	2	-	-	SYM
dpc-1867	353	3	1915	1915	NUM
dpc-1867	353	4	.	.	PUNCT
dpc-1867	354	1	doi	doi	NOUN
dpc-1867	354	2	:	:	PUNCT
dpc-1867	354	3	10.1007	10.1007	NUM
dpc-1867	354	4	/	/	SYM
dpc-1867	354	5	s10067	s10067	NOUN
dpc-1867	354	6	-	-	PUNCT
dpc-1867	354	7	007	007	NUM
dpc-1867	354	8	-	-	PUNCT
dpc-1867	354	9	0694	0694	NUM
dpc-1867	354	10	-	-	PUNCT
dpc-1867	354	11	y.	y.	NOUN
dpc-1867	354	12	pmid	pmid	PROPN
dpc-1867	354	13	:	:	PUNCT
dpc-1867	354	14	17636363	17636363	NUM
dpc-1867	354	15	.	.	PUNCT
dpc-1867	355	1	37	37	NUM
dpc-1867	355	2	.	.	PUNCT
dpc-1867	356	1	orbach	orbach	PROPN
dpc-1867	356	2	h	h	PROPN
dpc-1867	356	3	,	,	PUNCT
dpc-1867	356	4	katz	katz	PROPN
dpc-1867	356	5	u	u	PROPN
dpc-1867	356	6	,	,	PUNCT
dpc-1867	356	7	sherer	sherer	NOUN
dpc-1867	356	8	y	y	PROPN
dpc-1867	356	9	,	,	PUNCT
dpc-1867	356	10	et	et	PROPN
dpc-1867	356	11	al	al	PROPN
dpc-1867	356	12	.	.	PROPN
dpc-1867	356	13	intravenous	intravenous	ADJ
dpc-1867	356	14	immunoglobulin	immunoglobulin	NOUN
dpc-1867	356	15	:	:	PUNCT
dpc-1867	356	16	adverse	adverse	ADJ
dpc-1867	356	17	effects	effect	NOUN
dpc-1867	356	18	and	and	CCONJ
dpc-1867	356	19	safe	safe	ADJ
dpc-1867	356	20	administration	administration	NOUN
dpc-1867	356	21	.	.	PUNCT
dpc-1867	357	1	clin	clin	PROPN
dpc-1867	357	2	rev	rev	PROPN
dpc-1867	357	3	allergy	allergy	PROPN
dpc-1867	357	4	immunol	immunol	NOUN
dpc-1867	357	5	.	.	PUNCT
dpc-1867	358	1	2005;29(3):173	2005;29(3):173	NUM
dpc-1867	358	2	-	-	SYM
dpc-1867	358	3	184	184	NUM
dpc-1867	358	4	.	.	PUNCT
dpc-1867	359	1	doi	doi	NOUN
dpc-1867	359	2	:	:	PUNCT
dpc-1867	359	3	10.1385	10.1385	NUM
dpc-1867	359	4	/	/	SYM
dpc-1867	359	5	criai:29:3:173	criai:29:3:173	PROPN
dpc-1867	359	6	.	.	PUNCT
dpc-1867	360	1	pmid	pmid	NOUN
dpc-1867	360	2	:	:	PUNCT
dpc-1867	360	3	16391392	16391392	NUM
dpc-1867	360	4	.	.	PUNCT
dpc-1867	361	1	38	38	NUM
dpc-1867	361	2	.	.	PUNCT
dpc-1867	362	1	zhang	zhang	PROPN
dpc-1867	362	2	q	q	PROPN
dpc-1867	362	3	,	,	PUNCT
dpc-1867	362	4	ping	ping	PROPN
dpc-1867	362	5	j	j	PROPN
dpc-1867	362	6	,	,	PUNCT
dpc-1867	362	7	huang	huang	PROPN
dpc-1867	362	8	z	z	PROPN
dpc-1867	362	9	,	,	PUNCT
dpc-1867	362	10	et	et	PROPN
dpc-1867	362	11	al	al	PROPN
dpc-1867	362	12	.	.	PUNCT
dpc-1867	362	13	car	car	PROPN
dpc-1867	362	14	-	-	PUNCT
dpc-1867	362	15	t	t	NOUN
dpc-1867	362	16	cell	cell	NOUN
dpc-1867	362	17	therapy	therapy	NOUN
dpc-1867	362	18	in	in	ADP
dpc-1867	362	19	cancer	cancer	NOUN
dpc-1867	362	20	:	:	PUNCT
dpc-1867	362	21	tribulations	tribulation	NOUN
dpc-1867	362	22	and	and	CCONJ
dpc-1867	362	23	road	road	NOUN
dpc-1867	362	24	ahead	ahead	ADV
dpc-1867	362	25	.	.	PUNCT
dpc-1867	363	1	j	j	PROPN
dpc-1867	363	2	immunol	immunol	NOUN
dpc-1867	363	3	res	re	NOUN
dpc-1867	363	4	.	.	PUNCT
dpc-1867	364	1	2020;2020:1924379	2020;2020:1924379	NUM
dpc-1867	364	2	.	.	PUNCT
dpc-1867	365	1	doi	doi	NOUN
dpc-1867	365	2	:	:	PUNCT
dpc-1867	365	3	10.1155/2020/1924379	10.1155/2020/1924379	NUM
dpc-1867	365	4	.	.	PUNCT
dpc-1867	366	1	pmid	pmid	NOUN
dpc-1867	366	2	:	:	PUNCT
dpc-1867	366	3	32411789	32411789	NUM
dpc-1867	366	4	;	;	PUNCT
dpc-1867	366	5	pmcid	pmcid	NOUN
dpc-1867	366	6	:	:	PUNCT
dpc-1867	366	7	pmc7201836	pmc7201836	NOUN
dpc-1867	366	8	.	.	PUNCT
dpc-1867	367	1	39	39	NUM
dpc-1867	367	2	.	.	PUNCT
dpc-1867	368	1	dai	dai	PROPN
dpc-1867	368	2	h	h	PROPN
dpc-1867	368	3	,	,	PUNCT
dpc-1867	368	4	wang	wang	PROPN
dpc-1867	368	5	y	y	PROPN
dpc-1867	368	6	,	,	PUNCT
dpc-1867	368	7	lu	lu	PROPN
dpc-1867	368	8	x	x	PROPN
dpc-1867	368	9	,	,	PUNCT
dpc-1867	368	10	han	han	PROPN
dpc-1867	368	11	w.	w.	PROPN
dpc-1867	368	12	chimeric	chimeric	ADJ
dpc-1867	368	13	antigen	antigen	ADJ
dpc-1867	368	14	receptors	receptor	NOUN
dpc-1867	368	15	modified	modify	VERB
dpc-1867	368	16	t	t	NOUN
dpc-1867	368	17	-	-	PUNCT
dpc-1867	368	18	cells	cell	NOUN
dpc-1867	368	19	for	for	ADP
dpc-1867	368	20	cancer	cancer	NOUN
dpc-1867	368	21	therapy	therapy	NOUN
dpc-1867	368	22	.	.	PUNCT
dpc-1867	369	1	j	j	PROPN
dpc-1867	369	2	natl	natl	PROPN
dpc-1867	369	3	cancer	cancer	PROPN
dpc-1867	369	4	inst	inst	PROPN
dpc-1867	369	5	.	.	PUNCT
dpc-1867	370	1	2016;108(7):djv439	2016;108(7):djv439	NUM
dpc-1867	370	2	.	.	PUNCT
dpc-1867	371	1	doi	doi	NOUN
dpc-1867	371	2	:	:	PUNCT
dpc-1867	371	3	10.1093	10.1093	NUM
dpc-1867	371	4	/	/	SYM
dpc-1867	371	5	jnci	jnci	PROPN
dpc-1867	371	6	/	/	SYM
dpc-1867	371	7	djv439	djv439	NOUN
dpc-1867	371	8	.	.	PUNCT
dpc-1867	372	1	pmid	pmid	NOUN
dpc-1867	372	2	:	:	PUNCT
dpc-1867	372	3	26819347	26819347	NUM
dpc-1867	372	4	;	;	PUNCT
dpc-1867	372	5	pmcid	pmcid	ADJ
dpc-1867	372	6	:	:	PUNCT
dpc-1867	372	7	pmc4948566	pmc4948566	ADJ
dpc-1867	372	8	.	.	PUNCT
dpc-1867	373	1	40	40	NUM
dpc-1867	373	2	.	.	PUNCT
dpc-1867	374	1	ellebrecht	ellebrecht	PROPN
dpc-1867	374	2	ct	ct	PROPN
dpc-1867	374	3	,	,	PUNCT
dpc-1867	374	4	bhoj	bhoj	NOUN
dpc-1867	374	5	vg	vg	NOUN
dpc-1867	374	6	,	,	PUNCT
dpc-1867	374	7	nace	nace	NOUN
dpc-1867	374	8	a	a	X
dpc-1867	374	9	,	,	PUNCT
dpc-1867	374	10	et	et	PROPN
dpc-1867	374	11	al	al	PROPN
dpc-1867	374	12	.	.	PUNCT
dpc-1867	375	1	reengineering	reengineere	VERB
dpc-1867	375	2	chimeric	chimeric	ADJ
dpc-1867	375	3	antigen	antigen	ADJ
dpc-1867	375	4	receptor	receptor	NOUN
dpc-1867	375	5	t	t	NOUN
dpc-1867	375	6	cells	cell	NOUN
dpc-1867	375	7	for	for	ADP
dpc-1867	375	8	targeted	target	VERB
dpc-1867	375	9	therapy	therapy	NOUN
dpc-1867	375	10	of	of	ADP
dpc-1867	375	11	autoimmune	autoimmune	ADJ
dpc-1867	375	12	disease	disease	NOUN
dpc-1867	375	13	.	.	PUNCT
dpc-1867	376	1	science	science	NOUN
dpc-1867	376	2	.	.	PUNCT
dpc-1867	377	1	2016;353(6295):179	2016;353(6295):179	NUM
dpc-1867	377	2	-	-	SYM
dpc-1867	377	3	184	184	NUM
dpc-1867	377	4	.	.	PUNCT
dpc-1867	378	1	doi	doi	NOUN
dpc-1867	378	2	:	:	PUNCT
dpc-1867	378	3	10.1126	10.1126	NUM
dpc-1867	378	4	/	/	SYM
dpc-1867	378	5	science	science	NOUN
dpc-1867	378	6	.	.	PUNCT
dpc-1867	379	1	aaf6756	aaf6756	PROPN
dpc-1867	379	2	.	.	PUNCT
dpc-1867	380	1	pmid	pmid	NOUN
dpc-1867	380	2	:	:	PUNCT
dpc-1867	380	3	27365313	27365313	NUM
dpc-1867	380	4	;	;	PUNCT
dpc-1867	380	5	pmcid	pmcid	ADJ
dpc-1867	380	6	:	:	PUNCT
dpc-1867	380	7	pmc5343513	pmc5343513	NOUN
dpc-1867	380	8	.	.	PUNCT
dpc-1867	381	1	41	41	NUM
dpc-1867	381	2	.	.	PUNCT
dpc-1867	382	1	junghans	junghans	PROPN
dpc-1867	382	2	rp	rp	PROPN
dpc-1867	382	3	,	,	PUNCT
dpc-1867	382	4	anderson	anderson	PROPN
dpc-1867	382	5	cl	cl	PROPN
dpc-1867	382	6	.	.	PUNCT
dpc-1867	383	1	the	the	DET
dpc-1867	383	2	protection	protection	NOUN
dpc-1867	383	3	receptor	receptor	NOUN
dpc-1867	383	4	for	for	ADP
dpc-1867	383	5	igg	igg	PROPN
dpc-1867	383	6	catabolism	catabolism	NOUN
dpc-1867	383	7	is	be	AUX
dpc-1867	383	8	the	the	DET
dpc-1867	383	9	beta2	beta2	PROPN
dpc-1867	383	10	-	-	PUNCT
dpc-1867	383	11	microglobulin	microglobulin	NOUN
dpc-1867	383	12	-	-	PUNCT
dpc-1867	383	13	containing	contain	VERB
dpc-1867	383	14	neonatal	neonatal	ADJ
dpc-1867	383	15	intestinal	intestinal	ADJ
dpc-1867	383	16	transport	transport	NOUN
dpc-1867	383	17	receptor	receptor	NOUN
dpc-1867	383	18	.	.	PUNCT
dpc-1867	384	1	proc	proc	PROPN
dpc-1867	384	2	natl	natl	PROPN
dpc-1867	384	3	acad	acad	PROPN
dpc-1867	384	4	sci	sci	PROPN
dpc-1867	384	5	u	u	PROPN
dpc-1867	384	6	s	s	PART
dpc-1867	384	7	a.	a.	NOUN
dpc-1867	384	8	1996;93(11):55125516	1996;93(11):55125516	NUM
dpc-1867	384	9	.	.	PUNCT
dpc-1867	385	1	doi	doi	NOUN
dpc-1867	385	2	:	:	PUNCT
dpc-1867	385	3	10.1073	10.1073	NUM
dpc-1867	385	4	/	/	SYM
dpc-1867	385	5	pnas.93.11.5512	pnas.93.11.5512	NOUN
dpc-1867	385	6	.	.	PUNCT
dpc-1867	386	1	pmid	pmid	NOUN
dpc-1867	386	2	:	:	PUNCT
dpc-1867	386	3	8643606	8643606	NUM
dpc-1867	386	4	;	;	PUNCT
dpc-1867	386	5	pmcid	pmcid	ADJ
dpc-1867	386	6	:	:	PUNCT
dpc-1867	386	7	pmc39277	pmc39277	NOUN
dpc-1867	386	8	.	.	PUNCT
dpc-1867	387	1	42	42	NUM
dpc-1867	387	2	.	.	PUNCT
dpc-1867	388	1	goebl	goebl	PROPN
dpc-1867	388	2	na	na	PROPN
dpc-1867	388	3	,	,	PUNCT
dpc-1867	388	4	babbey	babbey	VERB
dpc-1867	388	5	cm	cm	PROPN
dpc-1867	388	6	,	,	PUNCT
dpc-1867	388	7	datta	datta	NOUN
dpc-1867	388	8	-	-	PUNCT
dpc-1867	388	9	mannan	mannan	PROPN
dpc-1867	388	10	a	a	PRON
dpc-1867	388	11	,	,	PUNCT
dpc-1867	388	12	witcher	witcher	PROPN
dpc-1867	388	13	dr	dr	PROPN
dpc-1867	388	14	,	,	PUNCT
dpc-1867	388	15	wroblewski	wroblewski	ADJ
dpc-1867	388	16	vj	vj	PROPN
dpc-1867	388	17	,	,	PUNCT
dpc-1867	388	18	dunn	dunn	PROPN
dpc-1867	388	19	kw	kw	PROPN
dpc-1867	388	20	.	.	PUNCT
dpc-1867	389	1	neonatal	neonatal	PROPN
dpc-1867	389	2	fc	fc	PROPN
dpc-1867	389	3	receptor	receptor	NOUN
dpc-1867	389	4	mediates	mediate	VERB
dpc-1867	389	5	internalization	internalization	NOUN
dpc-1867	389	6	of	of	ADP
dpc-1867	389	7	fc	fc	PROPN
dpc-1867	389	8	in	in	ADP
dpc-1867	389	9	transfected	transfecte	VERB
dpc-1867	389	10	human	human	ADJ
dpc-1867	389	11	endothelial	endothelial	NOUN
dpc-1867	389	12	cells	cell	NOUN
dpc-1867	389	13	.	.	PUNCT
dpc-1867	390	1	mol	mol	ADP
dpc-1867	390	2	biol	biol	ADJ
dpc-1867	390	3	cell	cell	NOUN
dpc-1867	390	4	.	.	PUNCT
dpc-1867	391	1	2008;19(12):5490	2008;19(12):5490	NUM
dpc-1867	391	2	-	-	SYM
dpc-1867	391	3	5505	5505	NUM
dpc-1867	391	4	.	.	PUNCT
dpc-1867	392	1	doi	doi	NOUN
dpc-1867	392	2	:	:	PUNCT
dpc-1867	392	3	10.1091	10.1091	NUM
dpc-1867	392	4	/	/	SYM
dpc-1867	392	5	mbc.e07	mbc.e07	NUM
dpc-1867	392	6	-	-	PUNCT
dpc-1867	392	7	02	02	NUM
dpc-1867	392	8	-	-	PUNCT
dpc-1867	392	9	0101	0101	NUM
dpc-1867	392	10	.	.	PUNCT
dpc-1867	393	1	pmid	pmid	NOUN
dpc-1867	393	2	:	:	PUNCT
dpc-1867	393	3	18843053	18843053	NUM
dpc-1867	393	4	;	;	PUNCT
dpc-1867	393	5	pmcid	pmcid	ADJ
dpc-1867	393	6	:	:	PUNCT
dpc-1867	393	7	pmc2592658	pmc2592658	NOUN
dpc-1867	393	8	.	.	PUNCT
dpc-1867	394	1	43	43	NUM
dpc-1867	394	2	.	.	PUNCT
dpc-1867	395	1	ward	ward	PROPN
dpc-1867	395	2	es	es	PROPN
dpc-1867	395	3	,	,	PUNCT
dpc-1867	395	4	ober	ober	PROPN
dpc-1867	395	5	rj	rj	PROPN
dpc-1867	395	6	.	.	PUNCT
dpc-1867	395	7	targeting	target	VERB
dpc-1867	395	8	fcrn	fcrn	NOUN
dpc-1867	395	9	to	to	PART
dpc-1867	395	10	generate	generate	VERB
dpc-1867	395	11	antibody	antibody	NOUN
dpc-1867	395	12	-	-	PUNCT
dpc-1867	395	13	based	base	VERB
dpc-1867	395	14	therapeutics	therapeutic	NOUN
dpc-1867	395	15	.	.	PUNCT
dpc-1867	396	1	trends	trend	NOUN
dpc-1867	396	2	pharmacol	pharmacol	PROPN
dpc-1867	396	3	sci	sci	PROPN
dpc-1867	396	4	.	.	PUNCT
dpc-1867	397	1	2018;39(10):892	2018;39(10):892	PROPN
dpc-1867	397	2	-	-	PUNCT
dpc-1867	397	3	904	904	NUM
dpc-1867	397	4	.	.	PUNCT
dpc-1867	398	1	doi	doi	NOUN
dpc-1867	398	2	:	:	PUNCT
dpc-1867	398	3	10.1016	10.1016	NUM
dpc-1867	398	4	/	/	SYM
dpc-1867	398	5	j.tips.2018.07.007	j.tips.2018.07.007	PROPN
dpc-1867	398	6	.	.	PUNCT
dpc-1867	399	1	pmid	pmid	NOUN
dpc-1867	399	2	:	:	PUNCT
dpc-1867	399	3	30143244	30143244	NUM
dpc-1867	399	4	;	;	PUNCT
dpc-1867	399	5	pmcid	pmcid	NOUN
dpc-1867	399	6	:	:	PUNCT
dpc-1867	399	7	pmc6169532	pmc6169532	NOUN
dpc-1867	399	8	.	.	PUNCT
dpc-1867	400	1	44	44	NUM
dpc-1867	400	2	.	.	PUNCT
dpc-1867	401	1	li	li	PROPN
dpc-1867	401	2	n	n	CCONJ
dpc-1867	401	3	,	,	PUNCT
dpc-1867	401	4	zhao	zhao	PROPN
dpc-1867	401	5	m	m	PROPN
dpc-1867	401	6	,	,	PUNCT
dpc-1867	401	7	hilario	hilario	PROPN
dpc-1867	401	8	-	-	PUNCT
dpc-1867	401	9	vargas	vargas	PROPN
dpc-1867	401	10	j	j	PROPN
dpc-1867	401	11	,	,	PUNCT
dpc-1867	401	12	et	et	PROPN
dpc-1867	401	13	al	al	PROPN
dpc-1867	401	14	.	.	PROPN
dpc-1867	401	15	complete	complete	ADJ
dpc-1867	401	16	fcrn	fcrn	NOUN
dpc-1867	401	17	dependence	dependence	NOUN
dpc-1867	401	18	for	for	ADP
dpc-1867	401	19	intravenous	intravenous	ADJ
dpc-1867	401	20	ig	ig	PROPN
dpc-1867	401	21	therapy	therapy	NOUN
dpc-1867	401	22	in	in	ADP
dpc-1867	401	23	autoimmune	autoimmune	ADJ
dpc-1867	401	24	skin	skin	NOUN
dpc-1867	401	25	blistering	blister	VERB
dpc-1867	401	26	diseases	disease	NOUN
dpc-1867	401	27	.	.	PUNCT
dpc-1867	402	1	j	j	PROPN
dpc-1867	402	2	clin	clin	PROPN
dpc-1867	402	3	invest	invest	PROPN
dpc-1867	402	4	.	.	PUNCT
dpc-1867	403	1	2005;115(12):3440	2005;115(12):3440	NUM
dpc-1867	403	2	-	-	SYM
dpc-1867	403	3	3450	3450	NUM
dpc-1867	403	4	.	.	PUNCT
dpc-1867	404	1	doi	doi	NOUN
dpc-1867	404	2	:	:	PUNCT
dpc-1867	404	3	10.1172	10.1172	NUM
dpc-1867	404	4	/	/	SYM
dpc-1867	404	5	jci24394	jci24394	NOUN
dpc-1867	404	6	.	.	PUNCT
dpc-1867	405	1	pmid	pmid	NOUN
dpc-1867	405	2	:	:	PUNCT
dpc-1867	405	3	16284651	16284651	NUM
dpc-1867	405	4	;	;	PUNCT
dpc-1867	405	5	pmcid	pmcid	ADJ
dpc-1867	405	6	:	:	PUNCT
dpc-1867	405	7	pmc1280965	pmc1280965	NOUN
dpc-1867	405	8	.	.	PUNCT
dpc-1867	406	1	45	45	NUM
dpc-1867	406	2	.	.	PUNCT
dpc-1867	407	1	chen	chen	PROPN
dpc-1867	407	2	y	y	PROPN
dpc-1867	407	3	,	,	PUNCT
dpc-1867	407	4	chernyavsky	chernyavsky	ADV
dpc-1867	407	5	a	a	X
dpc-1867	407	6	,	,	PUNCT
dpc-1867	407	7	webber	webber	PROPN
dpc-1867	407	8	rj	rj	PROPN
dpc-1867	407	9	,	,	PUNCT
dpc-1867	407	10	grando	grando	PROPN
dpc-1867	407	11	sa	sa	PROPN
dpc-1867	407	12	,	,	PUNCT
dpc-1867	407	13	wang	wang	PROPN
dpc-1867	407	14	ph	ph	PROPN
dpc-1867	407	15	.	.	PROPN
dpc-1867	407	16	critical	critical	ADJ
dpc-1867	407	17	role	role	NOUN
dpc-1867	407	18	of	of	ADP
dpc-1867	407	19	the	the	DET
dpc-1867	407	20	neonatal	neonatal	ADJ
dpc-1867	407	21	fc	fc	PROPN
dpc-1867	407	22	receptor	receptor	NOUN
dpc-1867	407	23	(	(	PUNCT
dpc-1867	407	24	fcrn	fcrn	PROPN
dpc-1867	407	25	)	)	PUNCT
dpc-1867	407	26	in	in	ADP
dpc-1867	407	27	the	the	DET
dpc-1867	407	28	pathogenic	pathogenic	ADJ
dpc-1867	407	29	action	action	NOUN
dpc-1867	407	30	of	of	ADP
dpc-1867	407	31	antimitochondrial	antimitochondrial	ADJ
dpc-1867	407	32	autoantibodies	autoantibody	NOUN
dpc-1867	407	33	synergizing	synergize	VERB
dpc-1867	407	34	with	with	ADP
dpc-1867	407	35	anti	anti	ADJ
dpc-1867	407	36	-	-	ADJ
dpc-1867	407	37	desmoglein	desmoglein	ADJ
dpc-1867	407	38	autoantibodies	autoantibody	NOUN
dpc-1867	407	39	in	in	ADP
dpc-1867	407	40	pemphigus	pemphigus	NOUN
dpc-1867	407	41	vulgaris	vulgaris	NOUN
dpc-1867	407	42	.	.	PUNCT
dpc-1867	408	1	j	j	PROPN
dpc-1867	408	2	biol	biol	PROPN
dpc-1867	408	3	chem	chem	NOUN
dpc-1867	408	4	.	.	PUNCT
dpc-1867	409	1	2015;290(39):23826	2015;290(39):23826	NUM
dpc-1867	409	2	-	-	NOUN
dpc-1867	409	3	23837	23837	NUM
dpc-1867	409	4	.	.	PUNCT
dpc-1867	410	1	doi	doi	NOUN
dpc-1867	410	2	:	:	PUNCT
dpc-1867	410	3	10.1074	10.1074	NUM
dpc-1867	410	4	/	/	SYM
dpc-1867	410	5	jbc.m115.668061	jbc.m115.668061	NOUN
dpc-1867	410	6	.	.	PUNCT
dpc-1867	411	1	pmid	pmid	NOUN
dpc-1867	411	2	:	:	PUNCT
dpc-1867	411	3	26260795	26260795	NUM
dpc-1867	411	4	;	;	PUNCT
dpc-1867	411	5	pmcid	pmcid	ADJ
dpc-1867	411	6	:	:	PUNCT
dpc-1867	411	7	pmc4583029	pmc4583029	NOUN
dpc-1867	411	8	.	.	PUNCT
dpc-1867	412	1	46	46	NUM
dpc-1867	412	2	.	.	PUNCT
dpc-1867	413	1	ulrichts	ulricht	NOUN
dpc-1867	413	2	p	p	NOUN
dpc-1867	413	3	,	,	PUNCT
dpc-1867	413	4	guglietta	guglietta	VERB
dpc-1867	413	5	a	a	DET
dpc-1867	413	6	,	,	PUNCT
dpc-1867	413	7	dreier	dreier	PROPN
dpc-1867	413	8	t	t	PROPN
dpc-1867	413	9	,	,	PUNCT
dpc-1867	413	10	et	et	PROPN
dpc-1867	414	1	al	al	PROPN
dpc-1867	414	2	.	.	PROPN
dpc-1867	414	3	neonatal	neonatal	PROPN
dpc-1867	414	4	fc	fc	PROPN
dpc-1867	414	5	receptor	receptor	NOUN
dpc-1867	414	6	antagonist	antagonist	NOUN
dpc-1867	414	7	efgartigimod	efgartigimod	NOUN
dpc-1867	414	8	safely	safely	ADV
dpc-1867	414	9	and	and	CCONJ
dpc-1867	414	10	sustainably	sustainably	ADV
dpc-1867	414	11	reduces	reduce	VERB
dpc-1867	414	12	iggs	igg	NOUN
dpc-1867	414	13	in	in	ADP
dpc-1867	414	14	humans	human	NOUN
dpc-1867	414	15	.	.	PUNCT
dpc-1867	415	1	j	j	PROPN
dpc-1867	415	2	clin	clin	PROPN
dpc-1867	415	3	invest	invest	PROPN
dpc-1867	415	4	.	.	PUNCT
dpc-1867	416	1	2018;128(10):4372	2018;128(10):4372	NUM
dpc-1867	416	2	-	-	SYM
dpc-1867	416	3	4386	4386	NUM
dpc-1867	416	4	.	.	PUNCT
dpc-1867	417	1	doi	doi	NOUN
dpc-1867	417	2	:	:	PUNCT
dpc-1867	417	3	10.1172	10.1172	NUM
dpc-1867	417	4	/	/	SYM
dpc-1867	417	5	jci97911	jci97911	NOUN
dpc-1867	417	6	.	.	PUNCT
dpc-1867	418	1	pmid	pmid	NOUN
dpc-1867	418	2	:	:	PUNCT
dpc-1867	418	3	30040076	30040076	NUM
dpc-1867	418	4	;	;	PUNCT
dpc-1867	418	5	pmcid	pmcid	ADJ
dpc-1867	418	6	:	:	PUNCT
dpc-1867	418	7	pmc6159959	pmc6159959	NOUN
dpc-1867	418	8	.	.	PUNCT